10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

or

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-35064

EMERGENT CAPITAL, INC.

(Exact name of registrant as specified in its charter)

Florida	30-0663473
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

5355 Town Center Road—Suite 701

Boca Raton, Florida 33486

(Address of principal executive offices, including zip code)

(561) 995-4200

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	ý
Non-accelerated filer	¨ (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý

As of November 9, 2015, the Registrant had 28,130,508 shares of common stock outstanding.

EMERGENT CAPITAL, INC.

FORM 10-Q REPORT FOR THE QUARTER ENDED September 30, 2015

TABLE OF CONTENTS

	Page No.
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)	5
Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014	5
Consolidated Statements of Operations for the three months and nine months ended September 30, 2015 and 2014	6
Consolidated Statement of Stockholders’ Equity for the nine months ended September 30, 2015	7
Consolidated Statements of Cash Flows for the nine months ended September 30, 2015 and 2014	8
Notes to Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	34
Item 3. Quantitative and Qualitative Disclosures About Market Risk	46
Item 4. Controls and Procedures	47
PART II — OTHER INFORMATION
Item 1. Litigation	48
Item 1A. Risk Factors	48
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 3. Defaults Upon Senior Securities	48
Item 4. Mine Safety Disclosures	48
Item 5. Other Information	48
Item 6. Exhibits	49

“Forward Looking” Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry and Company, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although we believe that the expectations reflected in such forward-looking statements are reasonable as of the date made, results may prove to be materially different. Unless otherwise required by law, we disclaim any obligation to update our view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this report.

Factors that could cause our actual results to differ materially from those indicated in our forward-looking statements include, but are not limited to, the following:

• our ability to obtain financing on favorable terms or at all;

• our ability to receive distributions from policy proceeds from life insurance policies pledged as collateral under our revolving credit facilities;

• our ability to meet our debt service obligations;

• continuing costs associated with indemnification and cooperation obligations related to the investigation into our legacy premium finance business by the United States Attorneys’ Office for the District of New Hampshire (“USAO”) (the “USAO Investigation”), an investigation by the U.S. Securities and Exchange Commission (“SEC”) (the “SEC Investigation”) and an investigation by the Internal Revenue Services (“IRS”) (the “IRS Investigation”);

• cost and delays in the receipt of death benefits from our portfolio of life insurance policies;

• costs related to obtaining death benefits from our portfolio of life insurance policies;

• our ability to continue to comply with the covenants and other obligations, including the conditions precedent for additional fundings under our revolving credit facilities;

• changes in general economic conditions, including inflation, changes in interest or tax rates and other factors;

• our results of operations;

• our ability to continue to make premium payments on the life insurance policies that we own;

adverse developments, including financial ones, associated with the USAO Investigation, the SEC Investigation and the IRS Investigation, other litigation and judicial actions or similar matters;

• inaccurate estimates regarding the likelihood and magnitude of death benefits related to life insurance policies that we own;

• increases in premiums on life insurance policies that we own;

• lack of mortalities of insureds of the life insurance policies that we own;

• increases to the discount rates used to value the life insurance policies that we own;

• changes in mortality rates and inaccurate assumptions about life expectancies;

• changes in life expectancy calculation methodologies by third party medical underwriters;

• changes to actuarial life expectancy tables;

• the effect on our financial condition as a result of any lapse of life insurance policies;

• loss of business due to, or litigation arising from, the non-prosecution agreement executed in connection with the USAO Investigation, the SEC Investigation, the IRS Investigation or otherwise;

3

• our ability to sell the life insurance policies we own at favorable prices, if at all;

• adverse developments in capital markets;

• deterioration of the market for life insurance policies and life settlements;

• increased carrier challenges to the validity of our owned life insurance policies;

• adverse court decisions regarding insurable interest and the obligation of a life insurance carrier to pay death benefits or return premiums;

• challenges to the ownership of the life insurance policies in our portfolio;

• changes in laws and regulations;

• deterioration in the credit worthiness of the life insurance companies that issue the policies included in our portfolio;

• regulation of life settlement transactions as securities;

• liabilities associated with our legacy structured settlement business;

• our failure to maintain the security of personally identifiable information pertaining to insureds and counterparties;

• disruption or breaches of our information technology systems;

• loss of the services of any of our executive officers; and

• the effects of United States involvement in hostilities with other countries and large-scale acts of terrorism, or the threat of hostilities or terrorist acts; and other factors.

All forward-looking statements are expressly qualified in their entirety by these cautionary statements. See “Risk Factors” included in this Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2014. You should evaluate all forward-looking statements made in this Form 10-Q in the context of these risks and uncertainties. The Company cautions you that the important factors referenced above may not contain all of the factors that are important to you.

As used in this Form 10-Q, “Emergent Capital,” “Company,” “we,” “us,” “its,” or “our” refer to Emergent Capital, Inc. and its consolidated subsidiary companies, unless the context suggests otherwise.

4

Item 1        Financial Statements

Emergent Capital, Inc.

CONSOLIDATED BALANCE SHEETS

	September 30, 2015			December 31, 2014*
	(Unaudited)
	(In thousands except share data)
ASSETS
Assets
Cash and cash equivalents	$	31,260		$	51,166
Cash and cash equivalents (VIE Note 4)	9,157			3,751
Prepaid expenses and other assets	1,527			1,502
Deposits - other	1,347			1,340
Deposits on purchases of life settlements	—			1,630
Structured settlement receivables, at estimated fair value	—			384
Structured settlement receivables at cost, net	—			597
Life settlements, at estimated fair value	13,023			82,575
Life settlements, at estimated fair value (VIE Note 4)	444,787			306,311
Receivable for maturity of life settlements (VIE Note 4)	10,088			4,000
Fixed assets, net	335			355
Investment in affiliates	2,384			2,384
Deferred debt costs, net	1,907			3,936
Total assets	$	515,815		$	459,931
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Accounts payable and accrued expenses	$	4,817		$	6,140
Accounts payable and accrued expenses (VIE Note 4)	388			423
Other liabilities	419			1,256
Interest payable - Convertible Notes (Note 11)	768			2,272
Convertible Notes, net of discount (Note 11)	57,867			55,881
Interest payable - Secured Notes (Note 12)	—			261
Secured Notes, net of discount (Note 12)	—			24,036
White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 4)	157,946			145,831
Red Falcon Revolving Credit Facility, at estimated fair value (VIE Note 4)	55,685			—
Deferred tax liability	1,524			8,728
Total liabilities	279,414			244,828
Commitments and Contingencies (Note 15)
Stockholders’ Equity
Common stock (par value $0.01 per share, 80,000,000 authorized; 28,130,508 and 21,402,990 issued and outstanding as of September 30, 2015 and December 31, 2014, respectively)	281			214
Preferred stock (par value $0.01 per share, 40,000,000 authorized; 0 issued and outstanding as of September 30, 2015 and December 31, 2014)	—			—
Treasury Stock, net of cost (65,621 and 0 shares as of September 30, 2015 and December 31, 2014, respectively)	(348		)	—
Additional paid-in-capital	305,389			266,705
Accumulated deficit	(68,921		)	(51,816		)
Total stockholders’ equity	236,401			215,103
Total liabilities and stockholders’ equity	$	515,815		$	459,931

*    Derived from audited consolidated financial statements.

The accompanying notes are an integral part of these financial statements.

5

Emergent Capital, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2015			2014			2015			2014
	(in thousands, except share and per share data)
Income
Interest income	$	7		$	9		$	16		$	22
Loss on life settlements, net	—			—			—			(426		)
Change in fair value of life settlements (Notes 8 & 13)	2,667			(3,643		)	43,582			19,313
Other income	95			17			185			72
Total income (loss)	2,769			(3,617		)	43,783			18,981
Expenses
Interest expense	8,614			4,303			21,491			11,165
Extinguishment of Secured Notes	8,782			—			8,782			—
Change in fair value of Revolving Credit Facilities (Notes 9, 10 & 13)	(4,203		)	(8,375		)	13,489			(4,556		)
Change in fair value of conversion derivative liability (Notes 11 & 13)	—			—			—			6,759
Personnel costs	1,945			1,910			5,425			6,627
Legal fees	3,370			2,943			10,345			9,121
Professional fees	1,579			1,143			5,284			3,562
Insurance	309			414			966			1,253
Other selling, general and administrative expenses	585			544			1,671			1,365
Total expenses	20,981			2,882			67,453			35,296
Income (loss) from continuing operations before income taxes	(18,212		)	(6,499		)	(23,670		)	(16,315		)
Benefit for income taxes	4,721			2,235			6,981			2,452
Net income (loss) from continuing operations	$	(13,491	)	$	(4,264	)	$	(16,689	)	$	(13,863	)
Discontinued Operations:
Income (loss) from discontinued operations	(147		)	(249		)	(640		)	(454		)
Benefit for income taxes	34			—			224			—
Net income (loss) from discontinued operations	(113		)	(249		)	(416		)	(454		)
Net income (loss)	$	(13,604	)	$	(4,513	)	$	(17,105	)	$	(14,317	)
Basic and diluted income (loss) per share:
Continuing operations	$	(0.48	)	$	(0.20	)	$	(0.70	)	$	(0.65	)
Discontinued operations	$	—		$	(0.01	)	$	(0.02	)	$	(0.02	)
Net income (loss)	$	(0.48	)	$	(0.21	)	$	(0.72	)	$	(0.67	)
Weighted average shares outstanding:
Basic and diluted	28,084,254			21,361,930			23,827,030			21,352,086

The accompanying notes are an integral part of these financial statements.

6

Emergent Capital, Inc.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

For the Nine Months EndedSeptember 30, 2015

	Common Stock				Treasury Stock				Additional Paid-in Capital			Accumulated Deficit			Total
	Shares		Amount		Shares	Amount
	(in thousands, except share data)
Balance, January 1, 2015	21,402,990		$	214	—	$	—		$	266,705		$	(51,816	)	$	215,103
Net income (loss)	—		—		—	—			—			(17,105		)	(17,105		)
Stock-based compensation	41,259		—		—	—			429			—			429
Purchase of treasury stock, net of costs	—		—		65,621	(348		)	—			—			(348		)
Common stock issued for rights offering, net of costs	6,688,433		67		—	—			38,267			—			38,334
Retirement of common stock	(2,174	)	—		—	—			(12		)	—			(12		)
Balance, September 30, 2015	28,130,508		281		65,621	(348		)	305,389			(68,921		)	236,401

The accompanying notes are an integral part of these financial statements.

7

Emergent Capital, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	For the Nine Months Ended September 30,
	2015			2014
	(In thousands)
Cash flows from operating activities
Net income (loss)	$	(17,105	)	$	(14,317	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	74			59
Red Falcon Revolving Credit Facility origination cost	3,273			—
White Eagle Revolving Credit Facility financing cost and fees	5,566			4,238
Amortization of discount and deferred costs for Convertible Notes	2,281			1,648
Amortization of discount and deferred costs for Secured Notes	542			—
Stock-based compensation expense	429			762
Change in fair value of life settlements	(43,582		)	(19,313		)
Unrealized change in fair value of structured settlements	(20		)	(24		)
Loss on sale of structured settlements	(32		)	—
Change in fair value of Revolving Credit Facilities	13,489			(4,556		)
Loss on life settlements, net	—			426
Interest income	(81		)	(102		)
Extinguishment of Secured Notes	8,782			—
Change in fair value of conversion derivative liability	—			6,759
Deferred income tax	(7,205		)	(2,452		)
Change in assets and liabilities:
Restricted cash	—			13,506
Deposits - other	(654		)	243
Investment in affiliates	—			(7		)
Structured settlement receivables	1,097			578
Prepaid expenses and other assets	(188		)	(413		)
Accounts payable and accrued expenses	(1,491		)	2,512
Other liabilities	(812		)	(14,301		)
Interest payable - Convertible Notes	(1,503		)	768
Interest payable - Secured Notes	(261		)	—
Net cash used in operating activities	(37,401		)	(23,986		)
Cash flows from investing activities
Purchase of fixed assets, net of disposals	(47		)	(178		)
Purchase of life settlements	(28,904		)	(3,488		)
Premiums paid on life settlements	(48,243		)	(40,578		)
Proceeds from sale of life settlements, net	—			4,031
Proceeds from maturity of life settlements	47,519			13,641
Deposits on purchase of life settlements	—			(50		)
Net cash used in investing activities	(29,675		)	(26,622		)
Cash flows from financing activities
Borrowings from White Eagle Revolving Credit Facility	36,880			36,004
Repayment of borrowings under White Eagle Revolving Credit Facility	(43,241		)	(17,595		)
Borrowings under Red Falcon Revolving Credit Facility	2,967			—
Repayment of borrowings under Red Falcon Revolving Credit Facility	(1,863		)	—
Proceeds from Convertible Notes, net	—			67,892
Proceeds from rights offering	38,458			—
Proceeds from Secured Notes, net	23,750			—
Purchase of treasury stock	(348		)	—
Payment under finance lease obligations	(25		)	—
Extinguishment of Secured Notes	(3,570		)	—
Red Falcon Revolving Credit Facility origination costs	(427		)	—
Secured Notes deferred costs	(5		)	—
Net cash provided by financing activities	52,576			86,301
Net decrease/increase in cash and cash equivalents	(14,500		)	35,693
Cash and cash equivalents, at beginning of the period	54,917			22,699
Cash and cash equivalents, at end of the period	$	40,417		$	58,392
Supplemental disclosures of cash flow information:
Cash paid for interest during the period	$	12,143		$	4,496
Supplemental disclosures of non-cash financing activities:
Interest payment and fees withheld from borrowings by lender	$	5,566		$	4,962
Red Falcon Revolving Credit Facility origination cost paid to lender	$	2,200		—
Repayment of Secured Notes by lender of Red Falcon Revolving Credit Facility	$	51,800		—
Borrowings under Red Falcon Revolving Credit Facility	$	54,000		—

The accompanying notes are an integral part of these financial statements.

8

Emergent Capital, Inc.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

September 30, 2015

(1) Description of Business

Founded in December 2006 as a Florida limited liability company, Imperial Holdings, LLC, converted into Imperial Holdings, Inc. on February 3, 2011, in connection with the Company’s initial public offering. Effective September 1, 2015, the Company changed its name to Emergent Capital, Inc. (with its subsidiary companies, the “Company” or “Emergent Capital”).

Incorporated in Florida, Emergent Capital, through its subsidiary companies, owns a portfolio of 634 life insurance policies, also referred to as life settlements, with a fair value of $457.8 million and an aggregate death benefit of approximately $3.0 billion at September 30, 2015. The Company primarily earns income on these policies from changes in their fair value and through death benefits. 439 of these policies, with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million at September 30, 2015 are pledged under a $300.0 million, revolving credit agreement (the “White Eagle Revolving Credit Facility”) entered into by the Company’s indirect subsidiary, White Eagle Asset Portfolio, LP (“White Eagle”). Additionally, 157 policies, with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million at September 30, 2015 were pledged as collateral under a $110.0 million, revolving credit agreement (the “Red Falcon Revolving Credit Facility” and, together with the White Eagle Revolving Credit Facility, the "Revolving Credit Facilities") entered into by Red Falcon Trust (“Red Falcon”), a Delaware statutory trust formed by a wholly-owned Irish subsidiary of the Company.

(2) Principles of Consolidation and Basis of Presentation

The accompanying consolidated financial statements include the accounts of the Company, all of its wholly-owned subsidiary companies and its special purpose entities, with the exception of Imperial Settlements Financing 2010, LLC (“ISF 2010”), an unconsolidated special purpose entity which is accounted for using the cost method of accounting. The special purpose entity has been created to fulfill specific objectives. All significant intercompany balances and transactions have been eliminated in consolidation, including income from services performed by subsidiary companies in connection with the Revolving Credit Facilities. Notwithstanding consolidation, as referenced above, White Eagle is the owner of 439 policies, with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million and Red Falcon is the owner of 157 policies with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million, in each case, at September 30, 2015.

The unaudited consolidated financial statements have been prepared in conformity with the rules and regulations of the SEC for Form 10-Q and therefore do not include certain information, accounting policies, and footnote disclosures information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. However, all adjustments (consisting of normal recurring accruals), which, in the opinion of management, are necessary for a fair presentation of the financial statements, have been included. Operating results for the three months and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for future periods or for the year ended December 31, 2015. These interim financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in Emergent Capital's Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Discontinued Operations

On October 25, 2013, the Company sold substantially all of the assets comprising its structured settlement business for $12.0 million. As a result, the Company has discontinued segment reporting and classified its operating results of the structured settlement business as discontinued operations. The accompanying consolidated balance sheets of the Company as of September 30, 2015 and December 31, 2014, and the related consolidated statements of operations for each of the three months and nine months ended September 30, 2015 and 2014, and the related notes to the consolidated financial statements reflect the classification of its structured settlement business operating results as discontinued operations. See Note 7, “Discontinued Operations,” for further information. Unless otherwise noted, the following notes refer to the Company’s continuing operations.

9

Derivative Instrument

In February 2014, the Company issued and sold $70.7 million in aggregate principal amount of 8.50% senior unsecured convertible notes due 2019 (the “Convertible Notes”). Prior to shareholder approval on June 5, 2014 to issue shares of common stock upon conversion of the Convertible Notes in excess of New York Stock Exchange limits for share issuances without shareholder approval, the Convertible Notes contained an embedded derivative feature. In accordance with Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, derivative instruments are recognized as either assets or liabilities on the Company’s balance sheet and are measured at fair value with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract, such as the Convertible Notes, are bifurcated and recognized at fair value with changes in fair value recognized as either a gain or loss in earnings if they can be reliably measured. The Company determined the fair value of its embedded derivative based upon available market data and unobservable inputs using a Black Scholes pricing model. In accordance with ASC 815, upon receipt of shareholder approval on June 5, 2014, the Company reclassified the embedded derivative to equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity. See Note 11, "8.50% Senior Unsecured Convertible Notes."

Foreign Currency

The Company owns certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to the Company’s financial statements.

Use of Estimates

The preparation of these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material. Significant estimates made by management include income taxes, the valuation of life settlements, the valuation of the debt owing under the Revolving Credit Facilities, the valuation of equity awards and the valuation of the conversion derivative liability formerly embedded within the Company’s Convertible Notes.

(3) Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (‘FASB’) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB and the International Accounting Standards Board standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

In August 2014, the FASB issued ASU No. 2014-15, “Disclosures of Uncertainties About an Entity’s Ability to Continue as a Going Concern.” The standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis.” This guidance focuses on a reporting company’s consolidation evaluation to determine whether they should consolidate certain legal entities. This guidance is effective for annual periods beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the effect that this pronouncement will have on its consolidated financial statements, but does not anticipate it will be material.

10

In April 2015, the FASB issued ASU No. 2015-03, “Interest—Imputation of Interest (Subtopic 835-30).” This standard provides guidance on the balance sheet presentation for debt issuance costs and debt discounts and debt premiums. To simplify the presentation of debt issuance costs, this standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. This ASU is effective for fiscal years beginning after December 15, 2015. The Company does not expect that this guidance will have a material impact on its consolidated financial statements.

(4) Consolidation of Variable Interest Entities

The Company evaluates its interests in variable interest entities (“VIEs”) on an ongoing basis and consolidates those VIEs in which it has a controlling financial interest and is thus deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.

The following table presents the consolidated assets and consolidated liabilities of VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated in the Company’s financial statements as of September 30, 2015 as well as non-consolidated VIEs for which the Company has determined it is not the primary beneficiary (in thousands):

	Primary Beneficiary				Not Primary Beneficiary
	Consolidated VIEs				Non-consolidated VIEs
	Assets		Liabilities		Total Assets		Maximum Exposure To Loss
September 30, 2015	$	464,032	$	214,019	$	2,384	$	2,384
December 31, 2014	$	314,062	$	146,254	$	2,384	$	2,384

As of September 30, 2015, 439 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million were pledged as collateral under the White Eagle Revolving Credit Facility. In accordance with ASC 810, Consolidation, the Company consolidated White Eagle in its financial statements for the three months and nine months ended September 30, 2015 and 2014, and the year ended December 31, 2014.

As of September 30, 2015, 157 life insurance policies owned by Red Falcon with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million were pledged as collateral under the Red Falcon Revolving Credit Facility. In accordance with ASC 810, Consolidation, the Company consolidated Red Falcon in its financial statements for the three months and nine months ended September 30, 2015.

(5) Earnings Per Share

As of September 30, 2015 and 2014, there were 28,130,508 and 21,402,990 issued and outstanding shares of common stock, respectively.

Basic net income per share is computed by dividing the net earnings attributable to common shareholders by the weighted average number of common shares outstanding during the period.

Diluted earnings per share is computed by dividing net income, adjusted to include expenses recognized associated with convertible debt, attributable to common shareholders by the weighted average number of common shares outstanding, increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. Conversion or exercise of the potential common shares is not reflected in diluted earnings per share unless the effect is dilutive. The dilutive effect, if any, of outstanding common share equivalents is reflected in diluted earnings per share by application of the treasury stock method and if-converted method, as applicable.

11

The following tables reconcile actual basic and diluted earnings per share for the three months and nine months ended September 30, 2015 and 2014 (in thousands except share and per share data).

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2015(1)			2014(2)			2015(1)			2014(2)
Income (loss) per share:
Numerator:
Net income (loss) from continuing operations	$	(13,491	)	$	(4,264	)	$	(16,689	)	$	(13,863	)
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)
Net income (loss)	$	(13,604	)	$	(4,513	)	$	(17,105	)	$	(14,317	)
Basic and diluted income (loss) per common share:
Basic and diluted income (loss) from continuing operations	$	(0.48	)	$	(0.20	)	$	(0.70	)	$	(0.65	)
Basic and diluted income (loss) from discontinued operations	$	—		$	(0.01	)	$	(0.02	)	$	(0.02	)
Basic and diluted income (loss) per share available to common shareholders	$	(0.48	)	$	(0.21	)	$	(0.72	)	$	(0.67	)
Denominator:
Basic and diluted	28,084,254			21,361,930			23,827,030			21,352,086

(1) The computation of diluted EPS does not include 41,259 shares of restricted stock, 774,394 options, 6,240,521 warrants up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes and 323,500 performance shares, as the effect of their inclusion would have been anti-dilutive.

(2) The computation of diluted EPS did not include 815,448 options, 6,240,521 warrants, 41,060 shares of restricted stock, up to 10,464,491 shares of underlying common stock issuable upon conversion of the Convertible Notes and 299,500 performance shares for the three months and nine months ended September 30, 2014, as the effect of their inclusion would have been anti-dilutive.

(6) Stock-based Compensation

On May 28, 2015, the Company amended and restated its 2010 Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”). Awards under the Omnibus Plan may consist of incentive awards, stock options, stock appreciation rights, performance shares, performance units, and shares of common stock, restricted stock, restricted stock units or other stock-based awards as determined by the compensation committee. The Omnibus Plan provides for an aggregate of 2,700,000 shares of common stock to be reserved for issuance under the Omnibus Plan, subject to adjustment as provided in the Omnibus Plan.

The Company recognized approximately $0 and $140,000 in stock-based compensation expense relating to stock options during the three months ended September 30, 2015 and 2014, respectively, and approximately $237,000 and $632,000 during the nine months ended September 30, 2015 and 2014, respectively. The Company incurred additional stock-based compensation expense of approximately $61,000 relating to restricted stock granted to its board of directors during the three months ended September 30, 2015 and 2014, respectively, and approximately $192,000 and $130,000 during the nine months ended September 30, 2015 and 2014, respectively. During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan at the Company’s 2015 annual meeting, which was obtained on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance, as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0 –150% of the target performance shares. The Company evaluates on a quarterly basis whether it is probable that the Company’s financial performance conditions will be achieved. At September 30, 2015 and 2014, the Company determined that it was not probable that the performance conditions would be achieved and as a result, no related expense was recognized for the three months and nine months ended September 30, 2015 and 2014, respectively.

12

Options

As of September 30, 2015, options to purchase 774,394 shares of common stock were outstanding and unexercised under the Omnibus Plan at a weighted average exercise price of $8.50 per share. The following table presents the activity of the Company’s outstanding stock options of common stock for the nine months ended September 30, 2015:

Common Stock Options	Number of Shares		Weighted Average Price per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Options outstanding, January 1, 2015	807,949		$	8.50	4.48	—
Options granted	—					—
Options exercised	—					—
Options forfeited	(33,555	)	$	8.50	—	—
Options expired	—					—
Options outstanding, September 30, 2015	774,394		$	8.50	3.73	—
Exercisable at September 30, 2015	774,394		$	8.50	3.73	—
Unvested at September 30, 2015	—		—		—	—

As of September 30, 2015, all outstanding stock options had an exercise price above the fair market value of the common stock on that date. During the three months ended September 30, 2015 and 2014, the Company recognized expense of $0 and $140,000, respectively, related to these options and $237,000 and $632,000 during the nine months ended September 30, 2015 and 2014, respectively. There are no remaining unamortized amounts to be recognized on these options.

Restricted Stock

17,286 shares of restricted stock granted to the Company’s directors under the Omnibus Plan vested during the nine months ended September 30, 2014. The fair value of the vested restricted stock was valued at approximately $120,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company expensed approximately $0 and $52,000 in stock based compensation related to the 17,286 shares of restricted stock during the three months and nine months ended September 30, 2014, respectively.

Under the Omnibus Plan, 41,060 shares of restricted stock granted to the Company’s directors vested during the nine months ended September 30, 2015. The fair value of the vested restricted stock was valued at approximately $255,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company incurred additional stock-based compensation expense of approximately $61,000 and $78,000 related to these 41,060 shares of restricted stock during the three months and nine months ended September 30, 2014, respectively and approximately $0 and $108,000 during the three months and nine months ended September 30, 2015, respectively.

During the nine months ended September 30, 2015, 41,259 shares of restricted stock were granted to the Company’s directors under the Omnibus Plan, which are subject to a one year vesting period that commenced on the date of grant. The fair value of the unvested restricted stock was valued at approximately $255,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company expensed approximately $61,000 and $83,000 in stock based compensation related to these 41,259 shares of restricted stock during the three months and nine months periods ended September 30, 2015, respectively.

The following table presents the activity of the Company’s unvested shares of restricted stock for the nine months ended September 30, 2015:

Common Unvested Shares	Number of Shares
Outstanding January 1, 2015	41,060
Granted	41,259
Vested	(41,060	)
Forfeited	—
Outstanding September 30, 2015	41,259

13

The aggregate intrinsic value of these awards is $230,000 and the remaining weighted average life of these awards is 0.7 years as of September 30, 2015.

Performance Shares

During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan, which was obtained at the Company’s 2015 annual meeting on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance, as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0 – 150% of the 323,500 shares. At September 30, 2015, the Company determined that it was not probable that the performance conditions would be achieved and no related expense was recognized for the three months and nine months ended September 30, 2015. If issued, the performance shares will be subject to a one year vesting period from the date of issuance.

The following table presents the activity of the Company’s performance share awards for the nine months ended September 30, 2015:

Performance Shares	Number of Shares
Outstanding January 1, 2015	323,500
Awarded	—
Vested	—
Forfeited	—
Outstanding September 30, 2015	323,500

Warrants

On February 11, 2011, three shareholders received warrants that may be exercised for up to a total of 4,240,521 shares of the Company’s common stock at a weighted average exercise price of $14.51 per share. The warrants will expire seven years after the date of issuance and are exercisable as they are fully vested. At September 30, 2015, all 4,240,521 warrants remained outstanding.

In connection with a settlement of class action litigation arising in connection with the USAO Investigation, the Company issued warrants to purchase two million shares of the Company’s stock into an escrow account in April of 2014. The estimated fair value as of the measurement date of such warrants was $5.4 million, which is included in stockholders’ equity. The warrants were distributed in October 2014 and have a five-year term from the date they are distributed to the class participants with an exercise price of $10.75. The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement.

(7) Discontinued Operations

On October 25, 2013, the Company sold substantially all of the operating assets comprising its structured settlement business to Majestic Opco L.L.C for gross proceeds of $12.0 million pursuant to an Asset Purchase Agreement. No structured settlement receivables were sold and no on-balance sheet liabilities were transferred in connection with the sale. This sale resulted in the recognition of a gain of $11.3 million in the fourth quarter of 2013. On August 28, 2015, the Company sold its remaining structured settlement receivables assets for $920,000 to the buyer of its operating assets, an entity to which the Company continues to provide CEO consulting services (with the Company's chief executive officer serving as interim chief executive officer) pursuant to a transition services arrangement.

As a result of the sale of its structured settlements business, the Company reclassified its structured settlement business operating results as discontinued operations in the accompanying Consolidated Statements of Operations for all periods presented and the Company has discontinued segment reporting. All other footnotes in these financial statements that were affected by this reclassification of discontinued operations have been updated accordingly.

14

Operating results related to the Company’s discontinued structured settlement business are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total income (loss)	$	(13	)	$	38		$	60		$	150
Total expenses	(134		)	(287		)	(700		)	(604		)
Income (loss) before income taxes	(147		)	(249		)	(640		)	(454		)
Income tax benefit	34			—			224			—
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)

(8) Life Settlements (Life Insurance Policies)

The Company accounts for policies it acquires using the fair value method in accordance with ASC 325-30-50 Investments—Other—Investment in Insurance Contracts. Under the fair value method, the Company recognizes the initial investment at the purchase price. For policies that were relinquished in satisfaction of premium finance loans at maturity, the initial investment is the loan carrying value. For policies purchased in the secondary or tertiary markets, the initial investment is the amount of cash outlay at the time of purchase. At each reporting period, the Company re-measures the investment at fair value in its entirety and recognizes changes in fair value in the Statements of Operations in the period in which the changes occur.

As of September 30, 2015 and December 31, 2014, the Company owned 634 and 607 policies, respectively, with an aggregate estimated fair value of life settlements of $457.8 million and $388.9 million, respectively.

The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at September 30, 2015 was 10.0 years. The following table describes the Company’s life settlements as of September 30, 2015 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0 - 1	—	$	—	$	—
1 - 2	9	21,516		32,307
2 - 3	20	52,926		95,122
3 - 4	19	29,638		70,309
4 - 5	25	33,129		96,406
Thereafter	561	320,601		2,703,759
Total	634	$	457,810	$	2,997,903

The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at December 31, 2014 was 10.7 years. The following table describes the Company’s life settlements as of December 31, 2014 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0-1	—	$	—	$	—
1-2	4	9,227		12,728
2-3	10	23,202		45,852
3-4	16	29,531		67,735
4-5	19	23,012		65,614
Thereafter	558	303,914		2,739,137
Total	607	$	388,886	$	2,931,066

15

Estimated premiums to be paid for each of the five succeeding fiscal years to keep the life insurance policies in force as of September 30, 2015, are as follows (in thousands):

Remainder of 2015	$	16,292
2016	68,891
2017	75,602
2018	78,260
2019	85,030
Thereafter	1,110,449
	$	1,434,524

The amount of $1.43 billion noted above represents the estimated total future premium payments required to keep the life insurance policies in force during the life expectancies of all the underlying insured lives and does not give effect to projected receipt of death benefits. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differs from the estimated life expectancies.

(9) White Eagle Revolving Credit Facility

Effective April 29, 2013, White Eagle entered into a 15-year revolving credit agreement with LNV Corporation, as initial lender, Imperial Finance & Trading, LLC, as servicer and portfolio manager and CLMG Corp., as administrative agent, providing for up to $300.0 million in borrowings. Proceeds from the initial advance under the facility were used, in part, to retire a bridge facility and to fund a payment to the lender protection insurance provider to release subrogation rights in certain of the policies pledged as collateral for the White Eagle Revolving Credit Facility. On May 16, 2014, White Eagle Asset Portfolio, LLC converted from a Delaware limited liability company to White Eagle Asset Portfolio, LP, a Delaware limited partnership (the “Conversion”) and all of its ownership interests were transferred to an indirect, wholly-owned Irish subsidiary of the Company. In connection with the Conversion, the White Eagle Revolving Credit Facility was amended and restated among White Eagle, as borrower, Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders.

As of September 30, 2015, 439 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility.

General & Security. The White Eagle Revolving Credit Facility provides for an asset-based revolving credit facility backed by White Eagle’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $300.0 million, subject to borrowing base availability. 439 life insurance policies with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility at September 30, 2015. In addition, the equity interests in White Eagle have been pledged under the White Eagle Revolving Credit Facility.

Borrowing Base. Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances to acquire additional pledged policies or that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, plus (iii) 100% of accrued and unpaid interest on borrowings (excluding the rate floor portion described below), plus (iv) 100% of any other fees and expenses funded and to be funded as approved by the required lenders, less (v) any required payments of principal and interest previously distributed and to be distributed through the next distribution date; (B) 75% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 50% of the aggregate face amount of the policies pledged as collateral (excluding certain specified life insurance policies); and (D) the then applicable facility limit. At September 30, 2015, $140.1 million was undrawn and $1.9 million was available to borrow under the White Eagle Revolving Credit Facility.

Amortization & Distributions. Proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. Absent an event of default, after premium payments and fees to service providers, 100% of the remaining proceeds will be directed to pay outstanding interest and principal on the loan, unless the lenders determine otherwise. Generally, after payment of interest and principal, up to $76.1 million in collections

16

from policy proceeds are to be paid to White Eagle, then 50% of the remaining proceeds are to be directed to the lenders with the remainder paid to White Eagle and for any unpaid fees to service providers. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any “catch-up” payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, “catch-up” payments or percentage payments that would go to the lenders as described above.

Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral, to pay debt service (other than a “rate floor” component equal to the greater of LIBOR (or the applicable base rate) and 1.5%), and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders and the use of proceeds from those advances are at the discretion of the lenders.

Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.00% and subject to the rate floor described above. The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5%. The effective rate at September 30, 2015 was 5.5%.

Interest expense for the cash portion of interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. Interest expense on the facility was $2.3 million and $2.1 million, which includes $1.7 million and $1.5 million withheld from borrowings by the lender and $634,000 and $573,000 paid by White Eagle, for the three months ended September 30, 2015 and 2014, respectively. During the nine months ended September 30, 2015 and 2014, interest expense on the facility was $6.9 million and $5.8 million, which includes $5.0 million and $4.2 million withheld from borrowings by the lender and $1.9 million and $1.6 million paid by White Eagle, respectively.

Maturity. The term of the White Eagle Revolving Credit Facility expires April 28, 2028, which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments.

Covenants/Events of Defaults. The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. The White Eagle Revolving Credit Facility does not contain any financial covenants, but does contain certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion.

Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing.

The Company elected to account for the debt under the White Eagle Revolving Credit Facility, which includes the 50% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

17

At September 30, 2015, the fair value of the outstanding debt was $157.9 million and the borrowing base was approximately $161.8 million, including $159.9 million in outstanding principal.

There are no scheduled repayments of principal prior to maturity. Payments are due upon receipt of death benefits and distributed pursuant to the waterfall as described above.

(10) Red Falcon Revolving Credit Facility

Effective July 16, 2015, Red Falcon Trust (“Red Falcon”), a Delaware statutory trust formed by Blue Heron Designated Activity Company (“Blue Heron”), a wholly-owned Irish subsidiary of the Company, entered into a revolving loan and security agreement (together with its ancillary documents, the “Red Falcon Revolving Credit Facility”) with LNV Corporation, as initial lender, the other lenders party thereto from time to time, Imperial Finance & Trading, LLC, as guarantor, Blue Heron as portfolio administrator and CLMG Corp., as administrative agent (the “Agent”).

General & Security. The Red Falcon Revolving Credit Facility provides for a revolving credit facility backed by Red Falcon’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $110.0 million, subject to borrowing base availability. As of September 30, 2015, 157 life insurance policies owned by Red Falcon with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million are pledged as collateral under the Red Falcon Revolving Credit Facility. In connection with the Red Falcon Revolving Credit Facility, the residual interests in Red Falcon have also been pledged.

Borrowing Base & Availability. Revolving credit borrowings are permitted for a five-year period with the loans under the Red Falcon Revolving Credit Facility maturing on July 15, 2022. Borrowing availability under the Red Falcon Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances in respect of newly pledged policies that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, less (iii) any required amortization payments previously distributed and to be distributed through the next distribution date; (B) 60% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 45% of the aggregate face amount of the policies pledged as collateral; and (D) $110.0 million. At September 30, 2015, $54.9 million was undrawn and $110,000 was available to borrow under the Red Falcon Revolving Credit Facility.

Amortization & Distributions. Proceeds from the policies pledged as collateral under the Red Falcon Revolving Credit Facility are distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds are directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the greater of the then outstanding balance of the loan or the initial advance. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds are to be paid to the lenders, which will vary depending on the then loan to value ratio (“LTV”) as follows: (1) if the LTV is equal to or greater than 50%, all remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; (2) if the LTV is less than 50% but greater than or equal to 25%, 65% of the remaining proceeds will be directed the lenders to repay the then outstanding principal balance; or (3) if the LTV is less than 25%, 35% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance. To the extent there are not sufficient remaining proceeds in the waterfall to satisfy the amount of required interest and amortization then due, Red Falcon will pay any such shortfall amount.

Initial Advance and Use of Proceeds. Amounts advanced to Red Falcon following effectiveness of the Red Falcon Revolving Credit Facility were approximately $54.0 million with certain of the proceeds used to pay transaction expenses and to purchase the policies pledged as collateral under the Red Falcon Revolving Credit Facility from certain affiliates of the Company, who then made a distribution to the Company which was used to redeem the Secured Notes; see Note 12. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral, and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders.

Interest. Borrowings under the Red Falcon Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% and subject to a rate floor of 1.0%. The base rate under the Red Falcon Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight

18

federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5%. The effective interest rate at September 30, 2015 was 5.5%.

Interest expense for the cash portion of interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the Red Falcon Revolving Credit Facility. Interest expense on the facility was $3.8 million, which includes $3.2 million relating to the debt issuance cost which was not capitalized as a result of electing the fair value option for valuing this debt, and $601,000 relating to interest payments paid by Red Falcon, for the three months and nine months ended September 30, 2015.

Maturity. The term of the Red Falcon Revolving Credit Facility expires July 15, 2022.

Covenants/Events of Defaults. The Red Falcon Revolving Credit Facility contains covenants and events of default, including those that are customary for asset-based credit facilities of this type and including cross defaults under the servicing, portfolio management and sales agreements entered into in connection with the Red Falcon Revolving Credit Facility, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, Red Falcon and third parties. The Red Falcon Revolving Credit Facility does not contain any financial covenants, but does contain certain tests relating to asset maintenance, performance and valuation with determinations as to the satisfaction of such tests involving determinations made by the lenders with a high degree of discretion.

The Company elected to account for the debt under the Red Falcon Revolving Credit Facility using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

At September 30, 2015, the fair value of the outstanding debt was $55.7 million and the borrowing base was approximately $55.2 million, including $55.1 million in outstanding principal.

(11) 8.50% Senior Unsecured Convertible Notes

In February 2014, the Company issued $70.7 million in an aggregate principal amount of 8.50% senior unsecured convertible notes due 2019. The Convertible Notes were sold, in part, to certain accredited investors pursuant to Regulation D under the Securities Act of 1933 and, in part, to an initial purchaser who then resold such Convertible Notes to qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933. The Convertible Notes were issued pursuant to an indenture dated February 21, 2014, between the Company and U.S. Bank National Association, as trustee. Two members of the Company’s Board of Directors, Messrs. Dakos and Goldstein, are affiliated with Bulldog Investors, LLC, who purchased Convertible Notes in the aggregate principal amount of $9.2 million in the offering.

The Convertible Notes are general senior unsecured obligations and rank equally in right of payment with all of the Company’s other existing and future senior unsecured indebtedness. The Convertible Notes are effectively subordinate to all of the Company’s secured indebtedness to the extent of the value of the assets collateralizing such indebtedness. The Convertible Notes are not guaranteed by the Company’s subsidiaries.

The maturity date of the Convertible Notes is February 15, 2019. The Convertible Notes accrue interest at the rate of 8.50% per annum on the principal amount of the Convertible Notes, payable semi-annually in arrears on August 15 and February 15 of each year.

The Convertible Notes are convertible into shares of common stock at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Initially, the Convertible Notes were convertible into shares of common stock at a conversion rate of 147.9290 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.76 per share of common stock). In the second quarter of 2015, the conversion rate was adjusted to 151.7912 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.59 per share of common stock) in connection with anti-dilution adjustment triggered by a rights offering that resulted in the issuance of 6,688,433 shares of the Company’s stock.

19

The Company may not redeem the Convertible Notes prior to February 15, 2017. On and after February 15, 2017, and prior to the maturity date, the Company may redeem for cash all, but not less than all, of the Convertible Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the applicable conversion price for at least 20 trading days during the 30 consecutive trading day period ending on the trading day immediately prior to the date the Company delivers notice of the redemption. The redemption price will be equal to 100% of the principal amount of the Convertible Notes, plus any accrued and unpaid interest to, but excluding, the redemption date. In addition, if the Company calls the Convertible Notes for redemption, a make-whole fundamental charge will be deemed to occur. As a result, the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock for holders who convert their notes prior to the redemption date.

The Company determined that an embedded conversion option existed in the Convertible Notes, prior to June 5, 2014, that was required to be separately accounted for as a derivative under ASC 815 which required the Company to bifurcate the embedded conversion option and record it as a liability at fair value and record a debt discount by an equal amount with changes in the fair value of the conversion derivative liability recorded in earnings and the discount on the debt liability, together with the stated interest on the instrument, amortized to interest expense over the life of the debt using the effective interest method.

On June 5, 2014, the Company obtained shareholder approval to issue shares of common stock upon conversion of the Convertible Notes in an amount that exceeded applicable New York Stock Exchange limits for issuances without shareholder approval. In accordance with ASC 815, the Company reclassified the embedded conversion derivative liability to equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity.

The fair value of the conversion derivative liability was estimated at June 5, 2014 using a Black Scholes pricing model with the following assumptions:

	As of June  5, 2014
Expected Volatility	40.0	%
Expected Term in Years	4.7
Risk Free Rate	1.5	%

At June 5, 2014, the fair value of the conversion derivative liability was $23.7 million. In accordance with ASC 815, the Company reclassified this amount along with $756,000 of unamortized transaction costs offset by deferred taxes of $8.8 million to stockholders’ equity. As of September 30, 2015, the carrying value of the Convertible Notes was $57.9 million. The unamortized debt discount and origination cost of $12.8 million and $1.9 million, respectively, will be amortized over the remaining life of the Convertible Notes, using the effective interest method.

The Company recorded $2.3 million and $2.2 million of interest expense on the Convertible Notes, including $1.5 million, $711,000 and $105,000 and $1.5 million, $605,000 and $90,000 from interest, amortizing debt discounts and issuance costs, during the three months ended September 30, 2015 and 2014, respectively. During the nine months ended September 30, 2015 and 2014, the Company recorded $6.8 million and $5.3 million of interest expense on the Convertible Notes, including $4.5 million, $2.0 million and $294,000 and $3.7 million, $1.4 million and $239,000 from interest, amortizing debt discounts and issuance costs, respectively.

During the nine months ended September 30, 2014, the Company recorded a loss on the change in fair value of the conversion derivative liability of $6.8 million.

20

(12) 12.875% Senior Secured Notes

On November 10, 2014 (the “Initial Closing Date”), the Company, as issuer, entered into an indenture with certain of its subsidiary companies, Harbordale, LLC, Imperial Finance & Trading, LLC, Imperial Life and Annuity Services, LLC, Imperial Litigation Funding, LLC, Imperial Premium Finance, LLC, Red Reef Alternative Investments, LLC and Washington Square Financial, LLC, as guarantors (the “Guarantors”), and Wilmington Trust Company, as indenture trustee. The indenture provided for the issuance of up to $100 million in senior secured notes (the “Secured Notes), of which $25 million was issued by the Company on the Initial Closing Date. The Secured Notes issued on the Initial Closing Date were issued at 96% of their face amount and were purchased under a note purchase agreement (the “Note Purchase Agreement”) with the Company and the Guarantors by an affiliate of Indaba Capital Management, L.P. (the “Purchaser”) in a private transaction pursuant to exemptions from the registration requirements of the Securities Act of 1933, as amended. On January 21, 2015, the Company issued an additional $25.0 million in aggregate principal amount of Secured Notes, which were purchased by the Purchaser under the Note Purchase Agreement at 96% of their principal amount. Fees and expenses paid by the Company in connection with the Initial Closing Date and its subsequent issuance were approximately $1.8 million and $305,000, respectively.

Interest on issued Secured Notes accrued at 12.875% per annum and all Secured Notes issued under the indenture were scheduled to mature on November 10, 2017.

The Secured Notes were guaranteed by the Guarantors and were secured by substantially all of the Company’s and Guarantors’ assets, other than those securing the White Eagle Revolving Credit Facility, including cash on account as well as the Company’s life insurance policies that were not pledged as collateral under the White Eagle Revolving Credit Facility. The Secured Notes were also secured by pledges of the equity interests of the Guarantors and by pledges of 65% of their first tier foreign subsidiary companies.

On July 16, 2015, the Company redeemed all of the outstanding Secured Notes and discharged the Secured Note indenture. The Secured Notes were redeemed at 106% of their principal amount plus interest up to but excluding November 10, 2015. Effective as of the redemption of the Secured Notes, 159 of the life insurance policies that served as collateral for the Secured Notes were sold to Red Falcon in an internal transfer and pledged as collateral under the Red Falcon Revolving Credit Facility. Approximately $8.8 million was expensed as extinguishment related to the early repayment of the facility, in July 2015. This includes $5.2 million, $171,000, $1.7 million and $1.7 million related to interest and prepayment penalties, unused fees, write off of debt discount and write off of issuance cost.

The Company recorded $4.0 million of interest expense on the Secured Notes, including $3.2 million, $265,000, $264,000 and $277,000 from interest, unused fees, amortizing debt discounts and issuance costs, during the nine months ended September 30, 2015.

(13) Fair Value Measurements

The Company carries life settlements and debt under the Revolving Credit Facilities at fair value in the consolidated balance sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value measurements are classified based on the following fair value hierarchy:

Level 1—Valuation is based on unadjusted quoted prices in active markets for identical assets and liabilities that are accessible at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2—Valuation is determined from pricing inputs that are other than quoted prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.

Level 3—Valuation is based on inputs that are both significant to the fair value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management judgment or estimation.

21

Assets and liabilities measured at fair value on a recurring basis

The balances of the Company’s assets measured at fair value on a recurring basis as of September 30, 2015, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	457,810	$	457,810
	$	—	$	—	$	457,810	$	457,810

The balances of the Company’s liabilities measured at fair value on a recurring basis as of September 30, 2015 are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	157,946	$	157,946
Red Falcon Revolving Credit Facility	—		—		55,685		55,685
	$	—	$	—	$	213,631	$	213,631

The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	388,886	$	388,886
Structured settlement receivables	—		—		384		384
	$	—	$	—	$	389,270	$	389,270

The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	145,831	$	145,831
	$	—	$	—	$	145,831	$	145,831

The Company values its life settlement portfolio in two classes, non-premium financed and premium financed. In considering the categories, it is generally believed that market participants would require a lower risk premium for policies that were non-premium financed, while a higher risk premium would be required for policies that were premium financed although the Company believes that this risk premium has been declining.

22

($ in thousands)	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at 9/30/15		Aggregate death benefit at 9/30/15		Valuation Technique	Unobservable Input (s)	Range (Weighted Average)
Non-premium financed	$	97,022	$	343,803	Discounted cash flow	Discount rate	15.00%	-	21.00%
						Life expectancy evaluation	(6.6 years)
Premium financed	$	360,788	$	2,654,100	Discounted cash flow	Discount rate	16.00%	-	24.75%
						Life expectancy evaluation	(10.5 years)
Life settlements	$	457,810	$	2,997,903	Discounted cash flow	Discount rate	17.00%
						Life expectancy evaluation	(10.0 years)
White Eagle Revolving Credit Facility	$	157,946	N/A		Discounted cash flow	Discount rate	23.55%
						Life expectancy evaluation	(9.9 years)
Red Falcon Revolving Credit Facility	$	55,685	N/A		Discounted cash flow	Discount Rate	11.18%
						Life expectancy evaluation	(9.5 years)

Following is a description of the methodologies used to estimate the fair values of assets and liabilities measured at fair value on a recurring basis and within the fair value hierarchy.

Life settlements—The Company has elected to account for the life settlement policies it acquires using the fair value method. The Company uses a present value technique to estimate the fair value of its life settlements, which is a Level 3 fair value measurement as the significant inputs are unobservable and require significant management judgment or estimation. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate.

The Company provides medical records for each insured to independent life expectancy providers (each, an “LE provider”). Each LE provider reviews and analyzes the medical records and identifies all medical conditions it feels are relevant to the life expectancy determination of the insured. Debits and credits are assigned by each LE provider to the individual’s health based on identified medical conditions. The debit or credit that an LE provider assigns to a medical condition is derived from the experience of mortality attributed to this condition in the portfolio of lives that the LE provider monitors. The health of the insured is summarized by the LE provider into a life assessment of the individual’s life expectancy expressed both in terms of months and in mortality factor. The mortality factor represents the degree to which the given life can be considered more or less impaired than a life having similar characteristics (e.g. gender, age, smoking, etc.). For example, a standard insured (the average life for the given mortality table) would carry a mortality rating of 100%. A similar but impaired life bearing a mortality rating of 200% would be considered to have twice the chance of dying earlier than the standard life relative to the LE provider’s population. Since each provider’s mortality factor is based on its own mortality table, the Company calculates its own factors to apply to the table selected by the Company.

Since the quarter ended September 30, 2012, the Company has used a modified version of the 2008 Valuation Basic Table (“2008 VBT”), a mortality table developed by the U.S. Society of Actuaries (the “SOA”). The mortality table is created based on the expected rates of death among groups categorized by gender, age, and smoking status. Since the Company uses the 2008 VBT, the Company calculates its own mortality factor that, when applied to the 2008 VBT, produces the same life expectancy provided by each LE provider. The resulting mortality factors are then blended to determine a factor for each insured.

To generate the best estimate probabilistic cash flow stream, a mortality curve is generated by calculating the probability of mortality for each period based on the calculated mortality factors and the death rates from the 2008 VBT. The Company modifies the table by incorporating future mortality improvements to better reflect the curves used by the LE providers.

A discounted present value calculation is then used to determine the value of the policy. If the insured dies earlier than expected, the return will be higher than if the insured dies when expected or later than expected.

The calculation allows for the possibility that if the insured dies earlier than expected, the premiums needed to keep the policy in force will not have to be paid. Conversely, the calculation also considers the possibility that if the insured lives longer than expected, more premium payments will be necessary. Based on these considerations, each possible outcome is assigned a probability and the range of possible outcomes is then used to create a value for the policy.

23

During the three months ended September 30, 2015, the SOA released tables for an updated Valuation Basic Table (the “2015 VBT”). The Company is continuing to monitor the market reaction to the VBT. Additionally, the Company will continue to monitor its mortality experience to determine whether future adoption of the 2015 VBT would be an appropriate change to the Company’s valuation technique.

Future changes in the life expectancies could have a material effect on the fair value of the Company’s life settlements, which could have a material adverse effect on its business, financial condition and results of operations.

Life expectancy sensitivity analysis

If all of the insured lives in the Company’s life settlement portfolio live six months shorter or longer than the life expectancies provided by these third parties, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Value		Change in Value
+6	$	384,990	$	(72,820	)
-	$	457,810	—
-6	$	536,666	$	78,856

Discount rate

The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and the Company’s estimate of the risk premium an investor in the policy would require.

The Company re-evaluates its discount rates at the end of every reporting period in order to reflect the estimated discount rates that could reasonably be used in a market transaction involving the Company’s portfolio of life insurance policies. In doing so, the Company relies on management insight, engages third party consultants to corroborate its assessment, engages in discussions with other market participants and potential financing sources and extrapolates the discount rate underlying actual sales of policies.

Due to the Company’s association with the USAO Investigation and certain civil litigation involving the Company, the Company believes that, when given the choice to invest in a policy that was associated with the Company’s premium finance business and a similar policy without such an association, all else being equal, an investor would have generally opted to invest in the policy that was not associated with the Company’s premium finance business. However, since the Company entered into a non-prosecution agreement, investors have required less of a risk premium to transact in policies associated with the Company’s legacy premium finance business. In general, the Company believes that the risk premium an investor would require to transact in a policy that has been premium financed versus a policy without premium financing is lessening in the current market environment and further expects that, with the passage of time, investors will continue to require less of a risk premium to transact in policies associated with its legacy premium finance business.

Credit exposure of insurance company

The Company considers the financial standing of the issuer of each life insurance policy. Typically, the Company seeks to hold policies issued by insurance companies that are rated investment grade. At September 30, 2015, the Company had eighteen life insurance policies issued by two carriers that were rated non-investment grade as of that date. In order to compensate a market participant for the perceived credit and challenge risks associated with these policies, the Company applied an additional 300 basis point risk premium.

24

The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of the Company’s life settlements as of September 30, 2015:

Carrier	Percentage of Total Fair Value		Percentage of Total Death Benefit		Moody's Rating	S&P Rating
Transamerica Life Insurance Company	20.6	%	20.5	%	A1	AA-
Lincoln National Life Insurance Company	21.6	%	19.6	%	A1	AA-

Estimated risk premium

As of September 30, 2015, the Company owned 634 policies with an estimated fair value of $457.8 million. Of these 634 policies, 547 were previously premium financed and are valued using discount rates that range from 16.00% to 24.75%. The remaining 87 policies, which are non-premium financed, are valued using discount rates that range from 15.00% to 21.00%. As of September 30, 2015, the weighted average discount rate calculated based on death benefit used in valuing the policies in the Company’s life settlement portfolio was 17.00%.

The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and the Company’s estimate of the risk premium an investor in the policy would require. The extent to which the fair value could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount rate on the death benefit used to estimate the fair value. If the weighted average discount rate were increased or decreased by 1⁄2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value would be as follows (dollars in thousands):

Market interest rate sensitivity analysis

Weighted Average Rate Calculated Based on
Death Benefit	Rate Adjustment	Value		Change in Value
16.50%	-0.50%	$	469,610	$	11,800
17.00%	—	$	457,810	$	—
17.50%	+0.50%	$	446,512	$	(11,298	)

Future changes in the discount rates the Company uses to value life insurance policies could have a material effect on the Company’s yield on life settlement transactions, which could have a material adverse effect on its business, financial condition and results of its operations.

At the end of each reporting period the Company re-values the life insurance policies using the Company’s valuation model in order to update its estimate of fair value for investments in policies held on its balance sheet. This includes reviewing the Company’s assumptions for discount rates and life expectancies as well as incorporating current information for premium payments and the passage of time.

White Eagle Revolving Credit Facility—439 policies are pledged by White Eagle to serve as collateral for its obligations under the White Eagle Revolving Credit Facility. Absent an event of default under the White Eagle Revolving Credit Facility, ongoing borrowings will be used to pay the premiums on these policies and certain approved third party expenses. Proceeds from the policies pledged as collateral will be distributed pursuant to a waterfall. After premium payments and fees to service providers, 100% of the remaining proceeds will be directed to pay outstanding principal and interest on the loan. Generally, after payment of principal and interest, collections from policy proceeds are to be paid to White Eagle up to $76.1 million, then 50% of the remaining proceeds are to be directed to the lenders with the remainder paid to White Eagle. The Company has elected to account for this long-term debt, which includes the lender’s interest in policy proceeds, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the White Eagle Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

25

Life expectancy sensitivity analysis of the policies securing the White Eagle Revolving Credit Facility

A considerable portion of the fair value of the White Eagle Revolving Credit Facility is determined by the timing of receipt of future policy proceeds. Should life expectancies lengthen such that policy proceeds are collected further into the future, the fair value of this debt will decline. Conversely, should life expectancies shorten, the fair value of this debt will increase. Considerable judgment is required in interpreting market data to develop the estimates of fair value.

If all of the insured lives in the life settlement portfolio pledged under the White Eagle Revolving Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the White Eagle Revolving Credit Facility debt, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of White Eagle Revolving Credit Facility		Change in Value
+6	$	132,093	$	(25,853	)
	$	157,946	—
-6	$	182,793	$	24,847

Future changes in the life expectancies could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of operations.

Discount rate of the White EagleRevolving Credit Facility

The discount rate incorporates current information about market interest rates, credit exposure to insurance companies and the Company’s estimate of the return a lender lending against the policies would require.

Market interest rate sensitivity analysis of the White Eagle Revolving Credit Facility

The extent to which the fair value of the White Eagle Revolving Credit Facility could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount. If the weighted average discount rate were increased or decreased by 1⁄2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the White Eagle Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of White Eagle Revolving Credit Facility		Change in Value
23.05%	-0.50	%	$	160,730	$	2,784
23.55%	—		$	157,946	$	—
24.05%	+0.50	%	$	155,255	$	(2,691	)

Future changes in the discount rates could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of its operations.

At September 30, 2015, the fair value of the debt was $157.9 million and the outstanding principal was approximately $159.9 million.

Red Falcon Revolving Credit Facility—157 policies are pledged by Red Falcon to serve as collateral for its obligations under the Red Falcon Revolving Credit Facility. Proceeds from the policies pledged as collateral under the Red Falcon Credit Facility are distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds are directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the loan. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds are to be paid to the lenders, which will vary depending on the then loan to value ratio (“LTV”) as follows: (1) if the LTV is equal to or greater than 50%, all remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; (2) if the LTV is less than 50% but greater than or equal to 25%, 65% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; or (3) if the LTV is less than 25%, 35% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance. The Company has elected to account for this long-term debt using the fair value method. The fair value of the debt is the amount the

26

Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the Red Falcon Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

Life expectancy sensitivity analysis of the policies securing the Red Falcon Revolving Credit Facility

A considerable portion of the fair value of the Red Falcon Revolving Credit Facility is determined by the timing of receipt of future policy proceeds. Should life expectancies lengthen such that policy proceeds are collected further into the future, the fair value of this debt will decline. Conversely, should life expectancies shorten; the fair value of this debt will increase. Considerable judgment is required in interpreting market data to develop the estimates of fair value.

If all of the insured lives in the life settlement portfolio pledged under the Red Falcon Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the Red Falcon Revolving Credit Facility, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of Red Falcon Revolving Credit Facility		Change in Value
+6	$	53,734	$	(1,951	)
	$	55,685	—
-6	$	57,236	$	1,551

Future changes in the life expectancies could have a material effect on the fair value of the Red Falcon Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of operations.

Discount rate of the Red Falcon Revolving Credit Facility

The discount rate incorporates current information about market interest rates, credit exposure to insurance companies and the Company’s estimate of the return a lender lending against the policies would require.

Market interest rate sensitivity analysis of the Red Falcon Revolving Credit Facility

The extent to which the fair value of the Red Falcon Revolving Credit Facility could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount. If the weighted average discount rate were increased or decreased by ¹⁄₂ of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the Red Falcon Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of Red Falcon Revolving Credit Facility		Change in Value
10.68%	-0.50	%	$	56,523	$	838
11.18%	—		$	55,685	$	—
11.68%	+0.50	%	$	54,868	$	(817	)

Future changes in the discount rates could have a material effect on the fair value of the Red Falcon Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of its operations.

At September 30, 2015, the fair value of the debt was $55.7 million and the outstanding principal was approximately $55.1 million.

27

Senior Unsecured Convertible Notes—The Company determined that an embedded conversion option in the Convertible Notes was required to be separately accounted for as a derivative under Accounting Standards Codification 815, Derivatives and Hedging (“ASC 815”). ASC 815 required the Company to bifurcate the embedded conversion option and record it as a liability at fair value and reduce the debt liability by a corresponding discount of an equivalent amount. The Company used a Black Scholes pricing model that incorporates present valuation techniques and reflect both the time value and the intrinsic value of the embedded conversion option to approximate the fair value of the conversion derivative liability at the end of each reporting period. This model required assumptions as to expected volatility, dividends, terms, and risk free rates.

In accordance with ASC 815, upon receipt of shareholder approval on June 5, 2014, the Company reclassified the embedded derivative to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes continue to be recorded at accreted value up to the par value of the Convertible Notes at maturity. See Note 11, “8.50% Senior Unsecured Convertible Notes.” Although the Company believes its valuation method is appropriate, the use of different methodologies or assumptions to determine the fair value could result in different fair values.

Changes in Fair Value

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2015	$	388,886
Purchase of policies	30,534
Change in fair value	43,582
Matured/lapsed/sold policies	(53,435		)
Premiums paid	48,243
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	457,810
Changes in fair value included in earnings for the period relating to assets held at September 30, 2015	$	2,805

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2015	$	145,831
Draws under the White Eagle Revolving Credit Facility	42,448
Payments on credit facility	(43,241		)
Unrealized change in fair value	12,908
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	157,946
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	12,908

28

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the Red Falcon Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

Red Falcon Revolving Credit Facility:
Balance, January 1, 2015	$	—
Initial advance under the Red Falcon Revolving Credit Facility	54,000
Subsequent draws under the Red Falcon Revolving Credit Facility	2,967
Payments on Red Falcon Revolving Credit Facility	(1,863		)
Unrealized change in fair value	581
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	55,685
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	581

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2014, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consist solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2014	$	302,961
Purchase of policies	3,488
Change in fair value	19,313
Matured/sold policies	(15,957		)
Premiums paid	40,578
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	350,383
Changes in fair value included in earnings for the period relating to assets held at September 30, 2014	$	8,627

The following tables provide a roll-forward in the changes in fair value for the nine months ended September 30, 2014, for the White Eagle Revolving Credit Facility and conversion derivative liability for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2014	$	123,847
Subsequent draws under the revolving credit facility	40,965
Payments on credit facility	(17,595		)
Unrealized change in fair value	(4,556		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	142,661
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	(4,556	)

29

Conversion derivative liability:
Balance, at inception	$	16,901
Change in fair value	6,759
Reclassified to equity	(23,660		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	—
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	—

There were no transfers of financial assets or liabilities between levels of the fair value hierarchy during the nine months ended September 30, 2015 and 2014.

(14) Segment Information

On October 25, 2013, the Company sold its structured settlement business, which was previously reported as an operating segment. The operating results related to the Company’s structured settlement business have been included in discontinued operations in the Company’s Consolidated Statements of Operations for all periods presented and the Company has discontinued segment reporting.

(15) Commitments and Contingencies

Lease Agreements

The Company leases office space under a lease that commenced on October 1, 2014 and expires on September 30, 2020. The annual base rent is $225,100, with a provision for a 3% increase on each anniversary of the rent commencement date. Rent expense was approximately $122,000 and $126,000 for the three months ended September 30, 2015 and 2014, respectively, and approximately $319,000 and $377,000 for the nine months ended September 30, 2015 and 2014, respectively. Future minimum lease payments for the remainder of 2015 are approximately $58,000.

Employment Agreements

The Company has entered into employment agreements with certain of its officers, including with its chief executive officer, whose agreement provides for substantial payments in the event that the executive terminates his employment with the Company due to a material change in the geographic location where the chief executive officer performs his duties or upon a material diminution of his base salary or responsibilities, with or without cause. These payments are equal to three times the sum of the chief executive officer’s base salary and the average of the preceding three years’ annual cash bonus.

The Company does not have any general policies regarding the use of employment agreements, but has and may, from time to time, enter into such a written agreement to reflect the terms and conditions of employment of a particular named executive officer, whether at the time of hire or thereafter.

Separation Agreement

On April 26, 2012, the Company entered into a Separation Agreement and General Release of Claims (the “Separation Agreement”) with its former chief operating officer, Jonathan Neuman. The Separation Agreement obligates the Company to

indemnify Mr. Neuman for his legal expenses. The Company recognized indemnification expenses of $998,000 and $500,000 during the three months ended September 30, 2015 and 2014, respectively, and $2.5 million and $1.5 million during the nine months ended September 30, 2015 and 2014, respectively.

Litigation

In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency

30

that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of litigation-related expense. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability.

Non-Prosecution Agreement & Indemnification Obligations

On September 27, 2011, the Company was informed that it was being investigated by the U.S. Attorney’s Office for the District of New Hampshire (the “USAO Investigation”) in connection with the Company’s now legacy premium finance loan business. On April 30, 2012, the Company entered into a Non-Prosecution Agreement (the “Non-Prosecution Agreement”) with the USAO, which agreed not to prosecute the Company for its involvement in the making of misrepresentations on life insurance applications in connection with its premium finance business or any potential securities fraud claims related to its now legacy premium finance business.

The Non-Prosecution Agreement had a term of three years and expired in accordance with its terms on April 30, 2015. While the Non-Prosecution Agreement effectively resolved the USAO Investigation as it pertains to the Company, the Company still has continuing cooperation obligations to the USAO and understands that the USAO is continuing to investigate certain individuals and entities formerly associated with the Company's legacy premium finance business. Settlements of certain civil litigation with the Company’s director and officer liability insurance carriers related to the USAO Investigation and other contractual obligations require the Company to advance legal fees to and indemnify these individuals and entities. USAO litigation-related fees (inclusive of indemnification and advancement expenses) of $2.8 million and $1.2 million were recognized for the three months ended September 30, 2015 and 2014, respectively, and $7.0 million and $3.2 million were recognized for the nine months ended September 30, 2015 and 2014, respectively. The Company expects to continue to incur indemnification and advancement expenses and expenses related to continuing obligations related to the USAO investigation. Ongoing expenses in respect of these obligations, while currently unquantifiable, have been substantial in prior periods and could continue to have a material adverse effect on the Company’s financial position and results of operations.

SEC Investigation

On February 17, 2012, the Company received a subpoena issued by the staff of the SEC seeking documents from 2007 through the date of the subpoena, generally related to the Company’s premium finance business and corresponding financial reporting. The SEC is investigating whether any violations of federal securities laws have occurred and the Company has been cooperating with the SEC regarding this matter. The Company is unable to predict what action, if any, might be taken in the future by the SEC or its staff as a result of the investigation or what impact, if any, the cost of responding to the SEC might have on the Company’s financial position, results of operations, or cash flows. The Company has not established any provision for losses in respect of this matter.

Sun Life

On April 18, 2013, Sun Life Assurance Company of Canada (“Sun Life”) filed a complaint against the Company and several of its affiliates in the United States District Court for the Southern District of Florida, entitled Sun Life Assurance Company of Canada v. Imperial Holdings, Inc., et al. (“Sun Life Case”), asserting, among other things, that at least 28 life insurance policies issued by Sun Life and owned by the Company through certain of its subsidiary companies were invalid. The Sun Life complaint, as amended, asserted the following claims: (1) violations of the federal Racketeer Influenced and Corrupt Organizations (“RICO”) Act, (2) conspiracy to violate the RICO Act, (3) common law fraud, (4) aiding and abetting fraud, (5) civil conspiracy to commit fraud, (6) tortious interference with contractual obligations, and (7) a declaration that the policies issued were void. Following the filing of a motion by the Company to dismiss the Sun Life Case, on December 9, 2014, counts (2), (4), (5), (6) and (7) of the Sun Life Case were dismissed with prejudice. The Company then filed a motion for summary judgment on the remaining counts. On February 4, 2015, the Court issued an order (the “Order”) granting the Company’s motion for summary judgment on counts (1) and (3), resulting in the Company prevailing on all counts in the Sun Life Case.

On July 29, 2013, the Company filed a separate complaint against Sun Life in United States District Court for the Southern District of Florida, entitled Imperial Premium Finance, LLC v. Sun Life Assurance Company of Canada (“Imperial Case”), which was subsequently consolidated with the Sun Life Case. The Imperial complaint asserts claims against Sun Life for breach of contract, breach of the covenant of good faith and fair dealing, and fraud, and seeks a judgment declaring that Sun Life is obligated to comply with the promises made by it in certain insurance policies. The complaint also seeks compensatory

31

damages of no less than $30 million in addition to an award of punitive damages. On August 23, 2013, Sun Life moved to dismiss the complaint, which was denied by the Court as part of the Order. On February 26, 2015, Sun Life filed a Notice of Appeal to the United States Court of Appeals for the Eleventh Circuit from the Order, which had denied Sun Life’s motion to dismiss.

The District Court has stayed the Imperial Case until Sun Life’s appeal is resolved by the Eleventh Circuit, which has been fully briefed by the parties.

IRS Investigation

The Internal Revenue Service (“IRS”) Criminal Investigation Division notified the Company in February 2014 that it is conducting an investigation related to the Company and its legacy structured settlements business. The Company believes that it has been cooperating with the investigation and is unable, at this time, to predict what action, if any, might be taken in the future by the IRS. If the investigation results in a determination by the IRS that the Company has failed to comply with any of its obligations under the Internal Revenue Code or regulations thereunder, the Company could incur additional tax liability, restitution payment obligations, penalties, fines or other liabilities, including criminal penalties and fines and a reduction in the Company’s net operating losses, that could have a material adverse effect on the Company, its personnel, its financial condition, cash flows and its results of operations. The Company has not established any provision for losses related to this matter.

Class Action Litigation

On January 20, 2015, a purported shareholder of the Company filed a putative class action complaint against the Company, and the individual members of the Board of Directors, in the Circuit Court of the 15th Judicial Circuit, in and for Palm Beach County, entitled Harry Rothenberg v. Imperial Holdings, Inc., et al. (the “State Court Complaint”). The Rothenberg State Court Complaint alleged breaches of fiduciary duties of due care and sought to invalidate a by-law amendment adopted by the Board of Directors on October 30, 2014, which requires current and former shareholders who wish to file a class or derivative action against the Company, its directors or its officers to first obtain written consent from shareholders beneficially owning at least 3% of the outstanding shares of the Company. On March 2, 2015, the Company filed a motion to dismiss and motion to strike certain allegations in the State Court Complaint.

On April 20, 2015, Mr. Rothenberg filed a Verified Shareholder Class Action and Derivative Complaint (the “Federal Court Complaint”) in the United States District Court for the Southern District of Florida, which named the same defendants and asserted similar claims as in the State Court Complaint. The Federal Court Complaint also alleged violations of Sections 14(a) and 20(a) of the 1934 Securities Act, and asserted derivative claims for breach of fiduciary duty, among other claims, based on the previously disclosed IRS Investigation and allegations regarding the Company’s prior structured settlement business made in a case styled Michael Lafontant v. Washington Square Financial, LLC, et al. (“Lafontant Complaint”), which was filed in the United States District Court for the Southern District of New York. The Company has moved to dismiss the Lafontant Complaint based on contractual arbitration provisions, which is pending an order by the district court. On April 21, 2015, Mr. Rothenberg voluntarily dismissed the State Court Complaint, without prejudice. On June 9, 2015, Mr. Rothenberg filed an Amended Complaint. On June 29, 2015, the Company filed a motion to dismiss the Amended Complaint for lack of subject matter jurisdiction due to lack of injury in fact and ripeness and failure to state a claim pursuant to the Federal Rules of Civil Procedure.

On September 10, 2015, the United States District Court for the Southern District of Florida issued an order (the “Order”) granting Plaintiff’s Unopposed Motion for Approval of Dismissal of Shareholder’s Derivative Claims and Class Action Claims. As contemplated in the Order, the Federal Court Complaint was dismissed with prejudice, and the case was closed on October 14, 2015.

Other Litigation

On April 10, 2015, a complaint was filed against the Company’s subsidiary in the Circuit Court of the Twentieth Judicial Circuit in and for St. Clair County, Illinois, styled Kenneth Jennings v. Washington Square Financial, LLC d/b/a Imperial Structured Settlements (“Washington Square”). The plaintiff seeks, in a purported class action, to represent all individuals who sold all or a part of a structured settlement annuity to Washington Square under the Illinois Structured Settlement Protections Act (the “Illinois Act”), where the underlying annuity contract contained an anti-assignment clause, and where a court issued an order under the Illinois Act approving the transaction. The complaint seeks, among other things, a declaration that all such transactions are void and compensatory and punitive damages. The Company has not established any provision for losses in respect of this matter.

32

The Company is party to various other legal proceedings that arise in the ordinary course of business. Due to the inherent difficulty of predicting the outcome of litigation and other legal proceedings, the Company cannot predict the eventual outcome of these matters, and it is reasonably possible that some of them could be resolved unfavorably to the Company. As a result, it is possible that the Company’s results of operations or cash flows in a particular fiscal period could be materially affected by an unfavorable resolution of pending litigation or contingencies. However, the Company believes that the resolution of these other proceedings will not, based on information currently available, have a material adverse effect on the Company’s financial position or results of operations.

(16) Stockholders’ Equity

During the second quarter of 2015, the Company commenced a rights offering and distributed one non-transferable subscription right for every four shares of common stock owned by its shareholders of record at the close of business on May 26, 2015. Each right entitled its holder to subscribe for one share of common stock at a price of $5.75 per share. Additionally, the Company allocated an additional 1,337,686 shares to honor over-subscription requests. The rights offering was over-subscribed and the Company issued 6,688,433 shares of common stock.

The Company has reserved an aggregate of 2,700,000 shares of common stock under its Omnibus Plan, of which 774,394 options to purchase shares of common stock granted to existing employees were outstanding as of September 30, 2015, and 103,112 shares of restricted stock had been granted to directors under the plan with 41,259 shares subject to vesting.

During 2014, upon receipt of shareholder approval, the Company reclassified the embedded derivative contained in its Convertible Notes to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. This resulted in an increase to additional paid-in-capital of $14.1 million, net of taxes on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of December 31, 2014. See Note 11, "8.50% Senior Unsecured Convertible Notes."

In connection with the settlement of derivative litigation, the Company issued 125,628 shares of the Company’s stock, which were issued in the first quarter of 2014 and are included in stockholders’ equity.

In connection with the settlement of class litigation filing in connection with the USAO Investigation, the Company issued warrants to purchase two million shares of the Company’s stock into an escrow account in April 2014 and were distributed in October 2014. The estimated fair value at the measurement date of such warrants was $5.4 million, which is included in stockholder’s equity. The warrants have a five-year term from the date of their distribution with an exercise price of $10.75. The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement.

During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan, which was obtained at the Company’s 2015 annual meeting on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0% – 150% of the target performance shares. As a result, the Company determined that it is not probable that the performance conditions will be achieved and no related expense was recognized for the three months and nine months periods ended September 30, 2015. The performance shares will be subject to a one year vesting period from the date of issuance.

Exclusive of the 323,500 target performance shares awarded to its directors, named executive officers and certain employees, there were 1,808,735 securities remaining for future issuance under the Omnibus Plan as of September 30, 2015.

During the nine months ended September 30, 2014, the Company adopted ASU No. 2013-11, resulting in an increase to additional paid-in-capital of $6.3 million on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of September 30, 2014. See Note 17, "Income Taxes."

On September 1, 2015, the Company announced that its Board of Directors authorized a $10 million share and note repurchase program. The program has a two-year expiration date, and authorizes the Company to repurchase up to $10 million of its common stock and/or its Convertible Notes due 2019. For the quarter ended September 30, 2015, the Company purchased 65,621 shares for a total cost of approximately $348,000, which is an average cost of $5.30 per share including transaction fees. As of September 30, 2015, the Company may purchase up to approximately $9.7 million of additional common stock or Convertible Notes under its board authorized plan.

33

(17) Income Taxes

The Company’s provision for income taxes from continuing operations is estimated to result in an annual effective tax rate of approximately 35.0% and 36.9% (before the third quarter 2015 establishment of a valuation allowance and before the 2014 adoption of ASU 2013-11, discussed below) during the nine month period ended September 30, 2015 and 2014, respectively. The Company’s quarterly effective income tax rates are based upon the Company’s current estimated annual rate. The Company’s annual effective income tax rate varies based upon the Company’s taxable earnings as well as on a mix of taxable earnings in the various state and foreign jurisdictions.

In the third quarter of 2015, the Company established a valuation allowance of $2.0 million for certain state net deferred tax assets. This valuation allowance is needed as realization is not expected due to the anticipation that sufficient future taxable earnings may not be generated in the state jurisdictions in which the Company operates. The tax expense from the increase valuation allowance was offset by a $927,000 tax benefit for the impact on tax rate changes in the third quarter.

The Company adopted ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”) effective on January 1, 2014, which required the Company to reclassify a $6.3 million current liability for unrecognized tax benefits to deferred taxes. Adoption of this guidance resulted in the recognition of a $3.7 million tax expense included in the Company’s provision for income taxes for the three months ended March 31, 2014, a $2.6 million reduction in the valuation allowance and an increase to additional paid-in-capital of $6.3 million on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of March 31, 2014.

In March of 2014, the Company was notified by the IRS of its intention to examine the Company’s tax returns for the years ended December 31, 2011 and 2012. See also “IRS Investigation” in Note 15 regarding the IRS Investigation related to the Company’s former structured settlement business.

The Company and its subsidiary companies are subject to U.S. federal income tax as well as to income tax in Florida and other states and foreign jurisdictions in which it operates.

Item 2.        Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion summarizes the significant factors affecting the consolidated operating results, financial condition, liquidity, and cash flows of our Company as of and for the periods presented below and should be read in conjunction with the financial statements and accompanying notes included with this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors. See “Forward-Looking Statements.”

Business Overview

Incorporated in Florida, Emergent Capital owns a portfolio of 634 life insurance policies, also referred to as life settlements, with an estimated fair value of $457.8 million and an aggregate death benefit of approximately $3.0 billion at September 30, 2015. The Company primarily earns income on these policies from changes in their fair value and through death benefits.

Our indirect subsidiary company, White Eagle Asset Portfolio, LP (“White Eagle”), is the owner of 439 of these life insurance policies with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million at September 30, 2015. White Eagle pledged its policies as collateral to secure borrowings made under a $300.0 million revolving credit agreement (the “White Eagle Revolving Credit Facility”), which is used, among other things, to pay premiums on the life insurance policies owned by White Eagle. During the quarter, an additional 157 policies, with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million at September 30, 2015 were pledged as collateral under a $110.0 million, revolving credit agreement (the “Red Falcon Revolving Credit Facility” and, together with the White Eagle Revolving Credit Facility, the "Revolving Credit Facilities") entered into by Red Falcon Trust (“Red Falcon”), a Delaware statutory trust formed by a wholly-owned Irish subsidiary of the Company.

Beginning in the fourth quarter of 2014, we began acquiring policies with a view towards enhancing projected short term cash flows. Prior to 2015, we acquired 14 policies and during the nine months ended September 30, 2015, we acquired an additional 41 life insurance policies. These 55 policies, with a face value of $176.6 million, had a weighted average life

34

expectancy at the time of acquisition of 68 months and the insureds underlying these policies had a weighted average age of 85 years. We believe that re-shaping the projected characteristics of this portfolio made it a more attractive candidate for longer-term financing at a lower cost of capital and, on July 16, 2015, we entered into the Red Falcon Revolving Credit Facility and redeemed all $50.0 million in aggregate principal amount of outstanding 12.875% Senior Secured Notes issued by the Company (the “Secured Notes”). These transactions materially impacted our results for the period as the redemption of the Secured Notes resulted in a $8.8 million expense related to the early extinguishment of debt and we incurred closing costs associated with the Red Falcon Revolving Credit Facility of $3.2 million that could not be amortized as the debt under the facility is being recorded at fair value.

During the nine months ended September 30, 2015, we acquired 41 life insurance policies with an aggregate face amount of $119.9 million, which resulted in a gain of approximately $5.9 million. During the nine months ended September 30, 2015, 14 life insurance policies with face amounts totaling $53.5 million matured, resulting in a gain of $40.2 million on these policies. The gains related to acquisitions and maturities are included in income from changes in the fair value of life settlements in the consolidated statements of operations for the three months and nine months ended September 30, 2015. We continue to believe that there are accretive opportunities to grow our existing portfolio of life settlements and intend, subject to our liquidity needs, to selectively deploy capital in both the secondary and tertiary life settlement markets.

During the three months ended September 30, 2015, the U.S. Society of Actuaries (the “SOA”) released tables for a new Valuation Basic Table (the “2015 VBT”). We are continuing to monitor the market reaction to the 2015 VBT and will continue to monitor our mortality experience to determine whether future adoption of the 2015 VBT would be an appropriate change to the Company’s valuation technique. We understand from discussions with our third-party life expectancy providers that the release of the 2015 VBT tables should not impact their life expectancy estimates. We do expect, however, that adoption of the 2015 VBT would impact our estimated probabilistic cash flow stream as a new mortality table inputted into the Company’s fair value model would likely result in a change to the mortality curve generated for a given insured. Future changes in life expectancies could have a material adverse effect on the fair value of our life settlements, which could have a material adverse effect on our business, financial condition and results of operations.

Critical Accounting Policies

Critical Accounting Estimates

The preparation of the financial statements requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. We base our judgments, estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions and conditions. We evaluate our judgments, estimates and assumptions on a regular basis and make changes accordingly. We believe that the judgments, estimates and assumptions involved in the accounting for income taxes, the valuation of life settlements, the valuation of the debt owing under the Revolving Credit Facilities and the valuation of our conversion derivative liability formerly embedded within the Convertible Notes have the greatest potential impact on our financial statements and accordingly believe these to be our critical accounting estimates.

Fair Value Measurement Guidance

We follow ASC 820, Fair Value Measurements and Disclosures, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our investments in life insurance policies and the debt under the Revolving Credit Facilities are considered Level 3 as there is currently no active market where we are able to observe quoted prices for identical assets/liabilities and our valuation model incorporates significant inputs that are not observable. See Note 13, “Fair Value Measurements” of the notes to Consolidated Financial Statements for a discussion of our fair value measurement.

35

Fair Value Option

We have elected to account for life settlements using the fair value method. The fair value of the asset is the estimated amount that would be received to sell an asset in an orderly transaction between market participants at the measurement date. We calculate the fair value of the asset using a present value technique to estimate the fair value of its life settlements. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. See Note 8, "Life Settlements (Life Insurance Policies)" and Note 13, "Fair Value Measurements."

We have elected to account for the debt under the Revolving Credit Facilities, which includes the interests in policy proceeds to the lender, using the fair value method. The fair value of the debt is the estimated amount that would have to be paid to transfer the debt to a market participant in an orderly transaction. We calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the applicable credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, our estimates are not necessarily indicative of the amounts that we, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of assumptions and/or estimation methodologies could have a material effect on the estimated fair different values.

We determined that an embedded conversion option existed in the Convertible Notes, prior to June 5, 2014, that was required to be separately accounted for as a derivative under Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging. On June 5, 2014, we obtained shareholder approval to issue shares of common stock upon conversion of the Convertible Notes in an amount that exceeded the New York Stock Exchange limits for issuances without shareholder approval. In accordance with ASC 815, we reclassified the conversion derivative liability to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. In subsequent reporting periods, the Convertible Notes will continue to be recorded at accreted value up to the par value of the Convertible Notes at maturity. The debt discount will be amortized into interest expense using the interest method, in an aggregate amount equal to the amount of the conversion derivative liability reclassified into equity along with any unamortized transaction costs. See Note 11, “8.50% Senior Unsecured Convertible Notes.”

Income Recognition

Our primary sources of income are in the form of changes in fair value of life settlements and gains/(losses) on life settlements, net. Our income recognition policies for this source of income is as follows:

• Changes in Fair Value of Life Settlements—When we acquire certain life insurance policies, we initially record these investments at the transaction price, which is the fair value of the policy for those acquired upon relinquishment or the amount paid for policies acquired for cash. The fair value of the insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the investment based on evaluations are recorded as changes in fair value of life settlements in our consolidated statement of operations. The fair value is determined on a discounted cash flow basis that incorporates current life expectancy assumptions. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. We recognize income from life settlement maturities upon receipt of death notice or verified obituary of the insured. This income is the difference between the death benefits and fair values of the policy at the time of maturity.

• Gain/(Loss) on Life Settlements, Net—We recognize gain/(loss) from life settlement contracts that we own upon the signed sale agreement and/or filing of ownership forms and funds transferred to escrow.

Deferred Debt Costs

Deferred debt costs include costs incurred in connection with acquiring and maintaining debt arrangements. These costs are amortized over the life of the related debt using the effective interest method and are classified as interest expense in the accompanying consolidated statement of operations. These deferred costs are related to our Convertible and Secured Notes. We did not recognize any deferred debt costs on the Revolving Credit Facilities given all costs were expensed due to electing the fair value option in valuing the Revolving Credit Facilities.

36

Income Taxes

We account for income taxes in accordance with ASC 740, Income Taxes. Under ASC 740, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, we consider tax regulations of the jurisdictions in which we operate, estimates of future taxable income and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies varies adjustments to the carrying value of the deferred tax assets and liabilities may be required. Valuation allowances are based on the “more likely than not” criteria of ASC 740.

Our provision for income taxes from continuing operations results in an annual effective tax rate of 35.0% and 36.9% in 2015 and 2014, respectfully, except as noted below. The accounting for uncertain tax positions guidance under ASC 740 requires that we recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. We recognize interest and penalties (if any) on uncertain tax positions as a component of income tax expense.

In the third quarter of 2015, the Company established a valuation allowance of $2.0 million for certain state net deferred tax assets as of the beginning of the year. This valuation allowance is needed as realization is not expected due to the anticipation that sufficient future taxable earnings may not be generated in the state jurisdictions in which the Company operates. The tax expense from the increase valuation allowance was offset by a $927,000 tax benefit for the impact on tax rate changes in the third quarter.

In March of 2014, we were notified by the IRS of its intention to examine our tax returns for the years ended December 31, 2011 and 2012. See also “IRS Investigation” in Note 15, Commitments and Contingencies regarding the IRS Investigation related to our former structured settlement business.

37

Stock-Based Compensation

We have adopted ASC 718, Compensation—Stock Compensation. ASC 718 addresses accounting for share-based awards, including stock options, restricted stock, performance shares and warrants, with compensation expense measured using fair value and recorded over the requisite service or performance period of the award. The fair value of equity instruments will be determined based on a valuation using an option pricing model that takes into account various assumptions that are subjective. Key assumptions used in the valuation will include the expected term of the equity award taking into account both the contractual term of the award, the effects of expected exercise and post-vesting termination behavior, expected volatility, expected dividends and the risk-free interest rate for the expected term of the award.

Held-for-sale and discontinued operations

We report a business as held-for-sale when management has approved or received approval to sell the business and is committed to a formal plan, the business is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the ensuing year and certain other specified criteria are met. A business classified as held-for-sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying amount of the business exceeds its estimated fair value, a loss is recognized. Depreciation is not recorded on assets of a business classified as held-for-sale. Assets and liabilities related to a business classified as held-for-sale are segregated in the Consolidated Balance Sheet and major classes are separately disclosed in the notes to the Consolidated Financial Statements commencing in the period in which the business is classified as held-for-sale. We report the results of operations of a business as discontinued operations if the business is classified as held-for-sale, the operations and cash flows of the business have been or will be eliminated from the ongoing operations of the Company as a result of a disposal transaction and we will not have any significant continuing involvement in the operations of the business after the disposal transaction. The results of discontinued operations are reported in Discontinued Operations in the Consolidated Statement of Operations for current and prior periods commencing in the period in which the business meets the criteria of a discontinued operation, and include any gain or loss recognized on closing or adjustment of the carrying amount to fair value less cost to sell. During the fourth quarter of 2013, we sold substantially all of our structured settlements business. As a result, we have classified our structured settlement operating results as discontinued operations.

Foreign Currency

We own certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. The foreign subsidiary companies financial statements are denominated in U.S. dollars and therefore, there are no translation gains and losses resulting from converting the financial statements at exchange rates other than the functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to our financial statements.

Accounting Changes

Note 3, “Recent Accounting Pronouncements,” of the Notes to Consolidated Financial Statements discusses accounting standards adopted in 2015, as well as accounting standards recently issued but not yet required to be adopted and the expected impact of these changes in accounting standards. Any material impact of adoption is discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements.

38

Selected Operating Data (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Period Acquisitions — Policies Owned
Number of policies acquired	3		2		41		2
Average age of insured at acquisition	85.4		84.5		85.0		84.5
Average life expectancy — Calculated LE (Years)	5.6		5.6		5.4		5.6
Average death benefit	$	6,232	$	7,176	$	2,924	$	7,176
Aggregate purchase price	$	2,679	$	3,488	$	30,534	$	3,488
End of Period — Policies Owned
Number of policies owned	634		595		634		595
Average Life Expectancy — Calculated LE (Years)	10.0		11.0		10.0		11.0
Aggregate Death Benefit	$	2,997,903	$	2,888,289	$	2,997,903	$	2,888,289
Aggregate fair value	$	457,810	$	350,383	$	457,810	$	350
Monthly premium — average per policy	$	8.9	$	7.6	$	8.9	$	7.6

Results of Operations

The following is our analysis of the results of operations for the periods indicated below. This analysis should be read in conjunction with our financial statements, including the related notes to the financial statements. Our results of operations are discussed below in two parts: (i) our consolidated results of continuing operations and (ii) our results of discontinued operations.

Consolidated Results of Continuing Operations

Three Months Ended September 30, 2015 Compared to Three Months Ended September 30, 2014

Net loss from continuing operations for the quarter ended September 30, 2015 was $13.5 million as compared to a loss of $4.3 million for the quarter ended September 30, 2014, an increase of $9.2 million. Total income from continuing operations was $2.8 million for the quarter ended September 30, 2015, an increase of $6.4 million as compared to loss from continuing operations of $3.6 million during the same period in 2014. Total expenses from continuing operations were $21.0 million for the quarter ended September 30, 2015 compared to total expenses from continuing operations of $2.9 million incurred during the same period in 2014, an increase of $18.1 million, primarily as a result of interest expense, the change in fair value of the Revolving Credit Facilities and extinguishment of the Secured Notes.

Our net loss for the quarter ended September 30, 2015 includes approximately $8.8 million related to the extinguishment of our Secured Notes and an income tax benefit of approximately $4.7 million. See Note 12, "12.875% Senior Secured Notes" and Note 17, "Income Taxes" to the accompanying consolidated financial statements.

Change in fair value of life settlements. Change in fair value of life settlements was a gain of approximately $2.7 million for the quarter ended September 30, 2015 compared to a loss of $3.6 million for the quarter ended September 30, 2014, an increase of $6.3 million.

During the quarter ended September 30, 2015, two life insurance policies with face amounts totaling $3.7 million matured. The net gain of these maturities was $2.4 million and is recorded as a change in fair value of life settlements in the consolidated statements of operations for the quarter ended September 30, 2015. Both of these maturities served as collateral under the Red Falcon Revolving Credit Facility. Proceeds from maturities totaling $28.3 million were received during the quarter ended September 30, 2015, including $24.6 million of which was outstanding for the quarter ended June 30, 2015. Approximately $24.7 million was utilized to repay borrowings under the White Eagle Revolving Credit Facility. Approximately $1.7 million was utilized to repay borrowings, interest and credit facility expenses under the Red Falcon Revolving Facility during the three months ended September 30, 2015. The Company recorded a $10.1 million receivable for maturity of life settlements at September 30, 2015 relating to the White Eagle Revolving Credit Facility.

39

As of September 30, 2015, we owned 634 policies with an estimated fair value of $457.8 million compared to 595 policies with a fair value of $350.4 million at September 30, 2014, an increase of $107.4 million or 31%. Of the 634 policies, 439 policies were pledged to the White Eagle Revolving Credit Facility and 157 policies were pledged to the Red Falcon Revolving Credit Facility. During the three months ended September 30, 2015, the Company acquired three life insurance policies that resulted in a gain of approximately $1.5 million compared to two policies during the same period in 2014. As of September 30, 2015, the aggregate death benefit of our life settlements was $3.0 billion.

Of these 634 policies owned as of September 30, 2015, 547 were previously premium financed and are valued using discount rates that range from 16.00% – 24.75%. The remaining 87 policies are valued using discount rates that range from 15.00% – 21.00%. See Note 13, “Fair Value Measurements,” to the accompanying consolidated financial statements.

Expenses

Interest expense. Interest expense increased to $8.6 million during the quarter ended September 30, 2015, compared to $4.3 million during the same period in 2014, an increase of $4.3 million, as the Company's outstanding debt increased to $285.7 million. Outstanding debt included $159.9 million of outstanding principal on the White Eagle Revolving Credit Facility, $55.1 million on the Red Falcon Revolving Credit Facility and $70.7 million of Convertible Notes. During the quarter ended September 30, 2015, the Company redeemed all outstanding Secured Notes.

Of the interest expense of $8.6 million for the third quarter of 2015, approximately $2.3 million represents interest paid on the White Eagle Revolving Credit Facility and approximately $3.8 million was attributable to the Red Falcon Revolving Credit Facility, which includes $3.2 million relating to the debt issuance cost which was not capitalized as a result of electing the fair value option for valuing this debt and an additional $601,000 related to interest payments paid during the quarter ended September 30, 2015. Interest expense on the Convertible Notes totaled $2.3 million, including $1.5 million, $711,000 and $105,000 representing interest, amortization of debt discount and issuance costs, respectively.

Of the interest expense of $4.3 million for third quarter of 2014, approximately $2.1 million represents interest paid on the White Eagle Revolving Credit Facility. Interest expense also includes $1.5 million, $605,000 and $90,000 representing interest, amortization of debt discount and issuance costs, respectively, on the Convertible Notes.

See Notes 9, 10, 11 and 12 to the accompanying consolidated financial statements.

Extinguishment of Secured Notes. During the quarter ended September 30, 2015, the Company redeemed all of the outstanding Secured Notes and discharged the related Secured Note indenture. The Secured Notes were redeemed at 106% of their principal amount plus interest up to but excluding November 10, 2015. Approximately $8.8 million was expensed as extinguishment related to the early repayment of the Secured Notes for the quarter ended September 30, 2015. This includes $5.2 million, $171,000, $1.7 million and $1.7 million related to interest and prepayment penalties, unused fees, write off of debt discount and write off of issuance cost.

Change in fair value of Revolving Credit Facilities. Change in fair value of Revolving Credit Facilities was a gain of $4.2 million, of this amount, approximately $4.8 million gain is attributable to the White Eagle Revolving Credit Facility for the quarter ended September 30, 2015 compared to a gain of $8.4 million for the quarter ended September 30, 2014. This change is associated with the lengthening of life expectancies of certain insureds underlying policies pledged as collateral in the facility and increased borrowings. This was offset by a reduction in the discount rate. The White Eagle Revolving Credit Facility is valued at September 30, 2015 using a discount rate of 23.55%.

Change in fair value of Revolving Credit Facilities also includes a loss of $581,000 attributable to the Red Falcon Revolving Credit Facility for the quarter ended September 30, 2015. This change is associated with the election of the fair value option in accounting for the facility and a reduction in the discount rate since inception. The Red Falcon Revolving Credit Facility is valued at September 30, 2015 using a discount rate of 11.18%. See Note 13, “Fair Value Measurements,” to the accompanying consolidated financial statements.

Selling, general and administrative expenses. SG&A expenses were $7.8 million for the quarter ended September 30, 2015 compared to $7.0 million for the same period in 2014. This was primarily a result of an increase in professional fees of $436,000, a $427,000increase in legal expense, a $35,000increase in personnel cost and a $41,000 increase in other SG&A expenses. These increases were offset by a $105,000decrease in insurance costs.

Legal expenses for the quarter ended September 30, 2015 were $3.4 million compared to $2.9 million for the quarter ended September 30, 2014. Of the legal expense, approximately $2.8 million is associated with the USAO Investigation, IRS

40

Investigation and related matters for the quarter ended September 30, 2015, compared to $1.2 million for the quarter ended September 30, 2014. See Note 15, “Commitments and Contingencies,” to the accompanying consolidated financial statements.

Results of Discontinued Operations

Three Months Ended September 30, 2015 Compared to Three Months Ended September 30, 2014

Net loss from our discontinued structured settlement operations for the quarter ended September 30, 2015 was $113,000 as compared to a net loss of $249,000 for the quarter ended September 30, 2014. Total income from our discontinued structured settlement operations was a loss of $13,000 and income of $38,000 for the quarter ended September 30, 2015 and 2014, respectively. Unrealized change in fair value of structured settlements receivable was $4,000 and $8,000 for the quarters ended September 30, 2015 and 2014, respectively. During the quarter ended September 30, 2015, our discontinued structured settlement operations sold 43 structured settlements for a loss of approximately $31,000 and proceeds of approximately $920,000. There was no such sale in 2014.

Total expenses from our discontinued structured settlement operations were $134,000 for the quarter ended September 30, 2015 compared to $287,000 incurred during the same period in 2014. This decrease was attributable to a $151,000decrease in legal fees.

Consolidated Results of Continuing Operations

Nine Months Ended September 30, 2015 Compared to Nine Months Ended September 30, 2014

Net loss from continuing operations for the nine months ended September 30, 2015 was $16.7 million as compared to a net loss of $13.9 million for the nine months ended September 30, 2014, an increase of $2.8 million. Total income from continuing operations was $43.8 million for the nine months ended September 30, 2015, an increase of $24.8 million as compared to total income from continuing operations of $19.0 million during the same period in 2014. Total expenses from continuing operations were $67.5 million for the nine months ended September 30, 2015 compared to total expenses from continuing operations of $35.3 million incurred during the same period in 2014, an increase of $32.2 million, or 91%, primarily as a result of interest expense, the change in fair value of the Revolving Credit Facilities and extinguishment of the Secured Notes.

Our net loss for the nine months ended September 30, 2015 includes approximately $8.8 million related to the extinguishment of our Secured Notes and an income tax benefit of approximately $7.0 million. See Notes 12 and 17 to the accompanying consolidated financial statements.

Change in fair value of life settlements. Change in fair value of life settlements was a gain of approximately $43.6 million for the nine months ended September 30, 2015 compared to a gain of $19.3 million for the nine months ended September 30, 2014, which represents an increase of $24.3 million.

During the nine months ended September 30, 2015, 14 life insurance policies with face amounts totaling $53.5 million matured compared to five policies with face amounts totaling $11.5 million for the same period in 2014. The net gain of these maturities was $40.2 million and $10.6 million for 2015 and 2014, respectively, and is recorded as a change in fair value of life settlements in the consolidated statements of operations for the nine months ended September 30, 2015 and 2014, respectively. 11 of these maturities served as collateral under the White Eagle Revolving Credit Facility and two under the Red Falcon Revolving Credit Facility. Proceeds from maturities totaling $47.5 million were received during the nine months ended September 30, 2015. Of this amount, approximately $43.2 million was utilized to repay borrowings under the White Eagle Revolving Credit Facility and $1.7 million under the Red Falcon Revolving Credit Facility during the nine months ended September 30, 2015. We recorded a $10.1 million receivable for maturity of life settlements at September 30, 2015.

As of September 30, 2015, we owned 634 policies with an estimated fair value of $457.8 million compared to 595 policies with a fair value of $350.4 million at September 30, 2014, an increase of $107.4 million or 31%. Of the 634 policies, 439 policies were pledged to the White Eagle Revolving Credit Facility and 157 policies to the Red Falcon Revolving Credit Facility. During the nine months ended September 30, 2015, we acquired 41 life insurance policies that resulted in a gain of approximately $5.9 million. As of September 30, 2015, the aggregate death benefit of our life settlements was $3.0 billion.

Of these 634 policies owned as of September 30, 2015, 547 were previously premium financed and are valued using discount rates that range from 16.00% – 24.75%. The remaining 87 policies are valued using discount rates that range from 15.00% – 21.00%. See Note 13, “Fair Value Measurements,” to the accompanying consolidated financial statements.

41

Loss on life settlements, net. There was no gain/loss on life settlements, net for the nine months ended September 30, 2015, as there were no policy sales. During the nine months ended September 30, 2014, 14 policies were sold resulting in a loss of approximately $426,000 on net proceeds received of $4.0 million.

Expenses

Interest expense. Interest expense increased to $21.5 million during the nine months ended September 30, 2015, compared to $11.2 million during the same period in 2014, an increase of $10.3 million, as our outstanding debt increased to $285.7 million. Outstanding debt included $159.9 million of outstanding principal on the White Eagle Revolving Credit Facility, $55.1 million of outstanding principal on the Red Falcon Revolving Credit Facility and $70.7 million of Convertible Notes. During the nine months ended September 30, 2015, the Company redeemed all outstanding Secured Notes.

Of the interest expense of $21.5 million in 2015, approximately $6.9 million represents interest paid on the White Eagle Revolving Credit Facility and approximately $3.8 million was attributable to the Red Falcon Revolving Credit Facility, which includes $3.2 million relating to the debt issuance cost that was not capitalized as a result of electing the fair value option for valuing this debt and an additional $601,000 related to interest payments paid during the nine months ended September 30, 2015.

Interest expense on the Convertible Notes totaled $6.8 million, including $4.5 million, $2.0 million and $294,000 representing interest, amortization of debt discount and issuance costs, respectively. We recorded $4.0 million of interest expense on the Secured Notes, including $3.2 million, $265,000, $264,000, and $277,000 from interest, unused fees, amortization of debt discounts and issuance costs, respectively.

Of the interest expense of $11.2 million for nine months ended September 30, 2014, approximately $5.8 million represents interest paid on the White Eagle Revolving Credit Facility. Interest expense on the Convertible Notes totaled $5.3 million including $3.7 million, $1.4 million and $239,000 representing interest, amortizing debt discounts and issuance costs, respectively.

See Notes 9, 10, 11 and 12 to the accompanying consolidated financial statements.

Extinguishment of Secured Notes. During the nine months ended September 30, 2015, the Company redeemed all of the outstanding Secured Notes and discharged the Secured Note Indenture. The Secured Notes were redeemed at 106% of their principal amount plus interest up to but excluding November 10, 2015. Approximately $8.8 million was expensed as extinguishment related to the early repayment of the facility for the nine months ended September 30, 2015. This includes $5.2 million, $171,000, $1.7 million and $1.7 million related to interest and prepayment penalties, unused fees, write off of debt discount and write off of issuance cost.

Change in fair value of Revolving Credit Facilities. Change in fair value of Revolving Credit Facilities was a loss of approximately $13.5 million for the nine months ended September 30, 2015 compared to a gain of approximately $4.6 million for the nine months ended September 30, 2014. Of this loss, approximately $12.9 million is attributable to the White Eagle Revolving Credit Facility compared to a gain of $4.6 million for the nine months ended September 30, 2014. This loss is associated with a projected early repayment of the White Eagle Revolving Credit Facility given earlier than projected maturities in the nine months ended September 30, 2015 and a reduction in the discount rate. These were offset by increased borrowings and the lengthening of life expectancies of certain insureds underlying policies pledged as collateral in the facility. The White Eagle Revolving Credit Facility is valued at September 30, 2015 using a discount rate of 23.55%.

Change in fair value of Revolving Credit Facilities also includes a loss of $581,000 attributable to the Red Falcon Revolving Credit Facility for the nine months ended September 30, 2015. This change is associated with the election of the fair value option in accounting for the facility and a reduction in the discount rate. The Red Falcon Revolving Credit Facility is valued at September 30, 2015 using a discount rate of 11.18%. See Note 13, “Fair Value Measurements,” to the accompanying consolidated financial statements.

Change in fair value of conversion derivative liability. Change in fair value of conversion derivative liability embedded in the Convertible Notes was zero for the nine months ended September 30, 2015 compared to a loss of approximately $6.8 million for the nine months ended September 30, 2014. ASC 815, Derivatives and Hedging, required us to bifurcate the embedded conversion option, which was valued on February 21, 2014 and June 5, 2014, which resulted in a fair value loss of approximately $6.8 million for the nine months ended September 30, 2014. Effective June 2014, the liability was reclassified to stockholders’ equity and was no longer required to be recorded at fair value

42

Selling, general and administrative expenses. SG&A expenses were $23.7 million for the nine months ended September 30, 2015 compared to $21.9 million for the same period in 2014. This was primarily a result of a $1.7 millionincrease in professional fees, a $1.2 millionincrease in legal expense, and a $306,000increase in other SG&A expenses. These increases were offset by a decrease in personnel costs of $1.2 million and insurance costs of $287,000.

Legal expenses for the nine months ended September 30, 2015 were $10.3 million compared to $9.1 million for the nine months ended September 30, 2014. Of the legal expense, approximately $7.0 million is associated with the USAO Investigation, IRS Investigation, SEC Investigation and related matters for the nine months ended September 30, 2015, compared to $3.2 million for the nine months ended September 30, 2014. See Note 15, “Commitments and Contingencies,” to the accompanying consolidated financial statements.

Results of Discontinued Operations

Nine Months Ended September 30, 2015 Compared to Nine Months Ended September 30, 2014

Net loss from our discontinued structured settlement operations for the nine months ended September 30, 2015 was $416,000 as compared to a net loss of $454,000 for the nine months ended September 30, 2014. Total income from our discontinued structured settlement operations was $60,000 for the nine months ended September 30, 2015 compared to $150,000 in 2014. During the nine months ended September 30, 2015, our discontinued structured settlement operations sold 43 structured settlement for a loss of approximately $31,000, the Company received proceeds of approximately $920,000. During the nine months ended September 30, 2014, our discontinued structured settlement operations sold eight structured settlement for a gain of $18,000. Unrealized change in fair value of structured settlements receivable was $20,000 and $24,000 for the nine months ended September 30, 2015 and 2014, respectively.

Total expenses from our discontinued structured settlement operations were $700,000 for the nine months ended September 30, 2015 compared to $604,000 incurred during the same period in 2014. This increase was attributable to a $103,000increase in legal fees.

Liquidity and Capital Resources

Our consolidated financial statements have been prepared assuming the realization of assets and the satisfaction of liabilities in the normal course, as well as continued compliance with the covenants contained in the Revolving Credit Facilities, the indenture governing our Convertible Notes and other financing arrangements.

At September 30, 2015, we had approximately $40.4 million of cash and cash equivalents. We expect to meet our liquidity needs for the foreseeable future primarily through a combination of the receipt of death benefits from life insurance policy maturities, borrowings under the Revolving Credit Facilities, strategic capital market raises, policy sales (subject to the asset sale restrictions in our debt arrangements) and cash on hand.

For the nine months ended September 30, 2015, we paid $48.2 million in premiums to maintain our policies in force. Of this amount, $34.8 million was paid by White Eagle through its borrowings and $3.1 million was paid by Red Falcon through its borrowings. While the liquidity risk associated with the policies that have been pledged as collateral under the Revolving Credit Facilities has been mitigated, any distributions from available proceeds under the Revolving Credit Facilities will vary based on the respective then current loan to value ratio. Accordingly, there can be no assurance as to when the proceeds from maturities of the policies pledged as collateral under the Revolving Credit Facilities will be distributed to the Company. As we continue to acquire additional life settlement assets, we expect our premium obligations to increase. Assuming no policy maturities, as of September 30, 2015, we expect to pay $1.1 million in premiums during the remainder of 2015 on the 38 policies that have not been pledged under the Revolving Credit Facilities. Additionally, at September 30, 2015, $70.7 million in aggregate principal amount of Convertible Notes was outstanding, which accrued interest at 8.50%. Interest on the Convertible Notes is due semi-annually.

As of September 30, 2015, the Company’s cumulative legal and related fees in respect of the USAO Investigation (including indemnification obligations), the SEC Investigation, the IRS Investigation and related matters were $47.4 million, including $2.8 million and $1.2 million incurred during the three months ended September 30, 2015 and 2014, respectively, and $7.0 million and $3.2 million incurred during the nine months ended September 30, 2015 and 2014, respectively. We believe we may continue to spend significant amounts on these matters as well as for general litigation and judicial proceedings over the next year, and possibly beyond. In addition, as part of the framework for the settlements of certain litigation arising from the USAO Investigation, the Company has undertaken to advance legal fees and indemnify certain individuals and entities

43

associated with the Company's legacy premium finance business. The remaining obligation to advance and indemnify on behalf of these individuals and entities, while currently unquantifiable, may be substantial and could have a material adverse effect on the Company’s financial position and results of operations.

Accordingly, the Company must pro-actively manage its cash in order to effectively run its businesses, service its debt and opportunistically grow its assets. To do so, the Company may in the future determine, subject to the covenants and restrictions in its debt arrangements, to sell or, under certain circumstances, lapse certain of its policies as its portfolio management strategy and liquidity needs dictate. The lapsing of policies, if any, could result in events of default under the Revolving Credit Facilities and would create losses as such assets would be written down to zero.

Financing Arrangements Summary

Red Falcon Revolving Credit Facility

Effective July 16, 2015, Red Falcon, as borrower, entered into a $110.0 million 7-year credit facility that provides for five years of revolving credit borrowing with LNV Corporation, as initial lender, the other lenders party thereto from time to time, Imperial Finance & Trading, LLC, as guarantor, Blue Heron as portfolio administrator and CLMG Corp., as administrative agent (the “Agent”).

Borrowing availability under the Red Falcon Revolving Credit Facility is subject to a borrowing base, which among other items is capped at 60% of the valuation of the policies pledged as collateral. This loan to value calculation is determined by the lenders with a high degree of discretion. At September 30, 2015, $54.9 million was undrawn and $110,000 was available to borrow under the Red Falcon Revolving Credit Facility. For a description of the facility see Note 10, “Red Falcon Revolving Credit Facility,” of the notes to Consolidated Financial Statements.

At September 30, 2015, the fair value of the debt under the Red Falcon Revolving Credit Facility $55.7 million. As of September 30, 2015, the borrowing base was approximately $55.2 million including $55.1 million in outstanding principal. Outstanding interest at 5.5% per annum and required amortization at 8% per annum on the greater of the then outstanding balance of the loan or the initial advance are due monthly. During the quarter ended September 30, 2015, required amortization paid was $740,000 which includes $367,000 paid directly by Red Falcon and $373,000 from policy proceeds. Interest totaling $601,000 was paid during the quarter ended September 30, 2015 which includes $268,000 paid directly by Red Falcon and $333,000 from policy proceeds.

White Eagle Revolving Credit Facility

Effective April 29, 2013, White Eagle, as borrower, entered into a $300.0 million revolving credit facility, which was amended and restated on May 16, 2014 in connection with the conversion of White Eagle from a Delaware limited liability company to a Delaware limited partnership, with Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders.

Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which, among other items, is capped at 75% of the valuation of the policies pledged as collateral. This loan to value calculation is determined by the lenders with a high degree of discretion. At September 30, 2015, $140.1 million was undrawn and $1.9 million was available to borrow under the White Eagle Revolving Credit Facility. For a description of the facility see Note 9, “White Eagle Revolving Credit Facility,” of the notes to Consolidated Financial Statements.

At September 30, 2015, the fair value of the debt under the White Eagle Revolving Credit Facility was $157.9 million. As of September 30, 2015, the borrowing base was approximately $161.8 million including $159.9 million in outstanding principal. There are no scheduled repayments of principal. Payments are due upon receipt of death benefits and distributed pursuant to the waterfall described in Note 9, “White Eagle Revolving Credit Facility,” of the notes to Consolidated Financial Statements.

8.50% Senior Unsecured Convertible Notes

At September 30, 2015, there was $70.7 million in aggregate principal amount of the Company’s 8.50% senior unsecured convertible notes due 2019 outstanding. For a description of the Convertible Notes see Note 11, “8.50% Senior Unsecured Convertible Notes,” of the notes to Consolidated Financial Statements.

44

12.875% Senior Secured Notes

During the quarter ended September 30, 2015, the Secured Notes were redeemed. For a description of the Secured Notes, see Note 12, “12.875% Senior Secured Notes” of the notes to Consolidated Financial Statements.

Cash Flows

Cash Flows

The following table summarizes our cash flows from operating, investing and financing activities for the nine months ended September 30, 2015 and 2014 (in thousands):

	Nine Months Ended September 30,
	2015			2014
Statement of Cash Flows Data:
Total cash (used in) provided by :
Operating activities	$	(37,401	)	$	(23,986	)
Investing activities	(29,675		)	(26,622		)
Financing activities	52,576			86,301
Increase (decrease) in cash and cash equivalents	$	(14,500	)	$	35,693

Operating Activities

During the nine months ended September 30, 2015, operating activities used cash of $37.4 million. Our net loss of $17.1 million was adjusted for: White Eagle Revolving Credit Facility financing costs and fees of $5.6 million, which represent interest expense and other fees associated with the White Eagle Revolving Credit Facility withheld by the lender and added to the outstanding loan balance; change in fair value of life settlement gains of $43.6 million that is mainly attributable to the maturities of 14 policies; change in fair value of Revolving Credit Facilities loss of $13.5 million mainly attributable to the projected early repayment of the White Eagle Revolving Credit Facility given earlier than projected maturities during the nine months ended September 30, 2015 and a reduction in the discount rate. These were offset by increased borrowings and the lengthening of life expectancies of certain insureds underlying policies pledged as collateral in the facility. Red Falcon Revolving Credit Facility origination cost was $3.3 million relating to the debt issuance cost which was not capitalized as a result of electing the fair value option for valuing this debt. Extinguishment of Secured Notes was $8.8 million which represents redemption at 106% of their principal amount plus interest; deferred income tax benefit of $7.2 million and a net negative change in the components of operating assets and liabilities of $3.8 million. This $3.8 million change in operating assets and liabilities is partially attributable to a $1.5 milliondecrease in accounts payable and accrued expenses, a $1.5 milliondecrease in interest payable for the Convertible Notes, a $812,000decrease in other liabilities, and a $654,000increase in deposit. These were offset by a $1.1 milliondecrease in structured settlement receivables associated with the sale during the period.

During the nine months ended September 30, 2014, operating activities used cash of $24.0 million. Our net loss of $14.3 million was adjusted for: White Eagle Revolving Credit Facility financing costs and fees of $4.2 million, which represent interest expense and other fees associated with the White Eagle Revolving Credit Facility withheld by the lender and added to the outstanding loan balance; change in fair value of life settlement gains of $19.3 million that is mainly attributable to the maturities of five policies; change in fair value of the White Eagle Revolving Credit Facility gain of $4.6 million that resulted from increased borrowings and an increase in the discount rate used to value the facility. These were offset by projected early repayment of the White Eagle Revolving Credit Facility given earlier than projected maturities; change in fair value of conversion derivative liability loss of $6.8 million resulted from an increase in the fair value of the embedded derivative included in the Convertible Notes, deferred income tax benefit of $2.5 million, and a net positive change in the components of operating assets and liabilities of $2.9 million. This $2.9 million change in operating assets and liabilities is partially attributable to a $14.3 milliondecrease in other liabilities, offset by a $13.5 milliondecrease in restricted cash, both associated with the settlement of the class action and derivative litigation. This reduction was offset by a $2.5 millionincrease in accounts payable and accrued expenses.

45

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2015 was $29.7 million and includes proceeds of $47.5 million from maturity of 14 life settlements. This was offset by $48.2 million for premiums paid on life settlements and $28.9 million for purchases of life settlements.

Net cash used in investing activities for the nine months ended September 30, 2014 was $26.6 million and includes $4.0 million from sale of investments in life settlements that were associated with the sale of 14 policies during the period and proceeds of $13.6 million from maturity of six life settlements. This was offset by $40.6 million for premiums paid on investments in life settlements and $3.5 million for purchase of life settlements.

Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2015 was $52.6 million and includes $38.5 million of net proceeds from the rights offering completed in the second quarter of 2015, $23.8 million of net proceeds from the Secured Notes, $36.9 million of borrowings from the White Eagle Revolving Credit Facility and $3.0 million of borrowings from the Red Falcon Revolving Credit Facility. These were offset by $43.2 million in repayment of borrowings under the White Eagle Revolving Credit Facility; $1.9 million in repayment of borrowings under the Red Falcon Revolving Credit Facility and $3.6 million for the extinguishment of the Secured Notes.

Net cash provided by financing activities for the nine months ended September 30, 2014 was $86.3 million and includes $67.9 million in net proceeds from the Convertible Notes and $36.0 million of borrowings from the White Eagle Revolving Credit Facility. These were offset by $17.6 million in repayment of borrowings under the White Eagle Revolving Credit Facility.

Inflation

Our assets and liabilities are, and will be in the future, interest-rate sensitive in nature. As a result, interest rates may influence our performance far more than inflation. Changes in interest rates do not necessarily correlate with inflation or changes in inflation rates. We do not believe that inflation had any material impact on our results of operations in the periods presented in our financial statements presented in this report.

Off-Balance Sheet Arrangements

At September 30, 2015, there were no off-balance sheet arrangements between us and any other entity that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to shareholders.

Item 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the risk of potential economic loss principally arising from adverse changes in the fair value of financial instruments. The major components of market risk are credit risk, interest rate risk and foreign currency risk. As of September 30, 2015, we did not hold a material amount of financial instruments for trading purposes.

Credit Risk

Credit risk consists primarily of the potential loss arising from adverse changes in the financial condition of the issuers of the life insurance policies that we own. Although we may purchase life settlements issued by carriers rated below investment grade, to limit our credit risk, we generally only purchase life settlements issued by carriers that are investment grade.

The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of our life settlements as of September 30, 2015:

Carrier	Percentage of Total Fair Value		Percentage of Total Death Benefit		Moody’s Rating	S&P Rating
Transamerica Life Insurance Company	20.6	%	20.5	%	A1	AA-
Lincoln National Life Insurance Company	21.6	%	19.6	%	A1	AA-

46

Interest Rate Risk

At September 30, 2015, fluctuations in interest rates did not impact interest expense in the life finance business. The White Eagle Revolving Credit Facility and the Red Falcon Revolving Credit Facility accrue interest at LIBOR plus an applicable margin. LIBOR under the White Eagle Revolving Credit Facility and Red Falcon Revolving Credit Facility, in each case, is subject to a floor of 1.5% and 1.0%, respectively, and the Company does not expect a fluctuation in interest rates to have a meaningful impact on the Company’s interest expense in the short term. Increases in LIBOR above the respective floors provided in the Revolving Credit Facilities, however, would likely affect the calculation of the fair value of the debt under the Revolving Credit Facilities. Additional increases in interest rates may impact the rates at which we are able to obtain financing in the future. Holding other variables constant, a hypothetical 1% increase in LIBOR would not be expected to have a material impact of interest expense for quarter ended September 30, 2015.

We earn income on the changes in fair value of the life insurance policies we own. However, if the fair value of the life insurance policies we own decreases, we record this reduction as a loss. As of September 30, 2015, we owned life settlements with a fair value of $457.8 million. A rise in interest rates could potentially have an adverse impact on the sale price if we were to sell some or all of these assets, which could also decrease the borrowing base available to White Eagle and Red Falcon under their respective Revolving Credit Facilities. There are several factors that affect the market value of life settlements, including the age and health of the insured, investors’ demand, available liquidity in the marketplace, duration and longevity of the policy, and interest rates. We currently do not view the risk of a decline in the sale price of life settlements due to normal changes in interest rates as a material risk.

Foreign Currency Exchange Rate Risk

Changes in the exchange rate between transactions denominated in a currency other than our foreign subsidiary companies functional currency are immaterial to our operating results. Exposure to foreign currency exchange rate risk may increase over time as our business evolves.

Item 4.        CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Limitations on Controls

Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures or our internal controls over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based on certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

47

Item 1.        Litigation

For a description of legal proceedings, see “Litigation” under Note 15, “Commitments and Contingencies” to our consolidated financial statements.

Item 1A.    Risk Factors

Except as set forth below, our risk factors have not changed materially from those disclosed in our Annual Report on Form 10-K filed for the year ended December 31, 2014.

Recent and future increases to the premiums due on life insurance policies that we own will adversely affect the fair value and our returns on such life insurance policies.

Certain insurance companies have recently announced that they were increasing the cost of insurance on certain types of their issued policies, which will result in increases to the premium payments necessary to keep the affected policies in force. To date, the Company has been informed that 22 policies that it owns will be impacted by these cost of insurance increases. While these increases have not impacted the Company's results of operations for the quarter ended September 30, 2015 and the Company is still assessing their long term impact on its portfolio, the Company expects that the increases will cause the fair value of the 22 policies to decrease during the quarter ending December 31, 2015 and will require us to incur additional costs to maintain these policies. Further cost of insurance increases could have a material adverse effect on our business, results of operations and the value of any affected policies.

Item 2.        Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities

The following table shows the purchases of shares of our common stock made by or on behalf of the Company during the three months ended September 30, 2015:

Period	Total Number of Shares Purchased (1)	Average Price Paid per share
July 1 through July 31	—	—
August 1 through August 31	—	—
September 1 through September 30	65,621	$5.30
Total	65,621	$5.30

(1) On September 1, 2015, the Company announced that its board of directors authorized a $10 million share and note repurchase program. The program has a two-year expiration date, and authorizes the Company to repurchase up to $10 million of its common stock and/or its Convertible Notes. For the quarter ended September 30, 2015, the Company purchased 65,621 shares for a total cost of approximately $348,000, which is an average cost of $5.30 per share including transaction fees. As of September 30, 2015, the Company may purchase up to approximately $9.7 million of additional common stock or notes under its board authorized plan.

Item 3.        Default Upon Senior Securities

None.

Item 4.        Mine Safety Disclosures

None.

Item 5.        Other Information

None.

48

Item 6.        Exhibits

See the Exhibit Index following the Signatures page of this Quarterly Report on Form 10-Q.

49

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Emergent Capital, Inc.
/s/ Richard S. O’Connell, Jr.	Chief Financial Officer and Chief Credit Officer
Richard S. O’Connell, Jr.	(Principal Financial Officer)
Date November 9, 2015

50

EXHIBIT INDEX

In reviewing the agreement included as an exhibit to this report, please remember it is included to provide you with information regarding its terms and is not intended to provide any other factual or disclosure information about the Company, its subsidiary companies or other parties to the agreement. The agreement contains representations and warranties that have been made solely for the benefit of the other parties to the agreement and:

• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;

• have been qualified by disclosures that were made to the other party in connection with the negotiation of the agreement, which disclosures are not necessarily reflected in the agreement;

• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and

• were made only as of the date of the agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. The Company acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material information regarding material contractual provisions are required to make the statements in this report not misleading. Additional information about the Company may be found elsewhere in this report and the Company’s other public files, which are available without charge through the SEC’s website at http://www.sec.gov.

Exhibit No.	Description
Exhibit 10.1	Employment Agreement between the Registrant and David Sasso, dated December 31, 2013 and effective January 1, 2014.
Exhibit 31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 101.	Interactive Data Files
Exhibit 101.INS +	XBRL Instance Document
Exhibit 101.SCH +	XBRL Taxonomy Extension Schema Document
Exhibit 101.CAL +	XBRL Taxonomy Extension Calculation Linkbase Document
Exhibit 101.DEF +	XBRL Taxonomy Definition Linkbase Document
Exhibit 101.LAB +	XBRL Taxonomy Extension Label Linkbase Document 10.1 & 10.2
Exhibit 101.PRE +	XBRL Taxonomy Extension Presentation Linkbase Document

+    Submitted electronically with this Quarterly Report

51

EX-10.1

EMPLOYMENT AGREEMENT

EMPLOYMENT AGREEMENT (“Agreement”) dated as of December 30, 2013 by and between Imperial Holdings, Inc., a Florida corporation (the "Company"), and David Sasso (the "Executive") (each a "Party" and together, the "Parties").

WHEREAS, the Executive has been the Director of Investor Relations of the Company; and

WHEREAS, the Parties wish to establish the terms of the Executive's employment as of January 1, 2014.

NOW THEREFORE, in consideration of the premises and mutual considerations herein and for other good and valuable consideration:

1.Employment and Acceptance. The Company shall employ the Executive, and the Executive shall accept employment, subject to the terms of this Agreement as of January 1, 2014 (the "Effective Date").

2.Term. Subject to earlier termination pursuant to Section 5 of this Agreement, this Agreement and the employment relationship hereunder shall continue from the Effective Date until the third anniversary of the Effective Date(the "Initial Term") and shall renew for one (1) year intervals thereafter (each, an "Extended Term") unless either Party shall have given written notice to the other at least sixty (60) days prior to the end of the Initial Term or an Extended Term that it does not wish to extend the Term. As used in this Agreement, the "Term" shall refer to the period beginning on the Effective Date and ending on the date of expiration of this Agreement, or, if earlier, the date the Executive's employment terminates in accordance with Section 5 (the "Termination Date"). In the event that the Executive's employment with the Company terminates, the Company's obligation to continue to pay, after the date of termination, Base Salary (as defined below), Bonus (as defined below) and other unaccrued benefits shall terminate except as may be provided for in Section 5.

3.Duties, Title and Location.

3.1Title. The Company shall employ the Executive to render exclusive and full-time services to the Company and its subsidiaries. The Executive shall serve in the capacity of Director of Investor Relations, and shall report directly to the Chief Executive Officer (“CEO”) and indirectly to the Board of Directors (“Board”).

3.2Duties. The Executive will have such duties, powers and authorities as are commensurate with his position as Director of Investor Relations of the Company and as may be reasonably assigned by the CEO and the Board from time to time. The Executive will devote his full working-time and attention (other than due to physical or mental incapacity) to the performance of such duties and to the promotion of the business and interests of the Company and its subsidiaries. The Executive shall obtain written approval in advance from the Board prior to serving on the board of directors of any outside company or organization.

3.3Location. The Executive shall perform his full-time services to the Company and its subsidiaries at the Company's headquarters, currently located in Boca Raton, Florida; providedthat the Executive shall be required to travel to other locations from time to time as required by the Company's business.

4.Compensation and Benefits by the Company. As compensation for all services rendered pursuant to this Agreement, the Company shall provide the Executive the following during the Term:

4.1Base Salary. The Company will pay to the Executive an annual base salary of One Hundred and Seventy-eight Thousand Dollars ($178,000), payable in accordance with the customary payroll practices of the Company ("Base Salary"). The Base Salary shall be reviewed by the Board and may be increased, but not decreased, from time to time during the Term, in the sole determination of the Board, based upon its assessment of performance, leadership, Company profitability and market conditions, or based upon any other good-faith evaluation performed by the Board. In its determination of performance, the Board may consider any individual, departmental or Company-level factor it deems relevant.

4.2Bonus. With respect to each fiscal year during the Term, the Executive shall beeligible to receivean annual bonus (the "Bonus") with a target amount equal to thirty percent (30%) of the Base Salary ("Target") and a potential of up to eighty percent (80%) of Base Salary (“Maximum”), to be paid at the sole discretion of the Board if, in the reasonable view of the Board, the Company achieves or exceeds targeted performance goals as may be established by the Board from time to time, or based upon any other good-faith evaluation performed by the Board pursuant to any Bonus arrangements. The Bonus for each fiscal year during the Term, if any, shall be payable to the Executive within two and one-half months following the fiscal year to which the Bonus relates. Except as otherwise set forth in Section 5, the Executive must be employed with the Company, and not have given notice of resignation, as of the last day of the fiscal year to which the Bonus relates in order to receive a Bonus.

4.3Long-Term Incentive. The Executive shall participate in the Long-Term Incentive Plan (“LTIP”) of the Company, to the extent such program exists and is offered to similarly-situated executives of the Company, subject to the terms and conditions of the LTIP, including terms regarding vesting and forfeiture set forth in the LTIP.

4.4Participation in Employee Benefit Plans. The Executive shall be entitled, if and to the extent eligible, to participate in all of the applicable benefit plans and perquisite programs of the Company, which are available to other senior executives of the Company. The Company may at any time or from time to time amend, modify, suspend or terminate any employee benefit plan, program, perquisite or arrangement for any reason without the Executive's consent if such amendment, modification, suspension or termination is consistent with the amendment, modification, suspension or termination for other executives of the Company.

4.5Expense Reimbursement.

(a)The Executive shall be entitled to receive reimbursement for all appropriate and reasonable business expensesincurred by him in connection with his duties under this Agreement in accordance with the policies of the Company as in effect from time to time.

(b)The payment or reimbursement of any expense pursuant to this Section 4.5 in one of the Executive's taxable years shall not affect the amount of the payment or reimbursement of any other expense pursuant to this Section 4.5 in any other of the Executive's taxable years. Any payment or reimbursement for expenses under this Section 4.5 shall in any event be made on or before the last day of the Executive's taxable year following the taxable year in which the expense was incurred. Notwithstanding the foregoing, expense reimbursement shall be made with 60 days following approval of appropriately documented expenses.

4.6Claw-Back. Executive acknowledges that incentive and equity compensation described in this Section 4 may be subject to Company claw-back policies applicable to all executive officers of the Company and adopted in good faith by the Company’s Board from time to time.

5.Termination of Employment.

5.1By the Company for Cause or by the Executive Without Good Reason. If: (i) the Company terminates the Executive's employment with the Company for Cause (as defined below) or (ii) the Executive terminates his employment without Good Reason upon at least sixty (60) days prior written notice, the Executive shall be entitled to receive within 60 days following employment termination the following:

(a)the Executive's accrued but unpaid Base Salary to the date of termination and any employee benefits that the Executive is entitled to receive pursuant to the employee benefit plans of the Company and its subsidiaries (other than any severance plans) in accordance with the terms of such employee benefit plans;

(b)expenses reimbursable under Section 4.5 above incurred but not yet reimbursed to the Executive to the date of termination (together with (a) the "Accrued Benefits"); and,

(c)other than upon a termination of Executive’s employment by the Company for Cause, the unpaid portion of the Bonus, if any, relating to any year prior to the fiscal year of the Executive's termination, payable in accordance with Section 4.2 above.

For the purposes of this Agreement, "Cause" means as determined by a majority vote of the Board (or its designee), (i) failed, neglected, or refused to perform the lawful employment duties related to his position or as from time to time assigned to him (other than due to Disability (as defined below)); (ii) committed any willful, intentional, or negligent act having the effect of materially injuring the interest, business, or reputation of the Company; (iii) violated or failed to comply in any material respect with the Company’s published rules, regulations, or policies, as in effect or amended from time to time; (iv) committed an act constituting a felony or misdemeanor involving moral turpitude, fraud, theft, or dishonesty; (v) misappropriated or embezzled any property of the Company (whether or not an act constituting a felony or misdemeanor); or (vi) breached any material provision of this Agreement or any other applicable confidentiality, non-compete, non-solicit, general release, covenant not-to-sue, or other agreement with the Company. For purposes of this Agreement, “Disability” shall have the meaning defined in Section 5.2, below.

For the purposes of this Agreement, "Good Reason" means (i) a reduction in Executive's then current Base Salary or Bonus at Target, (ii) a requirement by the Company, without Employee’s prior written consent, that Employee relocate his primary place of employment to a location that is more than fifty (50) miles away from the primary location of employment as of the Effective Date, or (iii) a substantial diminution of Executive's title, duties or responsibilities as Director of Investor Relations with the Company; provided that neither the merger, sale or acquisition of business units, subsidiaries or assets, nor any similar corporate transaction, shall, by itself, constitute a diminution of duties or responsibilities for purposes hereof. Each of the foregoing events will cease to constitute Good Reason unless Executive gives the Company notice of Executive's intention to resign his position with the Company within ninety (90) days after Executive's knowledge of the occurrence of such event, and the Company shall have 30 days from its receipt of such notice to cure any condition that constitutes Good Reason. For the avoidance of doubt, terms and conditions, including grant levels, of any long-term incentive plan adopted by the Company shall not give rise to Good Reason for purposes of this Agreement.

5.2Due to Death or Disability. If (x) the Executive's employment terminates due to his death or (y) the Company terminates the Executive's employment with the Company due to the Executive's Disability (as defined below), the Executive or the Executive's estate will be entitled to the Accrued Benefits and, subject to the Executive's or his estate's execution without revocation of a valid release agreement in a form acceptable to the Company within forty-five (45) days following the date of termination of the Executive's employment, beginning on the 60th day following such termination, the Executive or the Executive's estate shall receive the severance payments set forth in this Section 5.2.

(a)payment for accrued unused vacation days, payable in accordance with Company policy; and

(b)the unpaid portion of the Bonus, if any, relating to any year prior to the fiscal year of the Executive's termination, payable in accordance with Section 4.2 above.

For the purposes of this Agreement, "Disability" means the determination by the Company, its subsidiaries or affiliates that, as a result of a permanent physical or mental injury or illness, the Executive has been unable to perform the essential functions of his job with or without reasonable accommodation for (i) 90 consecutive days or (ii) a period of 180 days in any 12-month period.

5.3By the Company Without Cause, or By the Executive for Good Reason. If during the Term, (x) the Company terminates the Executive's employment without Cause (which may be done at any time without prior notice) or (y) the Executive terminates his employment for Good Reason, the Executive will be entitled to the Accrued Benefits and, subject to the Executive's execution without revocation of a valid release agreement in a form acceptable to the Company within forty-five (45) days following the date of termination of the Executive's employment, beginning on the 60th day following such termination, the Executive shall receive the severance payments set forth in this Section 5.3., specifically including:

(a)payment for accrued unused vacation days, payable in accordance with Company policy;

(b)a severance payment equal to the Executive's annual Base Salary, payable in equal installments pursuant to the regular payroll practices of the Company;

(c)a prorated portion of the Bonus (prorated through the Termination Date) that would otherwise be payable to the Executive at the same time payments are made to other participants as set forth in Section 4.2, for the fiscal year of the termination of employment;

(d)the unpaid portion of the Bonus, if any, relating to any year prior to the fiscal year of the Executive's termination, payable in accordance with Section 4.2 above; and,

(e)reimbursement of the cost of continuation coverage of group health coverage as enrolled at the time of termination of employment, pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended, for a maximum of twelve (12) months following the end of the Initial Term or any Extended Term to the extent the Executive elects such continuation coverage and is eligible and subject to the terms of the plan and applicable law; providedthat if the Executive is eligible to receive coverage from a new employer he shall not be entitled to such reimbursement.

Notwithstanding the foregoing, the Company shall have no obligation to provide the payments or benefits set forth above in the event that the Executive breaches any of the provisions of Section 6, below.

5.4By the Company Without Cause, By the Executive for Good Reason in Connection With a Change in Control. In the event that there is a Change in Control (as defined below) and Executive's employment with the Company and its subsidiaries terminates within two (2) years following such Change in Control (x) by the Company and any of its subsidiaries (i) without Cause or (ii) by giving written notice of non-renewal pursuant to Section 2 of this Agreement or (y) by Executive for Good Reason, the Executive will be entitled to the Accrued Benefits and, subject to the Executive's execution without revocation of a valid release agreement in a form acceptable to the Company within forty-five (45) days following the date of termination of the Executive's employment, beginning on the 60th day following such termination, the Executive shall receive the severance payments set forth in this Section 5.4., specifically including:

(c)payment for accrued unused vacation days, payable in accordance with Company policy;

(d)a lump sum severance payment equal to the product of two (2) and his Base Salary, payable on the sixtieth (60th) day following the Termination Date;

(e)a prorated portion of the Bonus (prorated through the Termination Date) that would otherwise be payable to the Executive at the same time payments are made to other participants as set forth in Section 4.2, for the fiscal year of the termination of employment;

(f)the unpaid portion of the Bonus, if any, relating to any year prior to the fiscal year of the Executive's termination, payable in accordance with Section 4.2 above; and,

(g)reimbursement of the cost of continuation coverage of group health coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended, for a maximum of twelve (12) months following the Termination Date to the extent the Executive elects such continuation coverage and is eligible and subject to the terms of the plan and applicable law; provided that if the Executive is eligible to receive coverage from a new employer he shall not be entitled to such reimbursement.

Notwithstanding the foregoing, the Company shall have no obligation to provide the payments or benefits set forth above in the event that the Executive breaches any of the provisions of Section 6, below.

For the avoidance of doubt, in the event the Executive's employment is terminated in accordance with this Section 5.4, the Executive shall not be entitled to any payments or benefits under Section 5.3.

For purposes of this Agreement, "Change in Control" means the first to occur of any of the following events (i) any one person, or more than one person acting as a group (as determined under Treas. Reg. section 1.409A-3(i)(5)(v)(B)), acquires ownership of stock of the Company that, together with the stock held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the stock of the Company; provided, however, that the acquisition of stock of the Company by any subsidiary of the Company shall not be deemed to result in a Change in Control, or any acquisition of stock of the Company that is passive as evidenced by no change in board representation shall not be deemed to result in a Change in Control; (ii) any one person, or more than one person acting as a group (as determined under Treas. Reg. section 1.409A-3(i)(5)(v)(B)), acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) assets of the Company that have a total gross fair market value (as determined under Treas. Reg. Section 1.409A-3(i)(5)(vii)(A)) equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately before such acquisition or acquisitions; provided, however, that the acquisition of assets of the Company by any subsidiary of the Company shall not be deemed to result in a Change in Control; (iii) a majority of members of the Company’s Board of Directors on the date hereof is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the directors of the Company’s Board of Directors before the date of the appointment or election; or (iv) the liquidation or dissolution of the Company, or a partial liquidation of the Company where the net assets of the Company are reduced by 50% or more within a twelve month period as a result of sales (in each case other than a liquidation or dissolution occurring upon a merger or consolidation thereof).

Notwithstanding the foregoing, a “Change in Control” shall not be deemed to occur if the Company files for bankruptcy, liquidation or reorganization under the United States Bankruptcy Code.

5.5Continued Employment Beyond the Expiration of the Term. Unless the Parties otherwise agree in writing, continuation of the Executive's employment with the Company beyond the expiration of the Initial Term or any Extended Term shall be deemed an employment at-will and shall not be deemed to extend any of the provisions of this Agreement and the Executive's employment may thereafter be terminated at will by either the Executive or the Company; providedthat the provisions of Section 6 of this Agreement shall survive any termination of this Agreement or the termination of the Executive's employment hereunder; providedfurtherthat, the provisions of Section 5.4 and Section 8 shall only survive the termination of this Agreement or the termination of Executive's employment hereunder in the event there is a Change in Control prior to such termination of this Agreement and then, only for three (3) years following such Change in Control.

5.6No Mitigation. The Executive shall be under no obligation to seek other employment after his termination of employment with the Company and the obligations of the Company to the Executive which arise upon the termination of his employment pursuant to this Section 5 shall not be subject to mitigation.

5.7Removal from any Boards and Position. If the Executive's employment is terminated for any reason under this Agreement, he shall be deemed to resign (i) if a member, from the Board or board of directors of any subsidiary of the Company or any other board to which he has been appointed or nominated by or on behalf of the Company and (ii) from any position with the Company or any subsidiary of the Company, including, but not limited to, as an officer of the Company and any of its subsidiaries.

6.Restrictions and Obligations of the Executive.

6.1Confidentiality. (a) During the course of the Executive's service to the Company (prior to and during the Term), the Executive has had and willhave access to certain trade secrets and confidential information relating to the Company and its subsidiaries and affiliates (the "Protected Parties") which is not readily available from sources outside the Company. The Executive acknowledges that such information constitutes “Confidential Information” that is valuable, highly confidential, special and unique property of the Protected Parties. The Executive shall hold in a fiduciary capacity for the benefit of the Protected Parties all Confidential Information relating to the Protected Parties and their businesses, which shall have been obtained by the Executive during the Executive's employment by the Company or its subsidiaries and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this Agreement). The Executive shall not, during the period the Executive is employed by the Company or its subsidiaries or at any time thereafter, disclose any Confidential Information, directly or indirectly, to any person or entity for any reason or purpose whatsoever, nor shall the Executive use it in any way, except (i) in the course of the Executive's employment with, and for the benefit of, the Protected Parties, (ii) to enforce any rights or defend any claims hereunder or under any other agreement to which the Executive is a party, providedthat such disclosure is relevant to the enforcement of such rights or defense of such claims, (iii) when required to do so by a court of law or similar legal process, or in connection with any administrative proceeding, by any governmental agency or regulatory organization or by any administrative or legislative body (including a committee thereof) with jurisdiction to order him to divulge, disclose or make accessible such information, providedthat the Executive shall give prompt written notice to the Company of such requirement (unless directed by governmental or judicial authority not to do so), disclose no more information than is so required, and cooperate with any attempts by the Company to obtain a protective order or similar treatment, (iv) as to such Confidential Information that becomes generally known to the public or trade without his violation of this Section 6.1(a) or (v) to the Executive's spouse, attorney and/or his personal tax and financial advisors as reasonably necessary or appropriate to advance the Executive's tax, financial and other personal planning (each an "Exempt Person"), provided, however, that any disclosure or use of Confidential Information by an Exempt Person shall be deemed to be a breach of this Section 6.1(a) by the Executive. The Executive shall take all reasonable steps to safeguard the Confidential Information and to protect it against disclosure, misuse, espionage, loss and theft. The Executive understands and agrees that the Executive shall acquire no rights to any such Confidential Information or his work product.

(b)    All files, records, documents, drawings, specifications, data, computer programs, evaluation mechanisms and analytics and similar items relating thereto or to the Business (for the purposes of this Agreement, "Business" shall be as defined in Section 6.4 hereof), as well as all customer lists, specific customer information, compilations of product research and marketing techniques of the Company and its subsidiaries, whether prepared by the Executive or otherwise coming into the Executive's possession, shall remain the exclusive property of the Company and its subsidiaries.

6.2Cooperation. During the Term and any period thereafter, the Executive shall cooperate fully with any investigation or inquiry by the Company, or any governmental or regulatory agency or body, concerning the Company or its subsidiaries' or affiliates' operations; provided that the Company shall reimburse the Executive for any reasonable expenses incurred during such cooperation.

6.3Non-Solicitation or Hire. During the Term and, following the termination of the Executive's employment for any reason, for a period of twelve (12) months, the Executive shall not (a) directly or indirectly solicit, attempt to solicit or induce (x) any party who is a customer of the Company or its subsidiaries, who was a customer of the Company or its subsidiaries at any time during the twelve (12) month period immediately prior to the date the Executive's employment terminates or who is a prospective customer that has been identified and targeted by the Company or its subsidiaries as of the Termination Date, for the purpose of marketing, selling or providing to any such party any services or products offered by or available from the Company or its subsidiaries, or (y) any supplier to the Company or any subsidiary to terminate, reduce or alter negatively its relationship with the Company or any subsidiary or in any manner interfere with any agreement or contract between the Company or any subsidiary and such supplier or (b) hire any employee of the Company or any of its subsidiaries or affiliates (a "Current Employee") or any person who was an employee of or consultant to the Company or any of its subsidiaries or affiliates during the six (6) month period immediately prior to the date the Executive's employment terminates (a "Former Employee") or directly or indirectly solicit or induce a Current or Former Employee to terminate such employee's employment relationship with the Protected Parties in order, in either case, to enter into a similar relationship with the Executive, or any other person or any entity; provided, however, that nothing in Section 6.3(b) (i) shall be deemed to prohibit general solicitations for employment through advertisements or other means that may be seen by employees of the Company or its subsidiaries or affiliates or (ii) preclude the Executive from employing any person whose employment with the Company or any of its subsidiaries or affiliates was involuntarily terminated.

6.4Non-Competition. Executive understands that the Company invests significant resources in the training and development of its executives and that in his position as Director of Investor Relations, he had access to Confidential Information. During the Term and for a period of twelve (12)months following the termination of the Executive's employment under Sections 5.2, 5.3 or 5.4, the Executive shall not, directly or indirectly, without the prior written consent of the Board:

(i)(A) own or control, whether as a shareholder (other than a less than five percent (5%) shareholder in a corporation or other entity whose securities are traded on a recognized stock exchange or traded on the over the counter market), member, partner, director or otherwise, any Competing Organization, or (B) manage, operate, be employed or compensated by, or consult with (whether or not compensated), whether as an officer, executive, consultant or otherwise, any Competing Organization, in any capacity where the Executive’s knowledge of Confidential Information or involvement with or knowledge of relationships with customers of the Company would be useful or beneficial, or where the goodwill of the Company would be considered useful or beneficial to such Competing Organization or would be affected; or,

(ii)undertake any action, on behalf of any Competing Organization relating to the sale or marketing of products or services that compete with products or services researched, developed, designed, manufactured, assembled, produced, marketed, distributed, sold, repaired or provided by the Company, or, to the extent the Executive has or receives notice or knowledge of such plans, within the active research, development, expansion or business plans of the Company, to any customers or prospective customers of the Company which the Executive had knowledge, or with respect to which the Executive obtained Confidential Information, or with whom the Executive had personal contact or communications in his capacity as an employee of the Company, at any time during his period of employment with the Company.

For purposes of this Section 6.4, “Competing Organization” shall mean any person (including, without limitation, the Executive as a sole proprietor) or entity engaged in or planning or attempting to become engaged in any business that engages in life settlements within the United States of America; provided, however, that for the avoidance of doubt, Executive shall not be deemed to be employed or compensated by a Competing Organization for purposes of clause (i)(B) of this Section 6.4, if such entity is engaged in other business[es] that are substantially unrelated to the life settlement industry and the Executive’s involvement with such entity is solely related to such other business[es].

6.5Property. The Executive acknowledges that all originals and copies of materials, records and documents generated by him or coming into his possession during his employment by the Company or its subsidiaries are the sole property of the Company and its subsidiaries ("Company Property"). During the Term, and at all times thereafter, the Executive shall not remove, or cause to be removed, from the premises of the Company or its subsidiaries, copies of any record, file, memorandum, document, computer related information or equipment, or any other item relating to the business of the Company or its subsidiaries, except in furtherance of his duties under the Agreement. When the Executive's employment with the Company terminates, or upon request of the Company at any time, the Executive shall promptly deliver to the Company all copies of Company Property in his possession or control.

6.6Nondisparagement. The Executive agrees that he will not at any time (whether during or after the Term) publish or communicate to any person or entity any Disparaging (as defined below) remarks, comments or statements concerning the Company, subsidiaries and affiliates, and their respective present and former directors, officers, shareholders, employees, agents, attorneys, successors and assigns. "Disparaging" remarks, comments or statements are those that impugn the character, honesty, integrity or morality or business acumen or abilities in connection with any aspect of the operation of business of the individual or entity being disparaged. Notwithstanding the foregoing, nothing in this Section 6.6 shall be construed to preclude truthful disclosures in response to lawful process as required by applicable law, regulation, or order or directive of a court, administrative or legislative body, governmental agency or regulatory organization.

7.Remedies; Specific Performance. The Parties acknowledge and agree that the Executive's breach or threatened breach of any of the restrictions set forth in Section 6 will result in irreparable and continuing damage to the Protected Parties for which there may be no adequate remedy at law and that the Protected Parties shall be entitled to seek equitable relief, including specific performance and injunctive relief as remedies for any such breach or threatened or attempted breach, without requiring the posting of a bond. The Executive hereby consents to the grant of an injunction (temporary or otherwise) against the Executive or the entry of any other court order against the Executive prohibiting and enjoining him from violating, or directing him to comply with any provision of Section 6. The Executive also agrees that such remedies shall be in addition to any and all remedies, including damages, available to the Protected Parties against him for such breaches or threatened or attempted breaches. In addition, without limiting the Protected Parties' remedies for any breach of any restriction on the Executive set forth in Section 6, except as required by law, the Executive shall not be entitled to any payments set forth in Sections 5.2, 5.3 or 5.4 hereof if the Executive has breached the covenants applicable to the Executive contained in Section 6, the Executive will immediately return to the Protected Parties any such payments previously received under Sections 5.2, 5.3 or 5.4 upon such a breach, and, in the event of such breach, the Protected Parties will have no obligation to pay any of the amounts that remain payable by the Company under Sections 5.2, 5.3 or 5.4.

8.Section 280G Limitation

8.1Limitation on Payments. Notwithstanding any provision of this Agreement, if any portion of the severance payments or any other payment under this Agreement, or under any other agreement with Employee or plan of the Company or its affiliates (in the aggregate, the “Total Payments”), would constitute an “excess parachute payment” and would, but for this Section 8, result in the imposition on Employee of an excise tax under section 4999 of the Internal Revenue Code of 1986, as amended, then the Total Payments to be made to Employee shall be delivered in such amount so that no portion of the Total Payment will be subject to the excise tax.

8.2Determination of Limit. Within forty (40) days following the Date of Termination or notice by one party to the other of its belief that there is a payment or benefit due Employee that will result in an excess parachute payment, Employee and the Company, at the Company’s expense, shall obtain the opinion (which need not be unqualified) of a nationally recognized tax counsel (“National Tax Counsel”) selected by the Company (which may be regular outside counsel to the Company), which opinion sets forth (i) the amount of the Base Period Income (as defined below), (ii) the amount and present value of the Total Payments, (iii) the amount and present value of any excess parachute payments determined without regard to any reduction of Total Payments pursuant to Section 8.1. The opinion of National Tax Counsel shall be addressed to the Company and Employee and shall be binding upon the Company and Employee. If such National Tax Counsel opinion determines that the Total Payments should be reduced pursuant to Section 8.1, then the payments under Section 5.4 or any other payment or benefit determined by such counsel to be includable in Total Payments shall be reduced or eliminated so that under the bases of calculations set forth in such opinion there will be no excess parachute payment. In such event, payments or benefits included in the Total Payments shall be reduced or eliminated by applying the following principles: (1) the portion of the Total Payments that does not constitute deferred compensation under section 409A of the Code shall first be reduced (if necessary, to zero), and then (2) all other Total Payments shall thereafter be reduced (if necessary, to zero) with, in each case, cash payments being reduced before non-cash payments (and, within each category, payments to be paid last being reduced first).

8.3Excess Payments; Underpayments. It is possible that, after the determinations and selections made pursuant to Section 8, Employee will receive payments and/or benefits that are, in the aggregate, either more or less than the amount determined under Section 8 (hereafter referred to as an “Excess Payment” or “Underpayment”, as applicable). If it is established, pursuant to a final determination by a court of competent jurisdiction or by an Internal Revenue Service proceeding that has been finally and conclusively resolved, that an Excess Payment has been made, then Employee shall promptly repay the Excess Payment to the Company, together with interest on the Excess Payment at the applicable federal rate (as defined in section 1274(d) of the Code) from the date of Employee’s receipt of such Excess Payment until the date of such repayment. In the event that it is determined pursuant to a final determination by a court of competent jurisdiction or by the National Tax Counsel, upon request of either party, that an Underpayment has occurred, the Company shall promptly pay an amount equal to the Underpayment to Employee (but in any event within ten (10) days of such determination), together with interest on such amount at the applicable federal rate from the date such amount would have been paid to Employee had the provisions of Section 5 not been applied until the date of payment.

8.4Definitions and Assumptions. For purposes of this Agreement: (i) the terms “excess parachute payment” and “parachute payments” shall have the meanings assigned to them under section 280G of the Code and such “parachute payments” shall be valued as provided therein; (ii) present value shall be calculated in accordance with section 280G(d)(4) of the Code; (iii) the term “Base Period Income” means an amount equal to Employee’s “annualized includible compensation for the base period” as defined in section 280G(d)(1) of the Code; and (iv) for purposes of the opinion of National Tax Counsel, the value of any noncash benefits or any deferred payment or benefit shall be determined by the Company’s independent auditors in accordance with the principles of sections 280G(d)(3) and (4) of the Code, which determination shall be evidenced in a certificate of such auditors addressed to the Company and Employee.

8.5Reasonableness of Compensation. If such National Tax Counsel so requests in connection with the opinion required by this Section 8, Employee and the Company shall obtain, at the Company’s expense, and the National Tax Counsel may rely on, the advice of a firm of recognized executive compensation consultants as to the reasonableness of any item of compensation to be received by the Employee solely with respect to its status under section 280G of the Code.

8.6Indemnification. The Company agrees to bear all costs associated with, and to indemnify and hold harmless, the National Tax Counsel of and from any and all claims, damages, or expenses resulting from or relating to its determinations pursuant to this Section 8, except for claims, damages, or expenses resulting from the gross negligence or willful misconduct of such firm.

8.7Changes to Code Section. This Section 8 shall be amended to comply with any amendment or successor provision to sections 280G or 4999 of the Code. If such provisions are repealed without successor, then this Section 8 shall be cancelled without further effect.

9.Other Provisions.

9.1Notices. Any notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, sent by facsimile transmission or sent by certified, registered or express mail, postage prepaid or overnight mail and shall be deemed given when so delivered personally, or sent by facsimile transmission or, if mailed, four (4) business days after the date of mailing or one (1) business day after overnight mail, as follows:

(b)If the Company, to:

Imperial Holdings, Inc.

Office of the General Counsel

701 Park of Commerce Blvd., Suite 301

Boca Raton, FL 33487

(c)If the Executive, to the Executive's home address reflected in the Company's records.

9.2Entire Agreement. This Agreement contains the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior agreements, written or oral, with respect thereto, including, without limitation, the Retention Agreement.

9.3Representations and Warranties. The Executive represents and warrants that he is not a party to or subject to any restrictive covenants, legal restrictions or other agreements in favor of any entity or person which could arguably, in any way, preclude, inhibit, impair or limit the Executive's ability to perform his obligations under this Agreement, including, but not limited to, non-competition agreements, non-solicitation agreements or confidentiality agreements.

9.4Waiver and Amendments. This Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms and conditions hereof may be waived, only by a written instrument signed by the Parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any right, power or privilege hereunder, nor any single or partial exercise of any right, power or privilege hereunder, preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.

9.5Governing Law, Dispute Resolution and Venue. This Agreement shall be governed and construed in accordance with the laws of Florida, without regard to conflicts of laws principles, unless superseded by federal law.

(a)Arbitration. Any and all disputes arising under or relating to the interpretation or application of this Agreement or concerning Employee’s employment with the Company or termination thereof shall be subject to arbitration in Florida under the then existing rules of the American Arbitration Association. Judgment upon the award rendered may be entered in any court of competent jurisdiction. The cost of such arbitration shall be borne equally by the parties. Nothing contained in this Paragraph shall limit the right of the Company to enforce by court injunction or other equitable relief the Employee’s obligations under Paragraph 6 of this Agreement.

9.6Assignability by the Company and the Executive. This Agreement, and the rights and obligations hereunder, may not be assigned by the Company or the Executive without written consent signed by the other party; providedthat the Company may assign its rights and obligations hereunder in connection with a Change in Control.

9.7Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument.

9.8Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning of terms contained herein.

9.9Severability. If any term, provision, covenant or restriction of this Agreement, or any part thereof, is held by a court of competent jurisdiction of any foreign, federal, state, county or local government or any other governmental, regulatory or administrative agency or authority to be invalid, void, unenforceable or against public policy for any reason, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected or impaired or invalidated. The Executive acknowledges that the restrictive covenants contained in Section 6 are a condition of this Agreement and are reasonable and valid in temporal scope and in all other respects.

9.10Judicial Modification. If any court determines that any of the covenants in Section 6, or any part of any of them, is invalid or unenforceable, the remainder of such covenants and parts thereof shall not thereby be affected and shall be given full effect, without regard to the invalid portion. If any court determines that any of such covenants, or any part thereof, is invalid or unenforceable because of the geographic or temporal scope of such provision, such court shall reduce such scope to the minimum extent necessary to make such covenants valid and enforceable.

9.11Tax Withholding. The Company or other payor is authorized to withhold from any benefit provided or payment due hereunder, the amount of withholding taxes due any federal, state or local authority in respect of such benefit or payment and to take such other action as may be necessary in the opinion of the Board to satisfy all obligations for the payment of such withholding taxes.

9.12Section 409A. Notwithstanding any other provision of this Agreement, if at the time of the termination of the Executive's employment the Executive is a "specified employee" (as defined in Section 409A of the Internal Revenue Code of 1986, as amended ("Section 409A")) and any payments upon such termination under Section 5 hereof will result in additional tax or interest to the Executive under Section 409A, he will not be entitled to receive such payments until the date which is six (6) months after the termination of the Executive's employment for any reason, other than as a result of the Executive's death or disability (as such term is defined in Section 409A). In addition, to the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409(A), the provision shall be read in such a manner so that all payments hereunder shall comply with Section 409(A).

9.13Indemnification.  The Company hereby agrees to indemnify the Executive and hold him harmless (including advancing reasonable attorney’s fees) in the manner and to the extent provided under the by-laws of the Company against and in respect to any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses, losses, and damages resulting from the Executive’s good faith performance of his duties and obligations with the Company. The Executive shall be covered by any Director and Officer liability insurance purchased by the Company in the same amount and to the same extent as the Company covers its other officers and directors.

IN WITNESS WHEREOF, the Parties hereto, intending to be legally bound hereby, have executed this Agreement as of the day and year first above mentioned.

EXECUTIVE

By: /s/ David Sasso    

Name: David Sasso

Title:    Director of Investor Relations

IMPERIAL HOLDINGS, INC.

By: /s/ Phillip Goldstein    

Name: Phillip Goldstein

Title:    Chairman of the Board of Directors

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Antony Mitchell, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Imperial Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary companies, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Antony Mitchell

Antony Mitchell

Chief Executive Officer and Director

(Principal Executive Officer)

November 9, 2015

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Richard S. O’Connell, Jr., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Imperial Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary companies, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Richard S. O’Connell, Jr.

Richard S. O’Connell, Jr.

Chief Financial Officer and Chief Credit Officer

(Principal Financial Officer)

November 9, 2015

EX-32.1

Exhibit 32.1

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Imperial Holdings, Inc. (the Registrant) on Form 10-Q for the period ended September 30, 2015 as filed with the U.S. Securities and Exchange Commission on the date hereof (the Report), I, Antony Mitchell, Chief Executive Officer of the Registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Antony Mitchell

Antony Mitchell

Chief Executive Officer and Director

November 9, 2015

EX-32.2

Exhibit 32.2

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Imperial Holdings, Inc. (the Registrant) on Form 10-Q for the period ended September 30, 2015 as filed with the U.S. Securities and Exchange Commission on the date hereof (the Report), I, Richard S. O’Connell, Jr., Chief Financial Officer and Chief Credit Officer of the Registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Richard S. O’Connell, Jr.

Richard S. O’Connell, Jr.

Chief Financial Officer and Chief Credit Officer

November 9, 2015

XML

Stock-Based Compensation - Additional Information (Detail) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 11, 2011	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (shares)				0
Options granted strike price (usd per share)
Stock-based compensation expense				$ 429,000	$ 762,000
Options outstanding and unexercised (shares)		774,394		774,394		807,949
Options outstanding and unexercised, weighted average price (usd per share)		$ 8.50		$ 8.50		$ 8.50
Remaining unamortized amounts		$ 0		$ 0
Exercise price of warrants		$ 10.75		$ 10.75
Estimated Fair Value Of Warrants		$ 5,400,000		$ 5,400,000
Common stock warrants term				5 years
Including Overallotment Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of warrants	$ 14.51
Warrant expiration period	7 years
Warrants issued		4,240,521		4,240,521
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average daily trading closing price		$ 8.50		$ 8.50
Average daily trading closing price, period				45 days
Maximum | Including Overallotment Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected issuance of warrants for shares	4,240,521
Stock Option | Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock reserved for future grant		2,700,000		2,700,000
Options outstanding and unexercised (shares)		774,394		774,394
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (shares)				41,259
Stock vested (shares)				41,060
Restricted stock, aggregate intrinsic value		$ 230,000		$ 230,000
Restricted Stock | Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 61,000		$ 192,000	$ 130,000
Options outstanding and unexercised, weighted average price (usd per share)		$ 8.50		$ 8.50
Stock vested (shares)		41,060			17,286
Fair value of stock vested					$ 120,000
Fair value of stock granted		$ 255,000		$ 255,000
Stock vesting period		1 year
Restricted stock, weighted average remaining life		7 months 28 days
Restricted Stock | Omnibus Plan | Restricted Stock One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 0		52,000
Restricted Stock | Omnibus Plan | Restricted Stock Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 61,000		83,000
Restricted Stock | Omnibus Plan | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		0	61,000	108,000	$ 78,000
Stock granted (shares)					41,060
Fair value of stock granted		255,000		255,000
Stock Options | Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 0	$ 140,000	$ 237,000	$ 632,000
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (shares)				0
Stock vested (shares)				0
Performance Shares | Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (shares)		323,500				323,500
Stock granted, subject to shareholders' approval of an amended and restated of plan		150,000				150,000
Stock vesting period		1 year
Performance Shares | Omnibus Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Actual shares to be issued		0.00%		0.00%
Performance Shares | Omnibus Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Actual shares to be issued		150.00%		150.00%
USAO Investigation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of warrants		$ 10.75		$ 10.75
Litigation Settlement, Shares to Escrow				2,000,000
Estimated Fair Value Of Warrants		$ 5,400,000		$ 5,400,000
Common stock warrants term				5 years
USAO Investigation | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average daily trading closing price		$ 8.50		$ 8.50
Average daily trading closing price, period				45 days
Common Stock | Restricted Stock | Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted (shares)				41,259

XML

Fair Value Measurements - Quantitative Information about Level 3 Fair Value Measurements (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life settlements	$ 457,810		$ 388,886
Structured settlement receivables	0		384	[1]
Revolving Credit Facility debt			145,831
Life settlements	$ 2,997,903		2,931,066
Weighted average discount rate	17.00%
Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt	$ 157,946	$ 157,946
Minimum | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	15.00%
Minimum | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	16.00%
Maximum | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	21.00%
Maximum | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	24.75%
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life settlements	$ 457,810		388,886
Structured settlement receivables			384
Revolving Credit Facility debt			$ 145,831
Level 3 | Life Finance
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life settlements	457,810
Life settlements	$ 2,997,903
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	10 years
Weighted average discount rate	17.00%
Level 3 | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life settlements	$ 97,022
Life settlements	$ 343,803
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	6 years 7 months 6 days
Level 3 | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life settlements	$ 360,788
Life settlements	$ 2,654,100
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	10 years 6 months
Level 3 | Minimum | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	15.00%
Level 3 | Minimum | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	16.00%
Level 3 | Maximum | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	21.00%
Level 3 | Maximum | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	24.75%
Red Falcon | Level 3 | Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt	$ 55,685
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	9 years 6 months
Discount Rate	11.18%
White Eagle | Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt	$ 157,900
White Eagle | Level 3 | Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt	$ 157,946
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	9 years 10 months 24 days
Discount Rate	23.55%
White Eagle | Level 3 | Revolving Credit Facility | Structured settlements
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate	23.55%

[1] Derived from audited consolidated financial statements.

XML

White Eagle Revolving Credit Facility - Additional Information (Detail)		3 Months Ended		9 Months Ended
	Apr. 29, 2013 USD ($)	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Jun. 30, 2015 USD ($)	Dec. 31, 2014 USD ($) Contract
Debt Instrument [Line Items]
Number of policies owned (contracts) | Contract		634		634			607
Life insurance policies with aggregate death benefit		$ 2,997,903,000		$ 2,997,903,000			$ 2,931,066,000
Life insurance estimated fair value		457,810,000		457,810,000			388,886,000
Interest expense on the facility		8,614,000	$ 4,303,000	21,491,000	$ 11,165,000
Interest expense withheld from borrowings by lender				5,566,000	4,962,000
Interest paid				12,143,000	4,496,000
Revolving Credit Facility debt, at estimated fair value							$ 145,831,000
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving Credit Facility debt, at estimated fair value		157,946,000		157,946,000		$ 157,946,000
White Eagle Asset Portfolio, LLC | Revolving Credit Facility
Debt Instrument [Line Items]
Proceeds to be paid to White Eagle after payment of loan				$ 76,100,000
Percentage of remaining proceeds				50.00%
White Eagle | Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility effective date	Apr. 29, 2013
Revolving credit facility period	15 years
Revolving Credit facility, current borrowing capacity	$ 300,000,000.0	161,800,000		$ 161,800,000
Line of credit facility, maximum borrowing capacity		140,100,000.0		140,100,000.0
Line of credit facility, remaining borrowing capacity		$ 1,900,000		$ 1,900,000
Collateral pledge percentage for distributions to be altered		25.00%		25.00%
Base rate		0.50%		0.50%
Debt instrument effective rate		5.50%		5.50%
Interest expense on the facility		$ 2,300,000	2,100,000	$ 6,900,000	5,800,000
Interest expense withheld from borrowings by lender		1,700,000	1,500,000	5,000,000	4,200,000
Interest paid		634,000	$ 573,000	$ 1,900,000	$ 1,600,000
Credit agreement expiration date				Apr. 28, 2028
Revolving Credit Facility debt, at estimated fair value		157,900,000		$ 157,900,000
Revolving Credit Facility debt, outstanding		$ 159,900,000		$ 159,900,000
White Eagle | Revolving Credit Facility | Maintenance Costs
Debt Instrument [Line Items]
Line of credit borrowing base percentage		100.00%		100.00%
White Eagle | Revolving Credit Facility | Accrued and Unpaid Interest
Debt Instrument [Line Items]
Line of credit borrowing base percentage		100.00%		100.00%
Proceeds directed to pay outstanding interest and principal on loan				100.00%
White Eagle | Revolving Credit Facility | Other Fees and Expense [Member]
Debt Instrument [Line Items]
Line of credit borrowing base percentage		100.00%		100.00%
White Eagle | Revolving Credit Facility | Policies pledged as collateral as determined by the lenders
Debt Instrument [Line Items]
Line of credit borrowing base percentage		75.00%		75.00%
White Eagle | Revolving Credit Facility | Policies pledged as collateral excluding certain specified life insurance policies
Debt Instrument [Line Items]
Line of credit borrowing base percentage		50.00%		50.00%
White Eagle | Revolving Credit Facility | Securities Pledged as Collateral
Debt Instrument [Line Items]
Revolving Credit facility, current borrowing capacity	$ 300,000,000	$ 300,000,000.0		$ 300,000,000.0
Number of policies owned (contracts) | Contract		439		439
Life insurance policies with aggregate death benefit		$ 2,200,000,000		$ 2,200,000,000
Life insurance estimated fair value		$ 327,400,000		$ 327,400,000
White Eagle | Revolving Credit Facility | Floor Rate
Debt Instrument [Line Items]
Basis spread on variable rate				1.50%
White Eagle | Revolving Credit Facility | Applicable Margin
Debt Instrument [Line Items]
Basis spread on variable rate				4.00%
White Eagle | Revolving Credit Facility | Federal Funds Rate
Debt Instrument [Line Items]
Basis spread on variable rate				0.75%
White Eagle | White Eagle Asset Portfolio, LLC | Revolving Credit Facility
Debt Instrument [Line Items]
Proceeds to be paid to White Eagle after payment of loan				$ 76,100,000
Percentage of remaining proceeds				50.00%

XML

Fair Value Measurements - Changes in Life Expectancy Used to Estimate Fair Value (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	$ 457,810		$ 457,810		$ 388,886
Change in Value	0	$ 0	0	$ (426)
+6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	384,990		384,990
Change in Value			(72,820)
-6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	536,666		536,666
Change in Value			78,856
Red Falcon Trust
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	55,685		55,685
Change in Value			0
Red Falcon Trust | +6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	53,734		53,734
Change in Value			(1,951)
Red Falcon Trust | -6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	$ 57,236		57,236
Change in Value			$ 1,551

XML

Life Settlements (Life Insurance Policies) (Detail) $ in Thousands	Sep. 30, 2015 USD ($) Contract	Dec. 31, 2014 USD ($) Contract
Number of Life Settlement Contracts
0-1 | Contract	0	0
1-2 | Contract	9	4
2-3 | Contract	20	10
3-4 | Contract	19	16
4-5 | Contract	25	19
Thereafter | Contract	561	558
Total | Contract	634	607
Estimated Fair Value
0-1	$ 0	$ 0
1-2	21,516	9,227
2-3	52,926	23,202
3-4	29,638	29,531
4-5	33,129	23,012
Thereafter	320,601	303,914
Total	457,810	388,886
Face Value
0-1	0	0
1-2	32,307	12,728
2-3	95,122	45,852
3-4	70,309	67,735
4-5	96,406	65,614
Thereafter	2,703,759	2,739,137
Total	$ 2,997,903	$ 2,931,066

XML

Principles of Consolidation and Basis of Presentation - Additional Information (Detail) $ in Thousands	Aug. 28, 2015 USD ($)	Oct. 25, 2013 USD ($)	Sep. 30, 2015 USD ($) Contract	Jul. 16, 2015 Contract	Dec. 31, 2014 USD ($) Contract	Feb. 28, 2014 USD ($)
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract			634		607
Life insurance policies with aggregate death benefit			$ 2,997,903		$ 2,931,066
Life insurance estimated fair value			$ 457,810		$ 388,886
Sale of structured settlement business	$ 920	$ 12,000
8.50% Senior Unsecured Convertible Notes Due 2019
Organization and Nature of Operations [Line Items]
Debt instrument issued						$ 70,700
Stated interest rate						8.50%
White Eagle | Revolving Credit Facility | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract			439
Life insurance policies with aggregate death benefit			$ 2,200,000
Life insurance estimated fair value			$ 327,400
Red Falcon Trust | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract			157
Life insurance policies with aggregate death benefit			$ 604,800
Life insurance estimated fair value			$ 117,400
Red Falcon Trust | Revolving Credit Facility
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract				157
Red Falcon Trust | Revolving Credit Facility | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract			157
Life insurance policies with aggregate death benefit			$ 604,800
Life insurance estimated fair value			$ 117,400

XML

Fair Value Measurements - Changes in Weighted Average Discount Rate Used to Estimate Fair Value (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate			17.00%
Value	$ 457,810		$ 457,810		$ 388,886
Change in Value	0	$ 0	$ 0	$ (426)
.50% Decrease in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate			16.50%
Value	469,610		$ 469,610
Change in Value			$ 11,800
.50% Increase in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate			17.50%
Value	$ 446,512		$ 446,512
Change in Value			$ (11,298)

XML

Consolidation of Variable Interest Entities (Tables)

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation of Variable Interest Entities

The following table presents the consolidated assets and consolidated liabilities of VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated in the Company’s financial statements as of September 30, 2015 as well as non-consolidated VIEs for which the Company has determined it is not the primary beneficiary (in thousands):

	Primary Beneficiary				Not Primary Beneficiary
	Consolidated VIEs				Non-consolidated VIEs
	Assets		Liabilities		Total Assets		Maximum Exposure To Loss
September 30, 2015	$	464,032	$	214,019	$	2,384	$	2,384
December 31, 2014	$	314,062	$	146,254	$	2,384	$	2,384

XML

8.50% Senior Unsecured Convertible Notes - Additional Information (Detail)				1 Months Ended	3 Months Ended			9 Months Ended
	Jul. 16, 2015 USD ($)	Jun. 05, 2014 USD ($)	Feb. 21, 2014	Feb. 28, 2014 USD ($) d Director $ / shares	Sep. 30, 2015 USD ($)	Jun. 30, 2015 $ / shares shares	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Dec. 31, 2014 USD ($)	[1]
Debt Instrument [Line Items]
Common stock issued for rights offering, net of costs | shares						6,688,433
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Expected Volatility		40.00%
Convertible Notes, net of discount (Note 11)					$ 57,867,000			$ 57,867,000		$ 55,881,000
Debt instrument origination cost					1,907,000			1,907,000		$ 3,936,000
Interest	$ 5,200,000
Amortizing debt discounts	1,700,000
Debt issuance cost	$ 1,700,000
Change in fair value of conversion derivative liability					0		$ 0	$ 0	$ 6,759,000
8.50% Senior Unsecured Convertible Notes Due 2019
Debt Instrument [Line Items]
Debt instrument issued				$ 70,700,000
Stated interest rate				8.50%
Debt instrument, due date									2019
Debt instrument, issuance date			Feb. 21, 2014
Number of board of directors | Director				2
Debt instrument, maturity date								Feb. 15, 2019
Debt instrument, frequency of periodic payment								semi-annually in arrears on August 15 and February 15 of each year
Debt instrument, convertible, conversion rate				147.9290		151.7912
Debt Instrument, Convertible, Conversion Price | $ / shares				$ 6.76		$ 6.59
Common stock issued for rights offering, net of costs | shares						6,688,433
Debt instrument, redemption start date								Feb. 15, 2017
Debt instrument, convertible, minimum percentage of common stock price				130.00%
Debt instrument, convertible, threshold trading days | d				20
Debt instrument, convertible, threshold consecutive trading days				30 days
Debt instrument, redemption price, percentage				100.00%
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Conversion derivative liability, at estimated fair value		$ 23,700,000
Convertible Notes, net of discount (Note 11)					57,900,000			$ 57,900,000
Unamortized debt discount					12,800,000			12,800,000
Debt instrument origination cost					1,900,000			1,900,000
Interest expense of notes					2,300,000		2,200,000	6,800,000	$ 5,300,000
Interest					1,500,000		1,500,000	4,500,000	3,700,000
Amortizing debt discounts					711,000		605,000	2,000,000	1,400,000
Debt issuance cost					$ 105,000		$ 90,000	$ 294,000	239,000
Change in fair value of conversion derivative liability									$ 6,800,000
8.50% Senior Unsecured Convertible Notes Due 2019 | Reclassifications to Additional Paid in Capital
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Unamortized transaction costs		756,000
Deferred tax asset, conversion derivative liability		$ 8,800,000
8.50% Senior Unsecured Convertible Notes Due 2019 | Bulldog Investors Llc
Debt Instrument [Line Items]
Debt instrument issued				$ 9,200,000
Conversion derivative liability | 8.50% Senior Unsecured Convertible Notes Due 2019
Fair Value Assumptions and Methodology for Assets and Liabilities [Abstract]
Expected Term in Years		4 years 8 months 12 days
Risk Free Rate		1.50%

[1] Derived from audited consolidated financial statements.

XML

Stock-based Compensation - Activity of Performance Share Awards (Detail) - Performance Shares	9 Months Ended
	Sep. 30, 2015 shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Common Unvested Shares outstanding, Beginning Balance (shares)	323,500
Awarded (shares)	0
Vested (shares)	0
Forfeited (shares)	0
Common Unvested Shares outstanding, Ending Balance (shares)	323,500

XML

Earnings Per Share Earnings Per Share - Reconciliation (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator:
Net income (loss) from continuing operations	$ (13,491)	$ (4,264)	$ (16,689)	$ (13,863)
Net income (loss) from discontinued operations	(113)	(249)	(416)	(454)
Net income (loss)	$ (13,604)	$ (4,513)	$ (17,105)	$ (14,317)
Basic and diluted income (loss) per common share:
Basic and diluted income (loss) from continuing operations (usd per share)	$ (0.48)	$ (0.20)	$ (0.70)	$ (0.65)
Basic and diluted loss from discontinued operations (usd per share)	0.00	(0.01)	(0.02)	(0.02)
Basic and diluted income (loss) per share available to common shareholders (usd per share)	$ (0.48)	$ (0.21)	$ (0.72)	$ (0.67)
Denominator:
Basic and Diluted (shares)	28,084,254	21,361,930	23,827,030	21,352,086

XML

Fair Value Measurements - Additional Information (Detail) $ in Thousands		9 Months Ended
	Jul. 16, 2015 Contract	Sep. 30, 2015 USD ($) Contract policy carrier	Jun. 30, 2015 USD ($)	Dec. 31, 2014 USD ($) Contract
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Mortality rate		100.00%
Number of life insurance policies (contracts) | Contract		634		607
Life insurance estimated fair value		$ 457,810		$ 388,886
Weighted average discount rate		17.00%
Settlements with estimated fair value		$ 0		384	[1]
Revolving Credit Facility debt, at estimated fair value				$ 145,831
Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Life insurance estimated fair value		$ 55,685
Discount rates		11.18%
Revolving Credit Facility debt, at estimated fair value		$ 55,685
Securities Pledged as Collateral | Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract		157
Life insurance estimated fair value		$ 117,400
Noninvestment grade
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of non-investment grate life insurance polices issued | policy		18
Number of carriers related to non-investment grade policies | carrier		2
Additional basis point risk premium		3.00%
Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract		547
Premium Financed | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates		16.00%
Premium Financed | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates		24.75%
Non Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract		87
Non Premium Financed | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates		15.00%
Non Premium Financed | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates		21.00%
Impaired life bearing
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Mortality rate		200.00%
Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt, at estimated fair value		$ 157,946	$ 157,946
Revolving Credit Facility | Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract	157
Revolving Credit Facility debt, at estimated fair value		55,700
Revolving Credit Facility debt, outstanding		$ 55,100
Yield maintenance provision.	5.00%	5.00%
Line of credit, amortization percentage	8.00%	8.00%
Revolving Credit Facility | White Eagle Asset Portfolio, LLC
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Percentage of remaining proceeds		50.00%
Proceeds to be paid to White Eagle after payment of loan		$ 76,100
Revolving Credit Facility | Securities Pledged as Collateral | Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract		157
Life insurance estimated fair value		$ 117,400
Scenario 3 | Revolving Credit Facility | Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, percentage of remaining outstanding balance	35.00%	35.00%
Scenario 3 | Revolving Credit Facility | Red Falcon Trust | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, loan to value ratio	25.00%	25.00%
Life insurance issuer concentrations that exceed 10% of total death benefit | Revolving Credit Facility | Red Falcon Trust
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, percentage of remaining outstanding balance	65.00%	65.00%
Life insurance issuer concentrations that exceed 10% of total death benefit | Revolving Credit Facility | Red Falcon Trust | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, loan to value ratio	25.00%	25.00%
Life insurance issuer concentrations that exceed 10% of total death benefit | Revolving Credit Facility | Red Falcon Trust | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, loan to value ratio	50.00%	50.00%
10% of total fair value of our investments in life settlements | Revolving Credit Facility | Red Falcon Trust | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit, loan to value ratio	50.00%	50.00%
White Eagle | Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Revolving Credit Facility debt, at estimated fair value		$ 157,900
Revolving Credit Facility debt, outstanding		$ 159,900
White Eagle | Revolving Credit Facility | White Eagle Asset Portfolio, LLC
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Percentage of remaining proceeds		50.00%
Proceeds to be paid to White Eagle after payment of loan		$ 76,100
White Eagle | Revolving Credit Facility | Securities Pledged as Collateral
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of life insurance policies (contracts) | Contract		439
Life insurance estimated fair value		$ 327,400

[1] Derived from audited consolidated financial statements.

XML

Commitments and Contingencies - Additional Information (Detail)		3 Months Ended		9 Months Ended
	Jul. 29, 2013 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Oct. 30, 2014	Apr. 18, 2013 Contract
Commitments and Contingencies [Line Items]
Lease expiration date				Sep. 30, 2020
Annual base rent				$ 225,100
Percentage of annual increase of base rent				3.00%
Rent expense under operating lease		$ 122,000	$ 126,000	$ 319,000	$ 377,000
Operating leases, remainder of year ended december 31, 2015		58,000		58,000
Indemnification expenses		998,000	500,000	$ 2,500,000	1,500,000
Non-prosecution agreement terms				3 years
Percentage of outstanding shares to be obtained written consent						3.00%
Pending Litigation
Commitments and Contingencies [Line Items]
Litigation-related fees		$ 2,800,000	$ 1,200,000	$ 7,000,000	$ 3,200,000
Number of policies | Contract							28
Pending Litigation | Minimum
Commitments and Contingencies [Line Items]
Compensatory damages sought in addition to an award of punitive damages	$ 30,000,000

XML

Life Settlements (Life Insurance Policies) - Estimated Premiums to be Paid (Detail) $ in Thousands	Sep. 30, 2015 USD ($)
Investments, All Other Investments [Abstract]
Remainder of 2015	$ 16,292
2016	68,891
2017	75,602
2018	78,260
2019	85,030
Thereafter	1,110,449
Estimated future premium payments	$ 1,434,524

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2015

Accounting Changes and Error Corrections [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (‘FASB’) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB and the International Accounting Standards Board standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

In August 2014, the FASB issued ASU No. 2014-15, “Disclosures of Uncertainties About an Entity’s Ability to Continue as a Going Concern.” The standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis.” This guidance focuses on a reporting company’s consolidation evaluation to determine whether they should consolidate certain legal entities. This guidance is effective for annual periods beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the effect that this pronouncement will have on its consolidated financial statements, but does not anticipate it will be material.

In April 2015, the FASB issued ASU No. 2015-03, “Interest—Imputation of Interest (Subtopic 835-30).” This standard provides guidance on the balance sheet presentation for debt issuance costs and debt discounts and debt premiums. To simplify the presentation of debt issuance costs, this standard requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. This ASU is effective for fiscal years beginning after December 15, 2015. The Company does not expect that this guidance will have a material impact on its consolidated financial statements.

XML

Stockholders' Equity - Additional Information (Detail) - USD ($)	3 Months Ended			9 Months Ended	12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2014	Sep. 30, 2015	Dec. 31, 2014		Sep. 01, 2015	Sep. 30, 2014	Feb. 28, 2014
Stockholders Equity [Line Items]
Rights offering shares	400.00%			400.00%
Common stock, par value		$ 5.75
Number of common stock reserved for issuance		1,337,686
Common stock issued for rights offering, net of costs		6,688,433
Options Outstanding (shares)	774,394			774,394	807,949
Increase in additional paid-in-capital due to reclassification of embedded derivative					$ 14,100,000
Estimated Fair Value Of Warrants	$ 5,400,000			$ 5,400,000
Common stock warrants term				5 years
Exercise price of warrants	$ 10.75			$ 10.75
Additional paid-in-capital	$ 305,389,000			$ 305,389,000	266,705,000	[1]
Share and note repurchase program, authorized amount							$ 10,000,000
Cost of shares acquired	$ 348,000			348,000	$ 0	[1]
Average cost per share (usd per share)	$ 5.30
Remaining authorized amount	$ 9,700,000			$ 9,700,000
Restricted Stock
Stockholders Equity [Line Items]
Stock granted (shares)				41,259
Performance Shares
Stockholders Equity [Line Items]
Stock granted (shares)				0
Minimum
Stockholders Equity [Line Items]
Average daily trading closing price	$ 8.50			$ 8.50
Average daily trading closing price, period				45 days
Common Stock
Stockholders Equity [Line Items]
Common stock issued for rights offering, net of costs				6,688,433
Treasury Stock
Stockholders Equity [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	65,621
Shares repurchased				(65,621,000)
Accounting Standards Update 2013-11
Stockholders Equity [Line Items]
Additional paid-in-capital			$ 6,300,000					$ 6,300,000
Derivative Actions | Common Stock
Stockholders Equity [Line Items]
Common stock issued for legal settlement			125,628
Omnibus Plan
Stockholders Equity [Line Items]
Securities remaining for future issuance	1,808,735			1,808,735
Omnibus Plan | Stock Option
Stockholders Equity [Line Items]
Shares of common stock reserved for future grant	2,700,000			2,700,000
Options Outstanding (shares)	774,394			774,394
Omnibus Plan | Restricted Stock
Stockholders Equity [Line Items]
Number of common stock reserved for issuance	103,112			103,112
Stock vesting period	1 year
Omnibus Plan | Performance Shares
Stockholders Equity [Line Items]
Stock granted (shares)	323,500				323,500
Stock granted, subject to shareholders' approval of an amendment and restatement	150,000				150,000
Stock vesting period	1 year
Omnibus Plan | Minimum | Performance Shares
Stockholders Equity [Line Items]
Actual shares to be issued	0.00%			0.00%
Omnibus Plan | Maximum | Performance Shares
Stockholders Equity [Line Items]
Actual shares to be issued	150.00%			150.00%
Omnibus Plan | Common Stock | Restricted Stock
Stockholders Equity [Line Items]
Stock granted (shares)				41,259
8.50% Senior Unsecured Convertible Notes Due 2019
Stockholders Equity [Line Items]
Common stock issued for rights offering, net of costs		6,688,433
Stated interest rate									8.50%

[1] Derived from audited consolidated financial statements.

XML

Discontinued Operations - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended	9 Months Ended
	Aug. 28, 2015	Oct. 25, 2013	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on sale of structured settlements				$ 32	$ 0
Sale of structured settlement business	$ 920	$ 12,000
Structured settlements
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of structured settlement business		$ 12,000
Loss on sale of structured settlements			$ 11,300

XML

Life Settlements (Life Insurance Policies) (Tables)

9 Months Ended

Sep. 30, 2015

Investments, All Other Investments [Abstract]

Life Settlements

The following table describes the Company’s life settlements as of September 30, 2015 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0 - 1	—	$	—	$	—
1 - 2	9	21,516		32,307
2 - 3	20	52,926		95,122
3 - 4	19	29,638		70,309
4 - 5	25	33,129		96,406
Thereafter	561	320,601		2,703,759
Total	634	$	457,810	$	2,997,903

The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at December 31, 2014 was 10.7 years. The following table describes the Company’s life settlements as of December 31, 2014 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0-1	—	$	—	$	—
1-2	4	9,227		12,728
2-3	10	23,202		45,852
3-4	16	29,531		67,735
4-5	19	23,012		65,614
Thereafter	558	303,914		2,739,137
Total	607	$	388,886	$	2,931,066

Estimated Premiums To Be Paid

Estimated premiums to be paid for each of the five succeeding fiscal years to keep the life insurance policies in force as of September 30, 2015, are as follows (in thousands):

Remainder of 2015	$	16,292
2016	68,891
2017	75,602
2018	78,260
2019	85,030
Thereafter	1,110,449
	$	1,434,524

XML

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2015

Discontinued Operations and Disposal Groups [Abstract]

Operating Results of Discontinued Structured Settlement Business

Operating results related to the Company’s discontinued structured settlement business are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total income (loss)	$	(13	)	$	38		$	60		$	150
Total expenses	(134		)	(287		)	(700		)	(604		)
Income (loss) before income taxes	(147		)	(249		)	(640		)	(454		)
Income tax benefit	34			—			224			—
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)

XML

Fair Value Measurements - Life Insurance Issuer concentrations (Detail) - Credit Concentration Risk [Member] - Moody's, A1 Rating - Standard & Poor's, AA- Rating	9 Months Ended
	Sep. 30, 2015
Lincoln National Life Insurance Company | 10% of total fair value of our investments in life settlements
Concentration Risk [Line Items]
Concentrations risk percentage	20.60%
Lincoln National Life Insurance Company | Life insurance issuer concentrations that exceed 10% of total death benefit
Concentration Risk [Line Items]
Concentrations risk percentage	20.50%
Transamerica Occidental Life Insurance Company | 10% of total fair value of our investments in life settlements
Concentration Risk [Line Items]
Concentrations risk percentage	21.60%
Transamerica Occidental Life Insurance Company | Life insurance issuer concentrations that exceed 10% of total death benefit
Concentration Risk [Line Items]
Concentrations risk percentage	19.60%

XML

Discontinued Operations - Operating Results of Structured Settlement Business (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]
Total income (loss)	$ (13)	$ 38	$ 60	$ 150
Total expenses	(134)	(287)	(700)	(604)
Income (loss) before income taxes	(147)	(249)	(640)	(454)
Income tax benefit	34	0	224	0
Net income (loss) from discontinued operations	$ (113)	$ (249)	$ (416)	$ (454)

XML

8.50% Senior Unsecured Convertible Notes 8.50% Senior Unsecured Convertible Notes (Tables)

9 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Convertible Debt

The fair value of the conversion derivative liability was estimated at June 5, 2014 using a Black Scholes pricing model with the following assumptions:

	As of June  5, 2014
Expected Volatility	40.0	%
Expected Term in Years	4.7
Risk Free Rate	1.5	%

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Assets And Liabilities Measured at Fair Value on Recurring Basis

The balances of the Company’s assets measured at fair value on a recurring basis as of September 30, 2015, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	457,810	$	457,810
	$	—	$	—	$	457,810	$	457,810

The balances of the Company’s liabilities measured at fair value on a recurring basis as of September 30, 2015 are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	157,946	$	157,946
Red Falcon Revolving Credit Facility	—		—		55,685		55,685
	$	—	$	—	$	213,631	$	213,631

The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	388,886	$	388,886
Structured settlement receivables	—		—		384		384
	$	—	$	—	$	389,270	$	389,270

The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	145,831	$	145,831
	$	—	$	—	$	145,831	$	145,831

Quantitative Information about Level 3 Fair Value Measurements

The Company values its life settlement portfolio in two classes, non-premium financed and premium financed. In considering the categories, it is generally believed that market participants would require a lower risk premium for policies that were non-premium financed, while a higher risk premium would be required for policies that were premium financed although the Company believes that this risk premium has been declining.

($ in thousands)	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at 9/30/15		Aggregate death benefit at 9/30/15		Valuation Technique	Unobservable Input (s)	Range (Weighted Average)
Non-premium financed	$	97,022	$	343,803	Discounted cash flow	Discount rate	15.00%	-	21.00%
						Life expectancy evaluation	(6.6 years)
Premium financed	$	360,788	$	2,654,100	Discounted cash flow	Discount rate	16.00%	-	24.75%
						Life expectancy evaluation	(10.5 years)
Life settlements	$	457,810	$	2,997,903	Discounted cash flow	Discount rate	17.00%
						Life expectancy evaluation	(10.0 years)
White Eagle Revolving Credit Facility	$	157,946	N/A		Discounted cash flow	Discount rate	23.55%
						Life expectancy evaluation	(9.9 years)
Red Falcon Revolving Credit Facility	$	55,685	N/A		Discounted cash flow	Discount Rate	11.18%
						Life expectancy evaluation	(9.5 years)

Changes in Estimated Fair Value, If All of Insured Lives in Company's Life Settlement Portfolio Live Six Months Shorter or Longer Than Life Expectancies Provided by Third Parties

If all of the insured lives in the Company’s life settlement portfolio live six months shorter or longer than the life expectancies provided by these third parties, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Value		Change in Value
+6	$	384,990	$	(72,820	)
-	$	457,810	—
-6	$	536,666	$	78,856

Life Insurance Issuer concentrations

The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of the Company’s life settlements as of September 30, 2015:

Carrier	Percentage of Total Fair Value		Percentage of Total Death Benefit		Moody's Rating	S&P Rating
Transamerica Life Insurance Company	20.6	%	20.5	%	A1	AA-
Lincoln National Life Insurance Company	21.6	%	19.6	%	A1	AA-

Changes in Fair Value for All Assets Using Material Level of Unobservable (Level 3) Inputs

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2014, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consist solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2014	$	302,961
Purchase of policies	3,488
Change in fair value	19,313
Matured/sold policies	(15,957		)
Premiums paid	40,578
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	350,383
Changes in fair value included in earnings for the period relating to assets held at September 30, 2014	$	8,627

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2015	$	388,886
Purchase of policies	30,534
Change in fair value	43,582
Matured/lapsed/sold policies	(53,435		)
Premiums paid	48,243
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	457,810
Changes in fair value included in earnings for the period relating to assets held at September 30, 2015	$	2,805

Changes in Fair Value for All Liabilities Using Material Level of Unobservable (Level 3) Inputs

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2015	$	145,831
Draws under the White Eagle Revolving Credit Facility	42,448
Payments on credit facility	(43,241		)
Unrealized change in fair value	12,908
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	157,946
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	12,908

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the Red Falcon Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

Red Falcon Revolving Credit Facility:
Balance, January 1, 2015	$	—
Initial advance under the Red Falcon Revolving Credit Facility	54,000
Subsequent draws under the Red Falcon Revolving Credit Facility	2,967
Payments on Red Falcon Revolving Credit Facility	(1,863		)
Unrealized change in fair value	581
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	55,685
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	581

The following tables provide a roll-forward in the changes in fair value for the nine months ended September 30, 2014, for the White Eagle Revolving Credit Facility and conversion derivative liability for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2014	$	123,847
Subsequent draws under the revolving credit facility	40,965
Payments on credit facility	(17,595		)
Unrealized change in fair value	(4,556		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	142,661
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	(4,556	)

Conversion derivative liability:
Balance, at inception	$	16,901
Change in fair value	6,759
Reclassified to equity	(23,660		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	—
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	—

Market Approach Valuation Technique

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Market Interest Rate Sensitivity Analysis

Market interest rate sensitivity analysis

Weighted Average Rate Calculated Based on
Death Benefit	Rate Adjustment	Value		Change in Value
16.50%	-0.50%	$	469,610	$	11,800
17.00%	—	$	457,810	$	—
17.50%	+0.50%	$	446,512	$	(11,298	)

Market Approach Valuation Technique | Revolving Credit Facility

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Changes in Estimated Fair Value, If All of Insured Lives in Company's Life Settlement Portfolio Live Six Months Shorter or Longer Than Life Expectancies Provided by Third Parties

If all of the insured lives in the life settlement portfolio pledged under the White Eagle Revolving Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the White Eagle Revolving Credit Facility debt, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of White Eagle Revolving Credit Facility		Change in Value
+6	$	132,093	$	(25,853	)
	$	157,946	—
-6	$	182,793	$	24,847

Market Interest Rate Sensitivity Analysis

If the weighted average discount rate were increased or decreased by 1⁄2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the White Eagle Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of White Eagle Revolving Credit Facility		Change in Value
23.05%	-0.50	%	$	160,730	$	2,784
23.55%	—		$	157,946	$	—
24.05%	+0.50	%	$	155,255	$	(2,691	)

Red Falcon Trust

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Changes in Estimated Fair Value, If All of Insured Lives in Company's Life Settlement Portfolio Live Six Months Shorter or Longer Than Life Expectancies Provided by Third Parties

If all of the insured lives in the life settlement portfolio pledged under the Red Falcon Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the Red Falcon Revolving Credit Facility, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of Red Falcon Revolving Credit Facility		Change in Value
+6	$	53,734	$	(1,951	)
	$	55,685	—
-6	$	57,236	$	1,551

Red Falcon Trust | Market Approach Valuation Technique

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Market Interest Rate Sensitivity Analysis

If the weighted average discount rate were increased or decreased by ¹⁄₂ of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the Red Falcon Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of Red Falcon Revolving Credit Facility		Change in Value
10.68%	-0.50	%	$	56,523	$	838
11.18%	—		$	55,685	$	—
11.68%	+0.50	%	$	54,868	$	(817	)

XML

Principles of Consolidation and Basis of Presentation

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation

The accompanying consolidated financial statements include the accounts of the Company, all of its wholly-owned subsidiary companies and its special purpose entities, with the exception of Imperial Settlements Financing 2010, LLC (“ISF 2010”), an unconsolidated special purpose entity which is accounted for using the cost method of accounting. The special purpose entity has been created to fulfill specific objectives. All significant intercompany balances and transactions have been eliminated in consolidation, including income from services performed by subsidiary companies in connection with the Revolving Credit Facilities. Notwithstanding consolidation, as referenced above, White Eagle is the owner of 439 policies, with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million and Red Falcon is the owner of 157 policies with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million, in each case, at September 30, 2015.

The unaudited consolidated financial statements have been prepared in conformity with the rules and regulations of the SEC for Form 10-Q and therefore do not include certain information, accounting policies, and footnote disclosures information or footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. However, all adjustments (consisting of normal recurring accruals), which, in the opinion of management, are necessary for a fair presentation of the financial statements, have been included. Operating results for the three months and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for future periods or for the year ended December 31, 2015. These interim financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in Emergent Capital's Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

Discontinued Operations

On October 25, 2013, the Company sold substantially all of the assets comprising its structured settlement business for $12.0 million. As a result, the Company has discontinued segment reporting and classified its operating results of the structured settlement business as discontinued operations. The accompanying consolidated balance sheets of the Company as of September 30, 2015 and December 31, 2014, and the related consolidated statements of operations for each of the three months and nine months ended September 30, 2015 and 2014, and the related notes to the consolidated financial statements reflect the classification of its structured settlement business operating results as discontinued operations. See Note 7, “Discontinued Operations,” for further information. Unless otherwise noted, the following notes refer to the Company’s continuing operations.

Derivative Instrument

In February 2014, the Company issued and sold $70.7 million in aggregate principal amount of 8.50% senior unsecured convertible notes due 2019 (the “Convertible Notes”). Prior to shareholder approval on June 5, 2014 to issue shares of common stock upon conversion of the Convertible Notes in excess of New York Stock Exchange limits for share issuances without shareholder approval, the Convertible Notes contained an embedded derivative feature. In accordance with Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, derivative instruments are recognized as either assets or liabilities on the Company’s balance sheet and are measured at fair value with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract, such as the Convertible Notes, are bifurcated and recognized at fair value with changes in fair value recognized as either a gain or loss in earnings if they can be reliably measured. The Company determined the fair value of its embedded derivative based upon available market data and unobservable inputs using a Black Scholes pricing model. In accordance with ASC 815, upon receipt of shareholder approval on June 5, 2014, the Company reclassified the embedded derivative to equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity. See Note 11, "8.50% Senior Unsecured Convertible Notes."

Foreign Currency

The Company owns certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to the Company’s financial statements.

Use of Estimates

The preparation of these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material. Significant estimates made by management include income taxes, the valuation of life settlements, the valuation of the debt owing under the Revolving Credit Facilities, the valuation of equity awards and the valuation of the conversion derivative liability formerly embedded within the Company’s Convertible Notes.

XML

Description of Business - Additional Information (Detail)	Sep. 30, 2015 USD ($) Contract	Jul. 16, 2015 USD ($) Contract	Dec. 31, 2014 USD ($) Contract		Apr. 29, 2013 USD ($)
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract	634		607
Life insurance estimated fair value	$ 457,810,000		$ 388,886,000
Life insurance policies with aggregate death benefit	2,997,903,000		2,931,066,000
Secured Notes, net of discount (Note 12)	0		$ 24,036,000	[1]
White Eagle | Securities Pledged as Collateral | 12.875% Senior Secured Notes Due 2017
Organization and Nature of Operations [Line Items]
Secured Notes, net of discount (Note 12)	110,000,000
White Eagle | Revolving Credit Facility
Organization and Nature of Operations [Line Items]
Revolving Credit facility, current borrowing capacity	$ 161,800,000				$ 300,000,000.0
White Eagle | Revolving Credit Facility | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract	439
Life insurance estimated fair value	$ 327,400,000
Life insurance policies with aggregate death benefit	2,200,000,000
Revolving Credit facility, current borrowing capacity	$ 300,000,000.0				$ 300,000,000
Red Falcon Trust | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract	157
Life insurance estimated fair value	$ 117,400,000
Life insurance policies with aggregate death benefit	604,800,000
Red Falcon Trust | Revolving Credit Facility
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract		157
Revolving Credit facility, current borrowing capacity	$ 55,200,000	$ 110,000,000
Red Falcon Trust | Revolving Credit Facility | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned (contracts) | Contract	157
Life insurance estimated fair value	$ 117,400,000
Life insurance policies with aggregate death benefit	$ 604,800,000

[1] Derived from audited consolidated financial statements.

XML

Stock-based Compensation - Common Stock Options Activity (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Number of Shares
Options outstanding, Beginning Balance (shares)	807,949
Options granted (shares)	0
Options exercised (shares)	0
Options forfeited (shares)	(33,555)
Options expired (shares)	0
Options outstanding, Ending Balance (shares)	774,394	807,949
Exercisable at end of period (shares)	774,394
Unvested at end of period (shares)	0
Weighted Average Price per Share
Options outstanding, Beginning Balance (usd per share)	$ 8.50
Options granted (usd per share)
Options exercised (usd per share)
Options forfeited (usd per share)	$ 8.50
Options expired (usd per share)
Options outstanding, Ending Balance (usd per share)	$ 8.50	$ 8.50
Exercisable at end of period (usd per share)	8.50
Unvested at end of period (usd per share)	$ 0.00
Weighted Average Remaining Contractual Term
Options outstanding, Beginning Balance (shares)	3 years 8 months 23 days	4 years 5 months 23 days
Exercisable at end of period (shares)	3 years 8 months 23 days
Unvested at end of period (shares)	0 years
Aggregate Intrinsic Value
Options outstanding, Beginning Balance	$ 0
Options granted	0
Options exercised	0
Options forfeited	0
Options expired	0
Options outstanding, Ending Balance	0	$ 0
Exercisable at end of period	0
Unvested at end of period	$ 0

XML

Fair Value Measurements - Assets And Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Life settlements	$ 457,810	$ 388,886
Structured settlement receivables	0	384	[1]
Total assets	457,810	389,270
Revolving Credit Facility debt, at estimated fair value		145,831
Total Liabilities	213,631	145,831
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Life settlements	0	0
Structured settlement receivables		0
Total assets	0	0
Revolving Credit Facility debt, at estimated fair value		0
Total Liabilities	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Life settlements	0	0
Structured settlement receivables		0
Total assets	0	0
Revolving Credit Facility debt, at estimated fair value		0
Total Liabilities	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Life settlements	457,810	388,886
Structured settlement receivables		384
Total assets	457,810	389,270
Revolving Credit Facility debt, at estimated fair value		145,831
Total Liabilities	213,631	$ 145,831
White Eagle Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	157,946
White Eagle Revolving Credit Facility | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	0
White Eagle Revolving Credit Facility | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	0
White Eagle Revolving Credit Facility | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	157,946
Red Falcon Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	55,685
Red Falcon Revolving Credit Facility | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	0
Red Falcon Revolving Credit Facility | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	0
Red Falcon Revolving Credit Facility | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revolving Credit Facility debt, at estimated fair value	$ 55,685

[1] Derived from audited consolidated financial statements.

XML

Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2015	Dec. 31, 2014
Assets
Cash and cash equivalents		$ 31,260	$ 51,166	[1]
Prepaid expenses and other assets		1,527	1,502	[1]
Deposits - other		1,347	1,340	[1]
Deposits on purchases of life settlements		0	1,630	[1]
Structured settlement receivables, at estimated fair value		0	384	[1]
Structured settlement receivables at cost, net		0	597	[1]
Life settlements, at estimated fair value		13,023	82,575	[1]
Fixed assets, net		335	355	[1]
Investment in affiliates	[1]	2,384	2,384
Deferred debt costs, net		1,907	3,936	[1]
Total assets		515,815	459,931	[1]
Liabilities
Accounts payable and accrued expenses		4,817	6,140	[1]
Other liabilities		419	1,256	[1]
Convertible Notes, net of discount (Note 11)		57,867	55,881	[1]
Secured Notes, net of discount (Note 12)		0	24,036	[1]
White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 4)			145,831
Total liabilities		$ 279,414	$ 244,828	[1]
Commitments and Contingencies (Note 15)				[1]
Stockholders’ Equity
Common stock (par value $0.01 per share, 80,000,000 authorized; 28,130,508 and 21,402,990 issued and outstanding as of September 30, 2015 and December 31, 2014, respectively)		$ 281	$ 214	[1]
Preferred stock (par value $0.01 per share, 40,000,000 authorized; 0 issued and outstanding as of September 30, 2015 and December 31, 2014)		0	0	[1]
Treasury Stock, net of cost (65,621 and 0 shares as of September 30, 2015 and December 31, 2014, respectively)		(348)	0	[1]
Additional paid-in-capital		305,389	266,705	[1]
Accumulated deficit		(68,921)	(51,816)	[1]
Total stockholders’ equity		236,401	215,103	[1]
Total liabilities and stockholders’ equity		515,815	459,931	[1]
Primary Beneficiary Variable Interest Entity
Assets
Cash and cash equivalents		9,157	3,751	[1]
Life settlements, at estimated fair value		444,787	306,311	[1]
Receivable for maturity of life settlements (VIE Note 4)		10,088	4,000	[1]
Liabilities
Accounts payable and accrued expenses		388	423	[1]
White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 4)		157,946	145,831	[1]
8.50% Senior Unsecured Convertible Notes Due 2019
Assets
Deferred debt costs, net		1,900
Liabilities
Interest payable		768	2,272	[1]
Convertible Notes, net of discount (Note 11)		57,900
12.875% Senior Secured Notes Due 2017
Liabilities
Interest payable		0	261	[1]
Revolving Credit Facility
Liabilities
White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 4)		55,685	0	[1]
Red Falcon Revolving Credit Facility, at estimated fair value (VIE Note 4)		$ 1,524	$ 8,728	[1]

[1] Derived from audited consolidated financial statements.

XML

Life Settlements (Life Insurance Policies) - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2015 USD ($) Contract	Dec. 31, 2014 USD ($) Contract
Investments, All Other Investments [Abstract]
Number of policies owned (contracts) | Contract	634	607
Life insurance estimated fair value	$ 457,810	$ 388,886
Average life expectancy of insured	10 years
Estimated future premium payments	$ 1,434,524

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net income (loss)	$ (17,105)	$ (14,317)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	74	59
Stock-based compensation expense	429	762
Change in fair value of life settlements	(43,582)	(19,313)
Unrealized change in fair value of structured settlements	(20)	(24)
Loss on sale of structured settlements	(32)	0
Change in fair value of Revolving Credit Facilities	13,489	(4,556)
Loss on sale of structured settlements	0	426
Interest income	(81)	(102)
Extinguishment of Secured Notes	8,782	0
Change in fair value of conversion derivative liability	0	6,759
Deferred income tax	(7,205)	(2,452)
Change in assets and liabilities:
Restricted cash	0	13,506
Deposits - other	(654)	243
Investment in affiliates	0	(7)
Structured settlement receivables	1,097	578
Prepaid expenses and other assets	(188)	(413)
Accounts payable and accrued expenses	(1,491)	2,512
Other liabilities	(812)	(14,301)
Net cash used in operating activities	(37,401)	(23,986)
Cash flows from investing activities
Purchase of fixed assets, net of disposals	(47)	(178)
Purchase of life settlements	(28,904)	(3,488)
Premiums paid on life settlements	(48,243)	(40,578)
Proceeds from sale of life settlements, net	0	4,031
Proceeds from maturity of life settlements	47,519	13,641
Deposits on purchase of life settlements	0	(50)
Net cash used in investing activities	(29,675)	(26,622)
Cash flows from financing activities
Proceeds from rights offering	38,458	0
Proceeds from Secured Notes, net	23,750	0
Purchase of treasury stock	(348)	0
Payment under finance lease obligations	(25)	0
Net cash provided by financing activities	52,576	86,301
Net decrease/increase in cash and cash equivalents	(14,500)	35,693
Cash and cash equivalents, at beginning of the period	54,917	22,699
Cash and cash equivalents, at end of the period	40,417	58,392
Supplemental disclosures of cash flow information:
Cash paid for interest during the period	12,143	4,496
Supplemental disclosures of non-cash financing activities:
Interest payment and fees withheld from borrowings by lender	5,566	4,962
Senior Unsecured Notes
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization of discount and deferred cost for notes	2,281	1,648
Change in fair value of conversion derivative liability		6,800
Change in assets and liabilities:
Interest Payable	(1,503)	768
Cash flows from financing activities
Proceeds from Convertible Notes, net	0	67,892
Extinguishment of Secured Notes	(3,570)	0
Senior Secured Notes
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization of discount and deferred cost for notes	542	0
Change in assets and liabilities:
Interest Payable	(261)	0
Cash flows from financing activities
Secured Notes deferred costs	(5)	0
Revolving Credit Facility
Adjustments to reconcile net income (loss) to net cash used in operating activities:
White Eagle Revolving Credit Facility financing cost and fees	5,566	4,238
Cash flows from financing activities
Borrowings from revolving credit facility	36,880	36,004
Repayment of borrowings under revolving credit facility	(43,241)	(17,595)
Red Falcon Trust
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Red Falcon Revolving Credit Facility origination cost	3,273	0
Red Falcon Trust | Revolving Credit Facility
Cash flows from financing activities
Borrowings from revolving credit facility	2,967	0
Repayment of borrowings under revolving credit facility	(1,863)	0
Red Falcon Revolving Credit Facility origination costs	(427)	0
Lender | Red Falcon Trust | Revolving Credit Facility
Cash flows from financing activities
Borrowings from revolving credit facility	54,000	0
Repayment of borrowings under revolving credit facility	(51,800)	0
Supplemental disclosures of non-cash financing activities:
Red Falcon Revolving Credit Facility origination cost paid to lender	$ 2,200	$ 0

XML

Fair Value Measurements - Changes in Weighted Average Discount Rate Used to Estimate Fair Value of Revolving Credit Facility (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value			$ 145,831
Change in Value	$ 0
Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value	$ 157,946	$ 157,946
.50% Decrease in Discount Rate | Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	23.05%
Value	$ 160,730
Change in Value	$ 2,784
.50% Increase in Discount Rate | Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	24.05%
Value	$ 155,255
Change in Value	$ (2,691)
Red Falcon Trust
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	11.18%
Value	$ 55,685
Change in Value	$ 0
Red Falcon Trust | .50% Decrease in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	10.68%
Value	$ 56,523
Change in Value	$ 838
Red Falcon Trust | .50% Increase in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	11.68%
Value	$ 54,868
Change in Value	$ (817)

XML

Consolidation of Variable Interest Entities - Additional Information (Detail) $ in Thousands	Sep. 30, 2015 USD ($) Contract	Dec. 31, 2014 USD ($) Contract
Variable Interest Entity [Line Items]
Number of policies owned (contracts) | Contract	634	607
Life insurance policies with aggregate death benefit	$ 2,997,903	$ 2,931,066
Life insurance estimated fair value	$ 457,810	$ 388,886
White Eagle | Revolving Credit Facility | Securities Pledged as Collateral
Variable Interest Entity [Line Items]
Number of policies owned (contracts) | Contract	439
Life insurance policies with aggregate death benefit	$ 2,200,000
Life insurance estimated fair value	$ 327,400
Red Falcon | Revolving Credit Facility | Securities Pledged as Collateral
Variable Interest Entity [Line Items]
Number of policies owned (contracts) | Contract	157
Life insurance policies with aggregate death benefit	$ 604,800
Life insurance estimated fair value	$ 117,400

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2015

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

During the second quarter of 2015, the Company commenced a rights offering and distributed one non-transferable subscription right for every four shares of common stock owned by its shareholders of record at the close of business on May 26, 2015. Each right entitled its holder to subscribe for one share of common stock at a price of $5.75 per share. Additionally, the Company allocated an additional 1,337,686 shares to honor over-subscription requests. The rights offering was over-subscribed and the Company issued 6,688,433 shares of common stock.

The Company has reserved an aggregate of 2,700,000 shares of common stock under its Omnibus Plan, of which 774,394 options to purchase shares of common stock granted to existing employees were outstanding as of September 30, 2015, and 103,112 shares of restricted stock had been granted to directors under the plan with 41,259 shares subject to vesting.

During 2014, upon receipt of shareholder approval, the Company reclassified the embedded derivative contained in its Convertible Notes to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. This resulted in an increase to additional paid-in-capital of $14.1 million, net of taxes on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of December 31, 2014. See Note 11, "8.50% Senior Unsecured Convertible Notes."

In connection with the settlement of derivative litigation, the Company issued 125,628 shares of the Company’s stock, which were issued in the first quarter of 2014 and are included in stockholders’ equity.

In connection with the settlement of class litigation filing in connection with the USAO Investigation, the Company issued warrants to purchase two million shares of the Company’s stock into an escrow account in April 2014 and were distributed in October 2014. The estimated fair value at the measurement date of such warrants was $5.4 million, which is included in stockholder’s equity. The warrants have a five-year term from the date of their distribution with an exercise price of $10.75. The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement.

During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan, which was obtained at the Company’s 2015 annual meeting on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0% – 150% of the target performance shares. As a result, the Company determined that it is not probable that the performance conditions will be achieved and no related expense was recognized for the three months and nine months periods ended September 30, 2015. The performance shares will be subject to a one year vesting period from the date of issuance.

Exclusive of the 323,500 target performance shares awarded to its directors, named executive officers and certain employees, there were 1,808,735 securities remaining for future issuance under the Omnibus Plan as of September 30, 2015.

During the nine months ended September 30, 2014, the Company adopted ASU No. 2013-11, resulting in an increase to additional paid-in-capital of $6.3 million on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of September 30, 2014. See Note 17, "Income Taxes."

On September 1, 2015, the Company announced that its Board of Directors authorized a $10 million share and note repurchase program. The program has a two-year expiration date, and authorizes the Company to repurchase up to $10 million of its common stock and/or its Convertible Notes due 2019. For the quarter ended September 30, 2015, the Company purchased 65,621 shares for a total cost of approximately $348,000, which is an average cost of $5.30 per share including transaction fees. As of September 30, 2015, the Company may purchase up to approximately $9.7 million of additional common stock or Convertible Notes under its board authorized plan.

XML

Earnings Per Share - Additional Information (Detail) - shares	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014
Earnings Per Share [Abstract]
Common stock, shares outstanding (shares)	28,130,508	21,402,990	21,402,990
Common stock, shares issued (shares)	28,130,508	21,402,990	21,402,990

XML

Principles of Consolidation and Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Derivative Instruments

Derivative Instrument

In February 2014, the Company issued and sold $70.7 million in aggregate principal amount of 8.50% senior unsecured convertible notes due 2019 (the “Convertible Notes”). Prior to shareholder approval on June 5, 2014 to issue shares of common stock upon conversion of the Convertible Notes in excess of New York Stock Exchange limits for share issuances without shareholder approval, the Convertible Notes contained an embedded derivative feature. In accordance with Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, derivative instruments are recognized as either assets or liabilities on the Company’s balance sheet and are measured at fair value with gains or losses recognized in earnings. Embedded derivatives that are not clearly and closely related to the host contract, such as the Convertible Notes, are bifurcated and recognized at fair value with changes in fair value recognized as either a gain or loss in earnings if they can be reliably measured. The Company determined the fair value of its embedded derivative based upon available market data and unobservable inputs using a Black Scholes pricing model. In accordance with ASC 815, upon receipt of shareholder approval on June 5, 2014, the Company reclassified the embedded derivative to equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity. See Note 11, "8.50% Senior Unsecured Convertible Notes.

Foreign Currency

Foreign Currency

The Company owns certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to the Company’s financial statements.

Use of Estimates

Use of Estimates

The preparation of these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America (“GAAP”), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material. Significant estimates made by management include income taxes, the valuation of life settlements, the valuation of the debt owing under the Revolving Credit Facilities, the valuation of equity awards and the valuation of the conversion derivative liability formerly embedded within the Company’s Convertible Notes.

XML

Description of Business

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Description of Business

Founded in December 2006 as a Florida limited liability company, Imperial Holdings, LLC, converted into Imperial Holdings, Inc. on February 3, 2011, in connection with the Company’s initial public offering. Effective September 1, 2015, the Company changed its name to Emergent Capital, Inc. (with its subsidiary companies, the “Company” or “Emergent Capital”).

Incorporated in Florida, Emergent Capital, through its subsidiary companies, owns a portfolio of 634 life insurance policies, also referred to as life settlements, with a fair value of $457.8 million and an aggregate death benefit of approximately $3.0 billion at September 30, 2015. The Company primarily earns income on these policies from changes in their fair value and through death benefits. 439 of these policies, with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million at September 30, 2015 are pledged under a $300.0 million, revolving credit agreement (the “White Eagle Revolving Credit Facility”) entered into by the Company’s indirect subsidiary, White Eagle Asset Portfolio, LP (“White Eagle”). Additionally, 157 policies, with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million at September 30, 2015 were pledged as collateral under a $110.0 million, revolving credit agreement (the “Red Falcon Revolving Credit Facility” and, together with the White Eagle Revolving Credit Facility, the "Revolving Credit Facilities") entered into by Red Falcon Trust (“Red Falcon”), a Delaware statutory trust formed by a wholly-owned Irish subsidiary of the Company.

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	80,000,000	80,000,000
Common stock, shares issued (shares)	28,130,508	21,402,990
Common stock, shares outstanding (shares)	28,130,508	21,402,990
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	40,000,000	40,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury Stock	65,621	0

XML

8.50% Senior Unsecured Convertible Notes

9 Months Ended

Sep. 30, 2015

8.50% Senior Unsecured Convertible Notes Due 2019

Debt Instrument [Line Items]

Senior Unsecured Notes

8.50% Senior Unsecured Convertible Notes

In February 2014, the Company issued $70.7 million in an aggregate principal amount of 8.50% senior unsecured convertible notes due 2019. The Convertible Notes were sold, in part, to certain accredited investors pursuant to Regulation D under the Securities Act of 1933 and, in part, to an initial purchaser who then resold such Convertible Notes to qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933. The Convertible Notes were issued pursuant to an indenture dated February 21, 2014, between the Company and U.S. Bank National Association, as trustee. Two members of the Company’s Board of Directors, Messrs. Dakos and Goldstein, are affiliated with Bulldog Investors, LLC, who purchased Convertible Notes in the aggregate principal amount of $9.2 million in the offering.

The Convertible Notes are general senior unsecured obligations and rank equally in right of payment with all of the Company’s other existing and future senior unsecured indebtedness. The Convertible Notes are effectively subordinate to all of the Company’s secured indebtedness to the extent of the value of the assets collateralizing such indebtedness. The Convertible Notes are not guaranteed by the Company’s subsidiaries.

The maturity date of the Convertible Notes is February 15, 2019. The Convertible Notes accrue interest at the rate of 8.50% per annum on the principal amount of the Convertible Notes, payable semi-annually in arrears on August 15 and February 15 of each year.

The Convertible Notes are convertible into shares of common stock at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Initially, the Convertible Notes were convertible into shares of common stock at a conversion rate of 147.9290 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.76 per share of common stock). In the second quarter of 2015, the conversion rate was adjusted to 151.7912 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.59 per share of common stock) in connection with anti-dilution adjustment triggered by a rights offering that resulted in the issuance of 6,688,433 shares of the Company’s stock.

The Company may not redeem the Convertible Notes prior to February 15, 2017. On and after February 15, 2017, and prior to the maturity date, the Company may redeem for cash all, but not less than all, of the Convertible Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the applicable conversion price for at least 20 trading days during the 30 consecutive trading day period ending on the trading day immediately prior to the date the Company delivers notice of the redemption. The redemption price will be equal to 100% of the principal amount of the Convertible Notes, plus any accrued and unpaid interest to, but excluding, the redemption date. In addition, if the Company calls the Convertible Notes for redemption, a make-whole fundamental charge will be deemed to occur. As a result, the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock for holders who convert their notes prior to the redemption date.

The Company determined that an embedded conversion option existed in the Convertible Notes, prior to June 5, 2014, that was required to be separately accounted for as a derivative under ASC 815 which required the Company to bifurcate the embedded conversion option and record it as a liability at fair value and record a debt discount by an equal amount with changes in the fair value of the conversion derivative liability recorded in earnings and the discount on the debt liability, together with the stated interest on the instrument, amortized to interest expense over the life of the debt using the effective interest method.

On June 5, 2014, the Company obtained shareholder approval to issue shares of common stock upon conversion of the Convertible Notes in an amount that exceeded applicable New York Stock Exchange limits for issuances without shareholder approval. In accordance with ASC 815, the Company reclassified the embedded conversion derivative liability to equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity.

The fair value of the conversion derivative liability was estimated at June 5, 2014 using a Black Scholes pricing model with the following assumptions:

	As of June  5, 2014
Expected Volatility	40.0	%
Expected Term in Years	4.7
Risk Free Rate	1.5	%

At June 5, 2014, the fair value of the conversion derivative liability was $23.7 million. In accordance with ASC 815, the Company reclassified this amount along with $756,000 of unamortized transaction costs offset by deferred taxes of $8.8 million to stockholders’ equity. As of September 30, 2015, the carrying value of the Convertible Notes was $57.9 million. The unamortized debt discount and origination cost of $12.8 million and $1.9 million, respectively, will be amortized over the remaining life of the Convertible Notes, using the effective interest method.

The Company recorded $2.3 million and $2.2 million of interest expense on the Convertible Notes, including $1.5 million, $711,000 and $105,000 and $1.5 million, $605,000 and $90,000 from interest, amortizing debt discounts and issuance costs, during the three months ended September 30, 2015 and 2014, respectively. During the nine months ended September 30, 2015 and 2014, the Company recorded $6.8 million and $5.3 million of interest expense on the Convertible Notes, including $4.5 million, $2.0 million and $294,000 and $3.7 million, $1.4 million and $239,000 from interest, amortizing debt discounts and issuance costs, respectively.

During the nine months ended September 30, 2014, the Company recorded a loss on the change in fair value of the conversion derivative liability of $6.8 million.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 09, 2015
Document And Entity Information [Abstract]
Entity Registrant Name	Emergent Capital, Inc..
Entity Central Index Key	0001494448
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Amendment Flag	false
Trading Symbol	IFT
Entity Common Stock, Shares Outstanding		28,130,508

XML

12.875% Senior Secured Notes

9 Months Ended

Sep. 30, 2015

12.875% Senior Secured Notes

Debt Instrument [Line Items]

Senior Unsecured Notes

12.875% Senior Secured Notes

On November 10, 2014 (the “Initial Closing Date”), the Company, as issuer, entered into an indenture with certain of its subsidiary companies, Harbordale, LLC, Imperial Finance & Trading, LLC, Imperial Life and Annuity Services, LLC, Imperial Litigation Funding, LLC, Imperial Premium Finance, LLC, Red Reef Alternative Investments, LLC and Washington Square Financial, LLC, as guarantors (the “Guarantors”), and Wilmington Trust Company, as indenture trustee. The indenture provided for the issuance of up to $100 million in senior secured notes (the “Secured Notes), of which $25 million was issued by the Company on the Initial Closing Date. The Secured Notes issued on the Initial Closing Date were issued at 96% of their face amount and were purchased under a note purchase agreement (the “Note Purchase Agreement”) with the Company and the Guarantors by an affiliate of Indaba Capital Management, L.P. (the “Purchaser”) in a private transaction pursuant to exemptions from the registration requirements of the Securities Act of 1933, as amended. On January 21, 2015, the Company issued an additional $25.0 million in aggregate principal amount of Secured Notes, which were purchased by the Purchaser under the Note Purchase Agreement at 96% of their principal amount. Fees and expenses paid by the Company in connection with the Initial Closing Date and its subsequent issuance were approximately $1.8 million and $305,000, respectively.

Interest on issued Secured Notes accrued at 12.875% per annum and all Secured Notes issued under the indenture were scheduled to mature on November 10, 2017.

The Secured Notes were guaranteed by the Guarantors and were secured by substantially all of the Company’s and Guarantors’ assets, other than those securing the White Eagle Revolving Credit Facility, including cash on account as well as the Company’s life insurance policies that were not pledged as collateral under the White Eagle Revolving Credit Facility. The Secured Notes were also secured by pledges of the equity interests of the Guarantors and by pledges of 65% of their first tier foreign subsidiary companies.

On July 16, 2015, the Company redeemed all of the outstanding Secured Notes and discharged the Secured Note indenture. The Secured Notes were redeemed at 106% of their principal amount plus interest up to but excluding November 10, 2015. Effective as of the redemption of the Secured Notes, 159 of the life insurance policies that served as collateral for the Secured Notes were sold to Red Falcon in an internal transfer and pledged as collateral under the Red Falcon Revolving Credit Facility. Approximately $8.8 million was expensed as extinguishment related to the early repayment of the facility, in July 2015. This includes $5.2 million, $171,000, $1.7 million and $1.7 million related to interest and prepayment penalties, unused fees, write off of debt discount and write off of issuance cost.

The Company recorded $4.0 million of interest expense on the Secured Notes, including $3.2 million, $265,000, $264,000 and $277,000 from interest, unused fees, amortizing debt discounts and issuance costs, during the nine months ended September 30, 2015.

XML

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income
Interest income	$ 7	$ 9	$ 16	$ 22
Loss on life settlements, net	0	0	0	(426)
Change in fair value of life settlements (Notes 8 & 13)	2,667	(3,643)	43,582	19,313
Other income	95	17	185	72
Total income (loss)	2,769	(3,617)	43,783	18,981
Expenses
Interest expense	8,614	4,303	21,491	11,165
Extinguishment of Secured Notes	8,782	0	8,782	0
Change in fair value of Revolving Credit Facilities (Notes 9, 10 & 13)	(4,203)	(8,375)	13,489	(4,556)
Change in fair value of conversion derivative liability (Notes 11 & 13)	0	0	0	6,759
Personnel costs	1,945	1,910	5,425	6,627
Legal fees	3,370	2,943	10,345	9,121
Professional fees	1,579	1,143	5,284	3,562
Insurance	309	414	966	1,253
Other selling, general and administrative expenses	585	544	1,671	1,365
Total expenses	20,981	2,882	67,453	35,296
Income (loss) from continuing operations before income taxes	(18,212)	(6,499)	(23,670)	(16,315)
Benefit for income taxes	4,721	2,235	6,981	2,452
Net income (loss) from continuing operations	(13,491)	(4,264)	(16,689)	(13,863)
Discontinued Operations:
Income (loss) from discontinued operations	(147)	(249)	(640)	(454)
Benefit for income taxes	34	0	224	0
Net income (loss) from discontinued operations	(113)	(249)	(416)	(454)
Net income (loss)	$ (13,604)	$ (4,513)	$ (17,105)	$ (14,317)
Basic and diluted income (loss) per share:
Continuing operations (usd per share)	$ (0.48)	$ (0.20)	$ (0.70)	$ (0.65)
Discontinued operations (usd per share)	0.00	(0.01)	(0.02)	(0.02)
Basic and diluted income (loss) per share available to common shareholders (usd per share)	$ (0.48)	$ (0.21)	$ (0.72)	$ (0.67)
Weighted average shares outstanding:
Basic and Diluted (shares)	28,084,254	21,361,930	23,827,030	21,352,086

XML

Stock-based Compensation

9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based Compensation

Stock-based Compensation

On May 28, 2015, the Company amended and restated its 2010 Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”). Awards under the Omnibus Plan may consist of incentive awards, stock options, stock appreciation rights, performance shares, performance units, and shares of common stock, restricted stock, restricted stock units or other stock-based awards as determined by the compensation committee. The Omnibus Plan provides for an aggregate of 2,700,000 shares of common stock to be reserved for issuance under the Omnibus Plan, subject to adjustment as provided in the Omnibus Plan.

The Company recognized approximately $0 and $140,000 in stock-based compensation expense relating to stock options during the three months ended September 30, 2015 and 2014, respectively, and approximately $237,000 and $632,000 during the nine months ended September 30, 2015 and 2014, respectively. The Company incurred additional stock-based compensation expense of approximately $61,000 relating to restricted stock granted to its board of directors during the three months ended September 30, 2015 and 2014, respectively, and approximately $192,000 and $130,000 during the nine months ended September 30, 2015 and 2014, respectively. During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan at the Company’s 2015 annual meeting, which was obtained on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance, as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0 –150% of the target performance shares. The Company evaluates on a quarterly basis whether it is probable that the Company’s financial performance conditions will be achieved. At September 30, 2015 and 2014, the Company determined that it was not probable that the performance conditions would be achieved and as a result, no related expense was recognized for the three months and nine months ended September 30, 2015 and 2014, respectively.

Options

As of September 30, 2015, options to purchase 774,394 shares of common stock were outstanding and unexercised under the Omnibus Plan at a weighted average exercise price of $8.50 per share. The following table presents the activity of the Company’s outstanding stock options of common stock for the nine months ended September 30, 2015:

Common Stock Options	Number of Shares		Weighted Average Price per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Options outstanding, January 1, 2015	807,949		$	8.50	4.48	—
Options granted	—					—
Options exercised	—					—
Options forfeited	(33,555	)	$	8.50	—	—
Options expired	—					—
Options outstanding, September 30, 2015	774,394		$	8.50	3.73	—
Exercisable at September 30, 2015	774,394		$	8.50	3.73	—
Unvested at September 30, 2015	—		—		—	—

As of September 30, 2015, all outstanding stock options had an exercise price above the fair market value of the common stock on that date. During the three months ended September 30, 2015 and 2014, the Company recognized expense of $0 and $140,000, respectively, related to these options and $237,000 and $632,000 during the nine months ended September 30, 2015 and 2014, respectively. There are no remaining unamortized amounts to be recognized on these options.

Restricted Stock

17,286 shares of restricted stock granted to the Company’s directors under the Omnibus Plan vested during the nine months ended September 30, 2014. The fair value of the vested restricted stock was valued at approximately $120,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company expensed approximately $0 and $52,000 in stock based compensation related to the 17,286 shares of restricted stock during the three months and nine months ended September 30, 2014, respectively.

Under the Omnibus Plan, 41,060 shares of restricted stock granted to the Company’s directors vested during the nine months ended September 30, 2015. The fair value of the vested restricted stock was valued at approximately $255,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company incurred additional stock-based compensation expense of approximately $61,000 and $78,000 related to these 41,060 shares of restricted stock during the three months and nine months ended September 30, 2014, respectively and approximately $0 and $108,000 during the three months and nine months ended September 30, 2015, respectively.

During the nine months ended September 30, 2015, 41,259 shares of restricted stock were granted to the Company’s directors under the Omnibus Plan, which are subject to a one year vesting period that commenced on the date of grant. The fair value of the unvested restricted stock was valued at approximately $255,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company expensed approximately $61,000 and $83,000 in stock based compensation related to these 41,259 shares of restricted stock during the three months and nine months periods ended September 30, 2015, respectively.

The following table presents the activity of the Company’s unvested shares of restricted stock for the nine months ended September 30, 2015:

Common Unvested Shares	Number of Shares
Outstanding January 1, 2015	41,060
Granted	41,259
Vested	(41,060	)
Forfeited	—
Outstanding September 30, 2015	41,259

The aggregate intrinsic value of these awards is $230,000 and the remaining weighted average life of these awards is 0.7 years as of September 30, 2015.

Performance Shares

During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan, which was obtained at the Company’s 2015 annual meeting on May 28, 2015. The issuance of the performance shares is contingent on the Company’s financial performance, as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0 – 150% of the 323,500 shares. At September 30, 2015, the Company determined that it was not probable that the performance conditions would be achieved and no related expense was recognized for the three months and nine months ended September 30, 2015. If issued, the performance shares will be subject to a one year vesting period from the date of issuance.

The following table presents the activity of the Company’s performance share awards for the nine months ended September 30, 2015:

Performance Shares	Number of Shares
Outstanding January 1, 2015	323,500
Awarded	—
Vested	—
Forfeited	—
Outstanding September 30, 2015	323,500

Warrants

On February 11, 2011, three shareholders received warrants that may be exercised for up to a total of 4,240,521 shares of the Company’s common stock at a weighted average exercise price of $14.51 per share. The warrants will expire seven years after the date of issuance and are exercisable as they are fully vested. At September 30, 2015, all 4,240,521 warrants remained outstanding.

In connection with a settlement of class action litigation arising in connection with the USAO Investigation, the Company issued warrants to purchase two million shares of the Company’s stock into an escrow account in April of 2014. The estimated fair value as of the measurement date of such warrants was $5.4 million, which is included in stockholders’ equity. The warrants were distributed in October 2014 and have a five-year term from the date they are distributed to the class participants with an exercise price of $10.75. The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

As of September 30, 2015 and 2014, there were 28,130,508 and 21,402,990 issued and outstanding shares of common stock, respectively.

Basic net income per share is computed by dividing the net earnings attributable to common shareholders by the weighted average number of common shares outstanding during the period.

Diluted earnings per share is computed by dividing net income, adjusted to include expenses recognized associated with convertible debt, attributable to common shareholders by the weighted average number of common shares outstanding, increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. Conversion or exercise of the potential common shares is not reflected in diluted earnings per share unless the effect is dilutive. The dilutive effect, if any, of outstanding common share equivalents is reflected in diluted earnings per share by application of the treasury stock method and if-converted method, as applicable.

The following tables reconcile actual basic and diluted earnings per share for the three months and nine months ended September 30, 2015 and 2014 (in thousands except share and per share data).

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2015(1)			2014(2)			2015(1)			2014(2)
Income (loss) per share:
Numerator:
Net income (loss) from continuing operations	$	(13,491	)	$	(4,264	)	$	(16,689	)	$	(13,863	)
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)
Net income (loss)	$	(13,604	)	$	(4,513	)	$	(17,105	)	$	(14,317	)
Basic and diluted income (loss) per common share:
Basic and diluted income (loss) from continuing operations	$	(0.48	)	$	(0.20	)	$	(0.70	)	$	(0.65	)
Basic and diluted income (loss) from discontinued operations	$	—		$	(0.01	)	$	(0.02	)	$	(0.02	)
Basic and diluted income (loss) per share available to common shareholders	$	(0.48	)	$	(0.21	)	$	(0.72	)	$	(0.67	)
Denominator:
Basic and diluted	28,084,254			21,361,930			23,827,030			21,352,086

(1) The computation of diluted EPS does not include 41,259 shares of restricted stock, 774,394 options, 6,240,521 warrants up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes and 323,500 performance shares, as the effect of their inclusion would have been anti-dilutive.

(2) The computation of diluted EPS did not include 815,448 options, 6,240,521 warrants, 41,060 shares of restricted stock, up to 10,464,491 shares of underlying common stock issuable upon conversion of the Convertible Notes and 299,500 performance shares for the three months and nine months ended September 30, 2014, as the effect of their inclusion would have been anti-dilutive.

XML

Income Taxes

9 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company’s provision for income taxes from continuing operations is estimated to result in an annual effective tax rate of approximately 35.0% and 36.9% (before the third quarter 2015 establishment of a valuation allowance and before the 2014 adoption of ASU 2013-11, discussed below) during the nine month period ended September 30, 2015 and 2014, respectively. The Company’s quarterly effective income tax rates are based upon the Company’s current estimated annual rate. The Company’s annual effective income tax rate varies based upon the Company’s taxable earnings as well as on a mix of taxable earnings in the various state and foreign jurisdictions.

In the third quarter of 2015, the Company established a valuation allowance of $2.0 million for certain state net deferred tax assets. This valuation allowance is needed as realization is not expected due to the anticipation that sufficient future taxable earnings may not be generated in the state jurisdictions in which the Company operates. The tax expense from the increase valuation allowance was offset by a $927,000 tax benefit for the impact on tax rate changes in the third quarter.

The Company adopted ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”) effective on January 1, 2014, which required the Company to reclassify a $6.3 million current liability for unrecognized tax benefits to deferred taxes. Adoption of this guidance resulted in the recognition of a $3.7 million tax expense included in the Company’s provision for income taxes for the three months ended March 31, 2014, a $2.6 million reduction in the valuation allowance and an increase to additional paid-in-capital of $6.3 million on the Company’s consolidated balance sheet and consolidated statement of stockholders’ equity as of March 31, 2014.

In March of 2014, the Company was notified by the IRS of its intention to examine the Company’s tax returns for the years ended December 31, 2011 and 2012. See also “IRS Investigation” in Note 15 regarding the IRS Investigation related to the Company’s former structured settlement business.

The Company and its subsidiary companies are subject to U.S. federal income tax as well as to income tax in Florida and other states and foreign jurisdictions in which it operates.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The Company carries life settlements and debt under the Revolving Credit Facilities at fair value in the consolidated balance sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value measurements are classified based on the following fair value hierarchy:

Level 1—Valuation is based on unadjusted quoted prices in active markets for identical assets and liabilities that are accessible at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2—Valuation is determined from pricing inputs that are other than quoted prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.

Level 3—Valuation is based on inputs that are both significant to the fair value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management judgment or estimation.

Assets and liabilities measured at fair value on a recurring basis

The balances of the Company’s assets measured at fair value on a recurring basis as of September 30, 2015, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	457,810	$	457,810
	$	—	$	—	$	457,810	$	457,810

The balances of the Company’s liabilities measured at fair value on a recurring basis as of September 30, 2015 are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	157,946	$	157,946
Red Falcon Revolving Credit Facility	—		—		55,685		55,685
	$	—	$	—	$	213,631	$	213,631

The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Assets:
Life settlements	$	—	$	—	$	388,886	$	388,886
Structured settlement receivables	—		—		384		384
	$	—	$	—	$	389,270	$	389,270

The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2014, are as follows (in thousands):

	Level 1		Level 2		Level 3		Total Fair Value
Liabilities:
White Eagle Revolving Credit Facility	$	—	$	—	$	145,831	$	145,831
	$	—	$	—	$	145,831	$	145,831

The Company values its life settlement portfolio in two classes, non-premium financed and premium financed. In considering the categories, it is generally believed that market participants would require a lower risk premium for policies that were non-premium financed, while a higher risk premium would be required for policies that were premium financed although the Company believes that this risk premium has been declining.

($ in thousands)	Quantitative Information about Level 3 Fair Value Measurements
	Fair Value at 9/30/15		Aggregate death benefit at 9/30/15		Valuation Technique	Unobservable Input (s)	Range (Weighted Average)
Non-premium financed	$	97,022	$	343,803	Discounted cash flow	Discount rate	15.00%	-	21.00%
						Life expectancy evaluation	(6.6 years)
Premium financed	$	360,788	$	2,654,100	Discounted cash flow	Discount rate	16.00%	-	24.75%
						Life expectancy evaluation	(10.5 years)
Life settlements	$	457,810	$	2,997,903	Discounted cash flow	Discount rate	17.00%
						Life expectancy evaluation	(10.0 years)
White Eagle Revolving Credit Facility	$	157,946	N/A		Discounted cash flow	Discount rate	23.55%
						Life expectancy evaluation	(9.9 years)
Red Falcon Revolving Credit Facility	$	55,685	N/A		Discounted cash flow	Discount Rate	11.18%
						Life expectancy evaluation	(9.5 years)

Following is a description of the methodologies used to estimate the fair values of assets and liabilities measured at fair value on a recurring basis and within the fair value hierarchy.

Life settlements—The Company has elected to account for the life settlement policies it acquires using the fair value method. The Company uses a present value technique to estimate the fair value of its life settlements, which is a Level 3 fair value measurement as the significant inputs are unobservable and require significant management judgment or estimation. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate.

The Company provides medical records for each insured to independent life expectancy providers (each, an “LE provider”). Each LE provider reviews and analyzes the medical records and identifies all medical conditions it feels are relevant to the life expectancy determination of the insured. Debits and credits are assigned by each LE provider to the individual’s health based on identified medical conditions. The debit or credit that an LE provider assigns to a medical condition is derived from the experience of mortality attributed to this condition in the portfolio of lives that the LE provider monitors. The health of the insured is summarized by the LE provider into a life assessment of the individual’s life expectancy expressed both in terms of months and in mortality factor. The mortality factor represents the degree to which the given life can be considered more or less impaired than a life having similar characteristics (e.g. gender, age, smoking, etc.). For example, a standard insured (the average life for the given mortality table) would carry a mortality rating of 100%. A similar but impaired life bearing a mortality rating of 200% would be considered to have twice the chance of dying earlier than the standard life relative to the LE provider’s population. Since each provider’s mortality factor is based on its own mortality table, the Company calculates its own factors to apply to the table selected by the Company.

Since the quarter ended September 30, 2012, the Company has used a modified version of the 2008 Valuation Basic Table (“2008 VBT”), a mortality table developed by the U.S. Society of Actuaries (the “SOA”). The mortality table is created based on the expected rates of death among groups categorized by gender, age, and smoking status. Since the Company uses the 2008 VBT, the Company calculates its own mortality factor that, when applied to the 2008 VBT, produces the same life expectancy provided by each LE provider. The resulting mortality factors are then blended to determine a factor for each insured.

To generate the best estimate probabilistic cash flow stream, a mortality curve is generated by calculating the probability of mortality for each period based on the calculated mortality factors and the death rates from the 2008 VBT. The Company modifies the table by incorporating future mortality improvements to better reflect the curves used by the LE providers.

A discounted present value calculation is then used to determine the value of the policy. If the insured dies earlier than expected, the return will be higher than if the insured dies when expected or later than expected.

The calculation allows for the possibility that if the insured dies earlier than expected, the premiums needed to keep the policy in force will not have to be paid. Conversely, the calculation also considers the possibility that if the insured lives longer than expected, more premium payments will be necessary. Based on these considerations, each possible outcome is assigned a probability and the range of possible outcomes is then used to create a value for the policy.

During the three months ended September 30, 2015, the SOA released tables for an updated Valuation Basic Table (the “2015 VBT”). The Company is continuing to monitor the market reaction to the VBT. Additionally, the Company will continue to monitor its mortality experience to determine whether future adoption of the 2015 VBT would be an appropriate change to the Company’s valuation technique.

Future changes in the life expectancies could have a material effect on the fair value of the Company’s life settlements, which could have a material adverse effect on its business, financial condition and results of operations.

Life expectancy sensitivity analysis

If all of the insured lives in the Company’s life settlement portfolio live six months shorter or longer than the life expectancies provided by these third parties, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Value		Change in Value
+6	$	384,990	$	(72,820	)
-	$	457,810	—
-6	$	536,666	$	78,856

Discount rate

The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and the Company’s estimate of the risk premium an investor in the policy would require.

The Company re-evaluates its discount rates at the end of every reporting period in order to reflect the estimated discount rates that could reasonably be used in a market transaction involving the Company’s portfolio of life insurance policies. In doing so, the Company relies on management insight, engages third party consultants to corroborate its assessment, engages in discussions with other market participants and potential financing sources and extrapolates the discount rate underlying actual sales of policies.

Due to the Company’s association with the USAO Investigation and certain civil litigation involving the Company, the Company believes that, when given the choice to invest in a policy that was associated with the Company’s premium finance business and a similar policy without such an association, all else being equal, an investor would have generally opted to invest in the policy that was not associated with the Company’s premium finance business. However, since the Company entered into a non-prosecution agreement, investors have required less of a risk premium to transact in policies associated with the Company’s legacy premium finance business. In general, the Company believes that the risk premium an investor would require to transact in a policy that has been premium financed versus a policy without premium financing is lessening in the current market environment and further expects that, with the passage of time, investors will continue to require less of a risk premium to transact in policies associated with its legacy premium finance business.

Credit exposure of insurance company

The Company considers the financial standing of the issuer of each life insurance policy. Typically, the Company seeks to hold policies issued by insurance companies that are rated investment grade. At September 30, 2015, the Company had eighteen life insurance policies issued by two carriers that were rated non-investment grade as of that date. In order to compensate a market participant for the perceived credit and challenge risks associated with these policies, the Company applied an additional 300 basis point risk premium.

The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of the Company’s life settlements as of September 30, 2015:

Carrier	Percentage of Total Fair Value		Percentage of Total Death Benefit		Moody's Rating	S&P Rating
Transamerica Life Insurance Company	20.6	%	20.5	%	A1	AA-
Lincoln National Life Insurance Company	21.6	%	19.6	%	A1	AA-

Estimated risk premium

As of September 30, 2015, the Company owned 634 policies with an estimated fair value of $457.8 million. Of these 634 policies, 547 were previously premium financed and are valued using discount rates that range from 16.00% to 24.75%. The remaining 87 policies, which are non-premium financed, are valued using discount rates that range from 15.00% to 21.00%. As of September 30, 2015, the weighted average discount rate calculated based on death benefit used in valuing the policies in the Company’s life settlement portfolio was 17.00%.

The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and the Company’s estimate of the risk premium an investor in the policy would require. The extent to which the fair value could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount rate on the death benefit used to estimate the fair value. If the weighted average discount rate were increased or decreased by 1⁄2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value would be as follows (dollars in thousands):

Market interest rate sensitivity analysis

Weighted Average Rate Calculated Based on
Death Benefit	Rate Adjustment	Value		Change in Value
16.50%	-0.50%	$	469,610	$	11,800
17.00%	—	$	457,810	$	—
17.50%	+0.50%	$	446,512	$	(11,298	)

Future changes in the discount rates the Company uses to value life insurance policies could have a material effect on the Company’s yield on life settlement transactions, which could have a material adverse effect on its business, financial condition and results of its operations.

At the end of each reporting period the Company re-values the life insurance policies using the Company’s valuation model in order to update its estimate of fair value for investments in policies held on its balance sheet. This includes reviewing the Company’s assumptions for discount rates and life expectancies as well as incorporating current information for premium payments and the passage of time.

White Eagle Revolving Credit Facility—439 policies are pledged by White Eagle to serve as collateral for its obligations under the White Eagle Revolving Credit Facility. Absent an event of default under the White Eagle Revolving Credit Facility, ongoing borrowings will be used to pay the premiums on these policies and certain approved third party expenses. Proceeds from the policies pledged as collateral will be distributed pursuant to a waterfall. After premium payments and fees to service providers, 100% of the remaining proceeds will be directed to pay outstanding principal and interest on the loan. Generally, after payment of principal and interest, collections from policy proceeds are to be paid to White Eagle up to $76.1 million, then 50% of the remaining proceeds are to be directed to the lenders with the remainder paid to White Eagle. The Company has elected to account for this long-term debt, which includes the lender’s interest in policy proceeds, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the White Eagle Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

Life expectancy sensitivity analysis of the policies securing the White Eagle Revolving Credit Facility

A considerable portion of the fair value of the White Eagle Revolving Credit Facility is determined by the timing of receipt of future policy proceeds. Should life expectancies lengthen such that policy proceeds are collected further into the future, the fair value of this debt will decline. Conversely, should life expectancies shorten, the fair value of this debt will increase. Considerable judgment is required in interpreting market data to develop the estimates of fair value.

If all of the insured lives in the life settlement portfolio pledged under the White Eagle Revolving Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the White Eagle Revolving Credit Facility debt, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of White Eagle Revolving Credit Facility		Change in Value
+6	$	132,093	$	(25,853	)
	$	157,946	—
-6	$	182,793	$	24,847

Future changes in the life expectancies could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of operations.

Discount rate of the White EagleRevolving Credit Facility

The discount rate incorporates current information about market interest rates, credit exposure to insurance companies and the Company’s estimate of the return a lender lending against the policies would require.

Market interest rate sensitivity analysis of the White Eagle Revolving Credit Facility

The extent to which the fair value of the White Eagle Revolving Credit Facility could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount. If the weighted average discount rate were increased or decreased by 1⁄2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the White Eagle Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of White Eagle Revolving Credit Facility		Change in Value
23.05%	-0.50	%	$	160,730	$	2,784
23.55%	—		$	157,946	$	—
24.05%	+0.50	%	$	155,255	$	(2,691	)

Future changes in the discount rates could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of its operations.

At September 30, 2015, the fair value of the debt was $157.9 million and the outstanding principal was approximately $159.9 million.

Red Falcon Revolving Credit Facility—157 policies are pledged by Red Falcon to serve as collateral for its obligations under the Red Falcon Revolving Credit Facility. Proceeds from the policies pledged as collateral under the Red Falcon Credit Facility are distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds are directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the loan. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds are to be paid to the lenders, which will vary depending on the then loan to value ratio (“LTV”) as follows: (1) if the LTV is equal to or greater than 50%, all remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; (2) if the LTV is less than 50% but greater than or equal to 25%, 65% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; or (3) if the LTV is less than 25%, 35% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance. The Company has elected to account for this long-term debt using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the Red Falcon Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

Life expectancy sensitivity analysis of the policies securing the Red Falcon Revolving Credit Facility

A considerable portion of the fair value of the Red Falcon Revolving Credit Facility is determined by the timing of receipt of future policy proceeds. Should life expectancies lengthen such that policy proceeds are collected further into the future, the fair value of this debt will decline. Conversely, should life expectancies shorten; the fair value of this debt will increase. Considerable judgment is required in interpreting market data to develop the estimates of fair value.

If all of the insured lives in the life settlement portfolio pledged under the Red Falcon Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the Red Falcon Revolving Credit Facility, the change in estimated fair value would be as follows (dollars in thousands):

Life Expectancy Months Adjustment	Fair Value of Red Falcon Revolving Credit Facility		Change in Value
+6	$	53,734	$	(1,951	)
	$	55,685	—
-6	$	57,236	$	1,551

Future changes in the life expectancies could have a material effect on the fair value of the Red Falcon Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of operations.

Discount rate of the Red Falcon Revolving Credit Facility

The discount rate incorporates current information about market interest rates, credit exposure to insurance companies and the Company’s estimate of the return a lender lending against the policies would require.

Market interest rate sensitivity analysis of the Red Falcon Revolving Credit Facility

The extent to which the fair value of the Red Falcon Revolving Credit Facility could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount. If the weighted average discount rate were increased or decreased by ¹⁄₂ of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the Red Falcon Revolving Credit Facility as of September 30, 2015 would be as follows (dollars in thousands):

Discount Rate	Rate Adjustment		Fair Value of Red Falcon Revolving Credit Facility		Change in Value
10.68%	-0.50	%	$	56,523	$	838
11.18%	—		$	55,685	$	—
11.68%	+0.50	%	$	54,868	$	(817	)

Future changes in the discount rates could have a material effect on the fair value of the Red Falcon Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of its operations.

At September 30, 2015, the fair value of the debt was $55.7 million and the outstanding principal was approximately $55.1 million.

Senior Unsecured Convertible Notes—The Company determined that an embedded conversion option in the Convertible Notes was required to be separately accounted for as a derivative under Accounting Standards Codification 815, Derivatives and Hedging (“ASC 815”). ASC 815 required the Company to bifurcate the embedded conversion option and record it as a liability at fair value and reduce the debt liability by a corresponding discount of an equivalent amount. The Company used a Black Scholes pricing model that incorporates present valuation techniques and reflect both the time value and the intrinsic value of the embedded conversion option to approximate the fair value of the conversion derivative liability at the end of each reporting period. This model required assumptions as to expected volatility, dividends, terms, and risk free rates.

In accordance with ASC 815, upon receipt of shareholder approval on June 5, 2014, the Company reclassified the embedded derivative to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes continue to be recorded at accreted value up to the par value of the Convertible Notes at maturity. See Note 11, “8.50% Senior Unsecured Convertible Notes.” Although the Company believes its valuation method is appropriate, the use of different methodologies or assumptions to determine the fair value could result in different fair values.

Changes in Fair Value

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2015	$	388,886
Purchase of policies	30,534
Change in fair value	43,582
Matured/lapsed/sold policies	(53,435		)
Premiums paid	48,243
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	457,810
Changes in fair value included in earnings for the period relating to assets held at September 30, 2015	$	2,805

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2015	$	145,831
Draws under the White Eagle Revolving Credit Facility	42,448
Payments on credit facility	(43,241		)
Unrealized change in fair value	12,908
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	157,946
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	12,908

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2015, for the Red Falcon Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

Red Falcon Revolving Credit Facility:
Balance, January 1, 2015	$	—
Initial advance under the Red Falcon Revolving Credit Facility	54,000
Subsequent draws under the Red Falcon Revolving Credit Facility	2,967
Payments on Red Falcon Revolving Credit Facility	(1,863		)
Unrealized change in fair value	581
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2015	$	55,685
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$	581

The following table provides a roll-forward in the changes in fair value for nine months ended September 30, 2014, for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consist solely of life settlements (in thousands):

Life Settlements:
Balance, January 1, 2014	$	302,961
Purchase of policies	3,488
Change in fair value	19,313
Matured/sold policies	(15,957		)
Premiums paid	40,578
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	350,383
Changes in fair value included in earnings for the period relating to assets held at September 30, 2014	$	8,627

The following tables provide a roll-forward in the changes in fair value for the nine months ended September 30, 2014, for the White Eagle Revolving Credit Facility and conversion derivative liability for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands):

White Eagle Revolving Credit Facility:
Balance, January 1, 2014	$	123,847
Subsequent draws under the revolving credit facility	40,965
Payments on credit facility	(17,595		)
Unrealized change in fair value	(4,556		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	142,661
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	(4,556	)

Conversion derivative liability:
Balance, at inception	$	16,901
Change in fair value	6,759
Reclassified to equity	(23,660		)
Transfers into level 3	—
Transfer out of level 3	—
Balance, September 30, 2014	$	—
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2014	$	—

There were no transfers of financial assets or liabilities between levels of the fair value hierarchy during the nine months ended September 30, 2015 and 2014.

XML

White Eagle Revolving Credit Facility

9 Months Ended

Sep. 30, 2015

Revolving Credit Facility

Debt Instrument [Line Items]

White Eagle Revolving Credit Facility

White Eagle Revolving Credit Facility

Effective April 29, 2013, White Eagle entered into a 15-year revolving credit agreement with LNV Corporation, as initial lender, Imperial Finance & Trading, LLC, as servicer and portfolio manager and CLMG Corp., as administrative agent, providing for up to $300.0 million in borrowings. Proceeds from the initial advance under the facility were used, in part, to retire a bridge facility and to fund a payment to the lender protection insurance provider to release subrogation rights in certain of the policies pledged as collateral for the White Eagle Revolving Credit Facility. On May 16, 2014, White Eagle Asset Portfolio, LLC converted from a Delaware limited liability company to White Eagle Asset Portfolio, LP, a Delaware limited partnership (the “Conversion”) and all of its ownership interests were transferred to an indirect, wholly-owned Irish subsidiary of the Company. In connection with the Conversion, the White Eagle Revolving Credit Facility was amended and restated among White Eagle, as borrower, Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders.

As of September 30, 2015, 439 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility.

General & Security. The White Eagle Revolving Credit Facility provides for an asset-based revolving credit facility backed by White Eagle’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $300.0 million, subject to borrowing base availability. 439 life insurance policies with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility at September 30, 2015. In addition, the equity interests in White Eagle have been pledged under the White Eagle Revolving Credit Facility.

Borrowing Base. Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances to acquire additional pledged policies or that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, plus (iii) 100% of accrued and unpaid interest on borrowings (excluding the rate floor portion described below), plus (iv) 100% of any other fees and expenses funded and to be funded as approved by the required lenders, less (v) any required payments of principal and interest previously distributed and to be distributed through the next distribution date; (B) 75% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 50% of the aggregate face amount of the policies pledged as collateral (excluding certain specified life insurance policies); and (D) the then applicable facility limit. At September 30, 2015, $140.1 million was undrawn and $1.9 million was available to borrow under the White Eagle Revolving Credit Facility.

Amortization & Distributions. Proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. Absent an event of default, after premium payments and fees to service providers, 100% of the remaining proceeds will be directed to pay outstanding interest and principal on the loan, unless the lenders determine otherwise. Generally, after payment of interest and principal, up to $76.1 million in collections from policy proceeds are to be paid to White Eagle, then 50% of the remaining proceeds are to be directed to the lenders with the remainder paid to White Eagle and for any unpaid fees to service providers. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any “catch-up” payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, “catch-up” payments or percentage payments that would go to the lenders as described above.

Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral, to pay debt service (other than a “rate floor” component equal to the greater of LIBOR (or the applicable base rate) and 1.5%), and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders and the use of proceeds from those advances are at the discretion of the lenders.

Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.00% and subject to the rate floor described above. The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5%. The effective rate at September 30, 2015 was 5.5%.

Interest expense for the cash portion of interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. Interest expense on the facility was $2.3 million and $2.1 million, which includes $1.7 million and $1.5 million withheld from borrowings by the lender and $634,000 and $573,000 paid by White Eagle, for the three months ended September 30, 2015 and 2014, respectively. During the nine months ended September 30, 2015 and 2014, interest expense on the facility was $6.9 million and $5.8 million, which includes $5.0 million and $4.2 million withheld from borrowings by the lender and $1.9 million and $1.6 million paid by White Eagle, respectively.

Maturity. The term of the White Eagle Revolving Credit Facility expires April 28, 2028, which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments.

Covenants/Events of Defaults. The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. The White Eagle Revolving Credit Facility does not contain any financial covenants, but does contain certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion.

Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing.

The Company elected to account for the debt under the White Eagle Revolving Credit Facility, which includes the 50% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

At September 30, 2015, the fair value of the outstanding debt was $157.9 million and the borrowing base was approximately $161.8 million, including $159.9 million in outstanding principal.

There are no scheduled repayments of principal prior to maturity. Payments are due upon receipt of death benefits and distributed pursuant to the waterfall as described above.

XML

Fair Value Measurements - Changes in Fair Value for All Assets and Liabilities Using Material Level of Unobservable (Level 3) Inputs (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Life Finance
Fair Value, Assets, Unobservable Input Reconciliation [Roll Forward]
Balance, January 1, 2015	$ 388,886	$ 302,961
Purchase of policies	30,534	3,488
Change in fair value	43,582	19,313
Matured/lapsed/sold policies	(53,435)	(15,957)
Premiums paid	48,243	40,578
Transfers into level 3	0	0
Transfer out of level 3	0	0
Balance, September 30, 2015	457,810	350,383
Changes in fair value included in earnings for the period relating to assets held at September 30, 2015	2,805	8,627
White Eagle Revolving Credit Facility:
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015		0
Conversion derivative liability
White Eagle Revolving Credit Facility:
Balance, January 1, 2015		16,901
Reclassified to equity		(23,660)
Transfers into level 3		0
Transfer out of level 3		0
Balance, September 30, 2015		0
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015		6,759
White Eagle | Revolving Credit Facility
White Eagle Revolving Credit Facility:
Balance, January 1, 2015	145,831	123,847
Draws under the White Eagle Revolving Credit Facility	42,448	40,965
Payments on credit facility	(43,241)	(17,595)
Unrealized change in fair value	12,908	(4,556)
Transfers into level 3	0	0
Transfer out of level 3	0	0
Balance, September 30, 2015	157,946	142,661
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	12,908	$ (4,556)
Red Falcon Trust | Revolving Credit Facility
White Eagle Revolving Credit Facility:
Balance, January 1, 2015	0
Draws under the White Eagle Revolving Credit Facility	54,000
Subsequent draws under the Red Falcon Revolving Credit Facility	2,967
Payments on credit facility	(1,863)
Unrealized change in fair value	581
Transfers into level 3	0
Transfer out of level 3	0
Balance, September 30, 2015	55,685
Changes in fair value included in earnings for the period relating to liabilities held at September 30, 2015	$ 581

XML

Discontinued Operations

9 Months Ended

Sep. 30, 2015

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

On October 25, 2013, the Company sold substantially all of the operating assets comprising its structured settlement business to Majestic Opco L.L.C for gross proceeds of $12.0 million pursuant to an Asset Purchase Agreement. No structured settlement receivables were sold and no on-balance sheet liabilities were transferred in connection with the sale. This sale resulted in the recognition of a gain of $11.3 million in the fourth quarter of 2013. On August 28, 2015, the Company sold its remaining structured settlement receivables assets for $920,000 to the buyer of its operating assets, an entity to which the Company continues to provide CEO consulting services (with the Company's chief executive officer serving as interim chief executive officer) pursuant to a transition services arrangement.

As a result of the sale of its structured settlements business, the Company reclassified its structured settlement business operating results as discontinued operations in the accompanying Consolidated Statements of Operations for all periods presented and the Company has discontinued segment reporting. All other footnotes in these financial statements that were affected by this reclassification of discontinued operations have been updated accordingly.

Operating results related to the Company’s discontinued structured settlement business are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total income (loss)	$	(13	)	$	38		$	60		$	150
Total expenses	(134		)	(287		)	(700		)	(604		)
Income (loss) before income taxes	(147		)	(249		)	(640		)	(454		)
Income tax benefit	34			—			224			—
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)

XML

Life Settlements (Life Insurance Policies)

9 Months Ended

Sep. 30, 2015

Investments, All Other Investments [Abstract]

Life Settlements (Life Insurance Policies)

Life Settlements (Life Insurance Policies)

The Company accounts for policies it acquires using the fair value method in accordance with ASC 325-30-50 Investments—Other—Investment in Insurance Contracts. Under the fair value method, the Company recognizes the initial investment at the purchase price. For policies that were relinquished in satisfaction of premium finance loans at maturity, the initial investment is the loan carrying value. For policies purchased in the secondary or tertiary markets, the initial investment is the amount of cash outlay at the time of purchase. At each reporting period, the Company re-measures the investment at fair value in its entirety and recognizes changes in fair value in the Statements of Operations in the period in which the changes occur.

As of September 30, 2015 and December 31, 2014, the Company owned 634 and 607 policies, respectively, with an aggregate estimated fair value of life settlements of $457.8 million and $388.9 million, respectively.

The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at September 30, 2015 was 10.0 years. The following table describes the Company’s life settlements as of September 30, 2015 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0 - 1	—	$	—	$	—
1 - 2	9	21,516		32,307
2 - 3	20	52,926		95,122
3 - 4	19	29,638		70,309
4 - 5	25	33,129		96,406
Thereafter	561	320,601		2,703,759
Total	634	$	457,810	$	2,997,903

The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at December 31, 2014 was 10.7 years. The following table describes the Company’s life settlements as of December 31, 2014 (dollars in thousands):

Remaining Life Expectancy (In Years)	Number of Life Settlement Contracts	Estimated Fair Value		Face Value
0-1	—	$	—	$	—
1-2	4	9,227		12,728
2-3	10	23,202		45,852
3-4	16	29,531		67,735
4-5	19	23,012		65,614
Thereafter	558	303,914		2,739,137
Total	607	$	388,886	$	2,931,066

Estimated premiums to be paid for each of the five succeeding fiscal years to keep the life insurance policies in force as of September 30, 2015, are as follows (in thousands):

Remainder of 2015	$	16,292
2016	68,891
2017	75,602
2018	78,260
2019	85,030
Thereafter	1,110,449
	$	1,434,524

The amount of $1.43 billion noted above represents the estimated total future premium payments required to keep the life insurance policies in force during the life expectancies of all the underlying insured lives and does not give effect to projected receipt of death benefits. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differs from the estimated life expectancies.

XML

Red Falcon Revolving Credit Facility - Revolving Credit Facility

9 Months Ended

Sep. 30, 2015

Debt Instrument [Line Items]

Red Falcon Revolving Credit Facility

White Eagle Revolving Credit Facility

Effective April 29, 2013, White Eagle entered into a 15-year revolving credit agreement with LNV Corporation, as initial lender, Imperial Finance & Trading, LLC, as servicer and portfolio manager and CLMG Corp., as administrative agent, providing for up to $300.0 million in borrowings. Proceeds from the initial advance under the facility were used, in part, to retire a bridge facility and to fund a payment to the lender protection insurance provider to release subrogation rights in certain of the policies pledged as collateral for the White Eagle Revolving Credit Facility. On May 16, 2014, White Eagle Asset Portfolio, LLC converted from a Delaware limited liability company to White Eagle Asset Portfolio, LP, a Delaware limited partnership (the “Conversion”) and all of its ownership interests were transferred to an indirect, wholly-owned Irish subsidiary of the Company. In connection with the Conversion, the White Eagle Revolving Credit Facility was amended and restated among White Eagle, as borrower, Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders.

As of September 30, 2015, 439 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility.

General & Security. The White Eagle Revolving Credit Facility provides for an asset-based revolving credit facility backed by White Eagle’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $300.0 million, subject to borrowing base availability. 439 life insurance policies with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million are pledged as collateral under the White Eagle Revolving Credit Facility at September 30, 2015. In addition, the equity interests in White Eagle have been pledged under the White Eagle Revolving Credit Facility.

Borrowing Base. Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances to acquire additional pledged policies or that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, plus (iii) 100% of accrued and unpaid interest on borrowings (excluding the rate floor portion described below), plus (iv) 100% of any other fees and expenses funded and to be funded as approved by the required lenders, less (v) any required payments of principal and interest previously distributed and to be distributed through the next distribution date; (B) 75% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 50% of the aggregate face amount of the policies pledged as collateral (excluding certain specified life insurance policies); and (D) the then applicable facility limit. At September 30, 2015, $140.1 million was undrawn and $1.9 million was available to borrow under the White Eagle Revolving Credit Facility.

Amortization & Distributions. Proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. Absent an event of default, after premium payments and fees to service providers, 100% of the remaining proceeds will be directed to pay outstanding interest and principal on the loan, unless the lenders determine otherwise. Generally, after payment of interest and principal, up to $76.1 million in collections from policy proceeds are to be paid to White Eagle, then 50% of the remaining proceeds are to be directed to the lenders with the remainder paid to White Eagle and for any unpaid fees to service providers. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any “catch-up” payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, “catch-up” payments or percentage payments that would go to the lenders as described above.

Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral, to pay debt service (other than a “rate floor” component equal to the greater of LIBOR (or the applicable base rate) and 1.5%), and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders and the use of proceeds from those advances are at the discretion of the lenders.

Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.00% and subject to the rate floor described above. The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5%. The effective rate at September 30, 2015 was 5.5%.

Interest expense for the cash portion of interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. Interest expense on the facility was $2.3 million and $2.1 million, which includes $1.7 million and $1.5 million withheld from borrowings by the lender and $634,000 and $573,000 paid by White Eagle, for the three months ended September 30, 2015 and 2014, respectively. During the nine months ended September 30, 2015 and 2014, interest expense on the facility was $6.9 million and $5.8 million, which includes $5.0 million and $4.2 million withheld from borrowings by the lender and $1.9 million and $1.6 million paid by White Eagle, respectively.

Maturity. The term of the White Eagle Revolving Credit Facility expires April 28, 2028, which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments.

Covenants/Events of Defaults. The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. The White Eagle Revolving Credit Facility does not contain any financial covenants, but does contain certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion.

Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing.

The Company elected to account for the debt under the White Eagle Revolving Credit Facility, which includes the 50% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

At September 30, 2015, the fair value of the outstanding debt was $157.9 million and the borrowing base was approximately $161.8 million, including $159.9 million in outstanding principal.

There are no scheduled repayments of principal prior to maturity. Payments are due upon receipt of death benefits and distributed pursuant to the waterfall as described above.

Red Falcon Trust

Debt Instrument [Line Items]

Red Falcon Revolving Credit Facility

Red Falcon Revolving Credit Facility

Effective July 16, 2015, Red Falcon Trust (“Red Falcon”), a Delaware statutory trust formed by Blue Heron Designated Activity Company (“Blue Heron”), a wholly-owned Irish subsidiary of the Company, entered into a revolving loan and security agreement (together with its ancillary documents, the “Red Falcon Revolving Credit Facility”) with LNV Corporation, as initial lender, the other lenders party thereto from time to time, Imperial Finance & Trading, LLC, as guarantor, Blue Heron as portfolio administrator and CLMG Corp., as administrative agent (the “Agent”).

General & Security. The Red Falcon Revolving Credit Facility provides for a revolving credit facility backed by Red Falcon’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $110.0 million, subject to borrowing base availability. As of September 30, 2015, 157 life insurance policies owned by Red Falcon with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million are pledged as collateral under the Red Falcon Revolving Credit Facility. In connection with the Red Falcon Revolving Credit Facility, the residual interests in Red Falcon have also been pledged.

Borrowing Base & Availability. Revolving credit borrowings are permitted for a five-year period with the loans under the Red Falcon Revolving Credit Facility maturing on July 15, 2022. Borrowing availability under the Red Falcon Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances in respect of newly pledged policies that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, less (iii) any required amortization payments previously distributed and to be distributed through the next distribution date; (B) 60% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 45% of the aggregate face amount of the policies pledged as collateral; and (D) $110.0 million. At September 30, 2015, $54.9 million was undrawn and $110,000 was available to borrow under the Red Falcon Revolving Credit Facility.

Amortization & Distributions. Proceeds from the policies pledged as collateral under the Red Falcon Revolving Credit Facility are distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds are directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the greater of the then outstanding balance of the loan or the initial advance. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds are to be paid to the lenders, which will vary depending on the then loan to value ratio (“LTV”) as follows: (1) if the LTV is equal to or greater than 50%, all remaining proceeds will be directed to the lenders to repay the then outstanding principal balance; (2) if the LTV is less than 50% but greater than or equal to 25%, 65% of the remaining proceeds will be directed the lenders to repay the then outstanding principal balance; or (3) if the LTV is less than 25%, 35% of the remaining proceeds will be directed to the lenders to repay the then outstanding principal balance. To the extent there are not sufficient remaining proceeds in the waterfall to satisfy the amount of required interest and amortization then due, Red Falcon will pay any such shortfall amount.

Initial Advance and Use of Proceeds. Amounts advanced to Red Falcon following effectiveness of the Red Falcon Revolving Credit Facility were approximately $54.0 million with certain of the proceeds used to pay transaction expenses and to purchase the policies pledged as collateral under the Red Falcon Revolving Credit Facility from certain affiliates of the Company, who then made a distribution to the Company which was used to redeem the Secured Notes; see Note 12. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral, and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders.

Interest. Borrowings under the Red Falcon Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% and subject to a rate floor of 1.0%. The base rate under the Red Falcon Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5%. The effective interest rate at September 30, 2015 was 5.5%.

Interest expense for the cash portion of interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the Red Falcon Revolving Credit Facility. Interest expense on the facility was $3.8 million, which includes $3.2 million relating to the debt issuance cost which was not capitalized as a result of electing the fair value option for valuing this debt, and $601,000 relating to interest payments paid by Red Falcon, for the three months and nine months ended September 30, 2015.

Maturity. The term of the Red Falcon Revolving Credit Facility expires July 15, 2022.

Covenants/Events of Defaults. The Red Falcon Revolving Credit Facility contains covenants and events of default, including those that are customary for asset-based credit facilities of this type and including cross defaults under the servicing, portfolio management and sales agreements entered into in connection with the Red Falcon Revolving Credit Facility, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, Red Falcon and third parties. The Red Falcon Revolving Credit Facility does not contain any financial covenants, but does contain certain tests relating to asset maintenance, performance and valuation with determinations as to the satisfaction of such tests involving determinations made by the lenders with a high degree of discretion.

The Company elected to account for the debt under the Red Falcon Revolving Credit Facility using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values.

At September 30, 2015, the fair value of the outstanding debt was $55.7 million and the borrowing base was approximately $55.2 million, including $55.1 million in outstanding principal.

XML

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	[1]
Income Taxes [Line Items]
Annual effective tax rate				35.00%	36.90%
Deferred tax assets valuation allowance	$ 2,000			$ 2,000
Tax benefit from tax rate changes	927
(Benefit) provision for income taxes	(4,721)	$ (2,235)		(6,981)	$ (2,452)
Additional paid-in-capital	$ 305,389			$ 305,389		$ 266,705
Accounting Standards Update 2013-11
Income Taxes [Line Items]
Unrecognized tax benefits			$ 6,300
(Benefit) provision for income taxes			3,700
Valuation allowance (decrease) increase			2,600
Additional paid-in-capital		$ 6,300	$ 6,300		$ 6,300

[1] Derived from audited consolidated financial statements.

XML

Consolidation of Variable Interest Entities Consolidation of Variable Interest Entities (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Primary Beneficiary Variable Interest Entity
Variable Interest Entity [Line Items]
Primary Beneficiary Consolidated VIEs, assets	$ 464,032	$ 314,062
Primary Beneficiary Consolidated VIEs, liabilities	214,019	146,254
Not Primary Beneficiary Variable Interest Entity
Variable Interest Entity [Line Items]
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets	2,384	2,384
Not Primary Beneficiary Non-consolidated VIEs, Maximum Exposure to Loss	$ 2,384	$ 2,384

XML

12.875% Senior Secured Notes - Additional Information (Detail)				3 Months Ended		9 Months Ended
	Jul. 16, 2015 USD ($) Contract	Jan. 21, 2015 USD ($)	Nov. 10, 2014 USD ($)	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Dec. 31, 2014 Contract
Debt Instrument [Line Items]
Extinguishment of Secured Notes	$ 8,800,000			$ 8,782,000	$ 0	$ 8,782,000	$ 0
Number of policies owned (contracts) | Contract				634		634		607
Interest	5,200,000
Unused fees of debt	171,000
Amortizing debt discounts	1,700,000
Debt issuance cost	$ 1,700,000
12.875% Senior Secured Notes Due 2017
Debt Instrument [Line Items]
Debt instrument, maturity date			Nov. 10, 2017
Percentage of first tier foreign subsidiaries equity interests pledge to secure debt						65.00%
Debt instrument, redemption price, percentage	106.00%
Number of policies owned (contracts) | Contract	159
Interest expense						$ 4,000,000
Interest						3,200,000
Unused fees of debt						265,000
Amortizing debt discounts						264,000
Debt issuance cost						$ 277,000
12.875% Senior Secured Notes Due 2017 | Indaba Capital Management Lp
Debt Instrument [Line Items]
Debt instrument, face amount		$ 25,000,000	$ 25,000,000
Secured notes issuance price as percentage of face amount		96.00%	96.00%
Payments of debt issuance costs		$ 305,000	$ 1,800,000
12.875% Senior Secured Notes Due 2017 | Maximum
Debt Instrument [Line Items]
Debt instrument, face amount			$ 100,000,000
12.875% Senior Secured Notes Due 2017 | Securities Pledged as Collateral
Debt Instrument [Line Items]
Stated interest rate				12.875%		12.875%

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Lease Agreements

The Company leases office space under a lease that commenced on October 1, 2014 and expires on September 30, 2020. The annual base rent is $225,100, with a provision for a 3% increase on each anniversary of the rent commencement date. Rent expense was approximately $122,000 and $126,000 for the three months ended September 30, 2015 and 2014, respectively, and approximately $319,000 and $377,000 for the nine months ended September 30, 2015 and 2014, respectively. Future minimum lease payments for the remainder of 2015 are approximately $58,000.

Employment Agreements

The Company has entered into employment agreements with certain of its officers, including with its chief executive officer, whose agreement provides for substantial payments in the event that the executive terminates his employment with the Company due to a material change in the geographic location where the chief executive officer performs his duties or upon a material diminution of his base salary or responsibilities, with or without cause. These payments are equal to three times the sum of the chief executive officer’s base salary and the average of the preceding three years’ annual cash bonus.

The Company does not have any general policies regarding the use of employment agreements, but has and may, from time to time, enter into such a written agreement to reflect the terms and conditions of employment of a particular named executive officer, whether at the time of hire or thereafter.

Separation Agreement

On April 26, 2012, the Company entered into a Separation Agreement and General Release of Claims (the “Separation Agreement”) with its former chief operating officer, Jonathan Neuman. The Separation Agreement obligates the Company to

indemnify Mr. Neuman for his legal expenses. The Company recognized indemnification expenses of $998,000 and $500,000 during the three months ended September 30, 2015 and 2014, respectively, and $2.5 million and $1.5 million during the nine months ended September 30, 2015 and 2014, respectively.

Litigation

In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of litigation-related expense. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability.

Non-Prosecution Agreement & Indemnification Obligations

On September 27, 2011, the Company was informed that it was being investigated by the U.S. Attorney’s Office for the District of New Hampshire (the “USAO Investigation”) in connection with the Company’s now legacy premium finance loan business. On April 30, 2012, the Company entered into a Non-Prosecution Agreement (the “Non-Prosecution Agreement”) with the USAO, which agreed not to prosecute the Company for its involvement in the making of misrepresentations on life insurance applications in connection with its premium finance business or any potential securities fraud claims related to its now legacy premium finance business.

The Non-Prosecution Agreement had a term of three years and expired in accordance with its terms on April 30, 2015. While the Non-Prosecution Agreement effectively resolved the USAO Investigation as it pertains to the Company, the Company still has continuing cooperation obligations to the USAO and understands that the USAO is continuing to investigate certain individuals and entities formerly associated with the Company's legacy premium finance business. Settlements of certain civil litigation with the Company’s director and officer liability insurance carriers related to the USAO Investigation and other contractual obligations require the Company to advance legal fees to and indemnify these individuals and entities. USAO litigation-related fees (inclusive of indemnification and advancement expenses) of $2.8 million and $1.2 million were recognized for the three months ended September 30, 2015 and 2014, respectively, and $7.0 million and $3.2 million were recognized for the nine months ended September 30, 2015 and 2014, respectively. The Company expects to continue to incur indemnification and advancement expenses and expenses related to continuing obligations related to the USAO investigation. Ongoing expenses in respect of these obligations, while currently unquantifiable, have been substantial in prior periods and could continue to have a material adverse effect on the Company’s financial position and results of operations.

SEC Investigation

On February 17, 2012, the Company received a subpoena issued by the staff of the SEC seeking documents from 2007 through the date of the subpoena, generally related to the Company’s premium finance business and corresponding financial reporting. The SEC is investigating whether any violations of federal securities laws have occurred and the Company has been cooperating with the SEC regarding this matter. The Company is unable to predict what action, if any, might be taken in the future by the SEC or its staff as a result of the investigation or what impact, if any, the cost of responding to the SEC might have on the Company’s financial position, results of operations, or cash flows. The Company has not established any provision for losses in respect of this matter.

Sun Life

On April 18, 2013, Sun Life Assurance Company of Canada (“Sun Life”) filed a complaint against the Company and several of its affiliates in the United States District Court for the Southern District of Florida, entitled Sun Life Assurance Company of Canada v. Imperial Holdings, Inc., et al. (“Sun Life Case”), asserting, among other things, that at least 28 life insurance policies issued by Sun Life and owned by the Company through certain of its subsidiary companies were invalid. The Sun Life complaint, as amended, asserted the following claims: (1) violations of the federal Racketeer Influenced and Corrupt Organizations (“RICO”) Act, (2) conspiracy to violate the RICO Act, (3) common law fraud, (4) aiding and abetting fraud, (5) civil conspiracy to commit fraud, (6) tortious interference with contractual obligations, and (7) a declaration that the policies issued were void. Following the filing of a motion by the Company to dismiss the Sun Life Case, on December 9, 2014, counts (2), (4), (5), (6) and (7) of the Sun Life Case were dismissed with prejudice. The Company then filed a motion for summary judgment on the remaining counts. On February 4, 2015, the Court issued an order (the “Order”) granting the Company’s motion for summary judgment on counts (1) and (3), resulting in the Company prevailing on all counts in the Sun Life Case.

On July 29, 2013, the Company filed a separate complaint against Sun Life in United States District Court for the Southern District of Florida, entitled Imperial Premium Finance, LLC v. Sun Life Assurance Company of Canada (“Imperial Case”), which was subsequently consolidated with the Sun Life Case. The Imperial complaint asserts claims against Sun Life for breach of contract, breach of the covenant of good faith and fair dealing, and fraud, and seeks a judgment declaring that Sun Life is obligated to comply with the promises made by it in certain insurance policies. The complaint also seeks compensatory damages of no less than $30 million in addition to an award of punitive damages. On August 23, 2013, Sun Life moved to dismiss the complaint, which was denied by the Court as part of the Order. On February 26, 2015, Sun Life filed a Notice of Appeal to the United States Court of Appeals for the Eleventh Circuit from the Order, which had denied Sun Life’s motion to dismiss.

The District Court has stayed the Imperial Case until Sun Life’s appeal is resolved by the Eleventh Circuit, which has been fully briefed by the parties.

IRS Investigation

The Internal Revenue Service (“IRS”) Criminal Investigation Division notified the Company in February 2014 that it is conducting an investigation related to the Company and its legacy structured settlements business. The Company believes that it has been cooperating with the investigation and is unable, at this time, to predict what action, if any, might be taken in the future by the IRS. If the investigation results in a determination by the IRS that the Company has failed to comply with any of its obligations under the Internal Revenue Code or regulations thereunder, the Company could incur additional tax liability, restitution payment obligations, penalties, fines or other liabilities, including criminal penalties and fines and a reduction in the Company’s net operating losses, that could have a material adverse effect on the Company, its personnel, its financial condition, cash flows and its results of operations. The Company has not established any provision for losses related to this matter.

Class Action Litigation

On January 20, 2015, a purported shareholder of the Company filed a putative class action complaint against the Company, and the individual members of the Board of Directors, in the Circuit Court of the 15th Judicial Circuit, in and for Palm Beach County, entitled Harry Rothenberg v. Imperial Holdings, Inc., et al. (the “State Court Complaint”). The Rothenberg State Court Complaint alleged breaches of fiduciary duties of due care and sought to invalidate a by-law amendment adopted by the Board of Directors on October 30, 2014, which requires current and former shareholders who wish to file a class or derivative action against the Company, its directors or its officers to first obtain written consent from shareholders beneficially owning at least 3% of the outstanding shares of the Company. On March 2, 2015, the Company filed a motion to dismiss and motion to strike certain allegations in the State Court Complaint.

On April 20, 2015, Mr. Rothenberg filed a Verified Shareholder Class Action and Derivative Complaint (the “Federal Court Complaint”) in the United States District Court for the Southern District of Florida, which named the same defendants and asserted similar claims as in the State Court Complaint. The Federal Court Complaint also alleged violations of Sections 14(a) and 20(a) of the 1934 Securities Act, and asserted derivative claims for breach of fiduciary duty, among other claims, based on the previously disclosed IRS Investigation and allegations regarding the Company’s prior structured settlement business made in a case styled Michael Lafontant v. Washington Square Financial, LLC, et al. (“Lafontant Complaint”), which was filed in the United States District Court for the Southern District of New York. The Company has moved to dismiss the Lafontant Complaint based on contractual arbitration provisions, which is pending an order by the district court. On April 21, 2015, Mr. Rothenberg voluntarily dismissed the State Court Complaint, without prejudice. On June 9, 2015, Mr. Rothenberg filed an Amended Complaint. On June 29, 2015, the Company filed a motion to dismiss the Amended Complaint for lack of subject matter jurisdiction due to lack of injury in fact and ripeness and failure to state a claim pursuant to the Federal Rules of Civil Procedure.

On September 10, 2015, the United States District Court for the Southern District of Florida issued an order (the “Order”) granting Plaintiff’s Unopposed Motion for Approval of Dismissal of Shareholder’s Derivative Claims and Class Action Claims. As contemplated in the Order, the Federal Court Complaint was dismissed with prejudice, and the case was closed on October 14, 2015.

Other Litigation

On April 10, 2015, a complaint was filed against the Company’s subsidiary in the Circuit Court of the Twentieth Judicial Circuit in and for St. Clair County, Illinois, styled Kenneth Jennings v. Washington Square Financial, LLC d/b/a Imperial Structured Settlements (“Washington Square”). The plaintiff seeks, in a purported class action, to represent all individuals who sold all or a part of a structured settlement annuity to Washington Square under the Illinois Structured Settlement Protections Act (the “Illinois Act”), where the underlying annuity contract contained an anti-assignment clause, and where a court issued an order under the Illinois Act approving the transaction. The complaint seeks, among other things, a declaration that all such transactions are void and compensatory and punitive damages. The Company has not established any provision for losses in respect of this matter.

The Company is party to various other legal proceedings that arise in the ordinary course of business. Due to the inherent difficulty of predicting the outcome of litigation and other legal proceedings, the Company cannot predict the eventual outcome of these matters, and it is reasonably possible that some of them could be resolved unfavorably to the Company. As a result, it is possible that the Company’s results of operations or cash flows in a particular fiscal period could be materially affected by an unfavorable resolution of pending litigation or contingencies. However, the Company believes that the resolution of these other proceedings will not, based on information currently available, have a material adverse effect on the Company’s financial position or results of operations.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Reconciliation of Actual Basic and Diluted Earnings Per Share

The following tables reconcile actual basic and diluted earnings per share for the three months and nine months ended September 30, 2015 and 2014 (in thousands except share and per share data).

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2015(1)			2014(2)			2015(1)			2014(2)
Income (loss) per share:
Numerator:
Net income (loss) from continuing operations	$	(13,491	)	$	(4,264	)	$	(16,689	)	$	(13,863	)
Net income (loss) from discontinued operations	$	(113	)	$	(249	)	$	(416	)	$	(454	)
Net income (loss)	$	(13,604	)	$	(4,513	)	$	(17,105	)	$	(14,317	)
Basic and diluted income (loss) per common share:
Basic and diluted income (loss) from continuing operations	$	(0.48	)	$	(0.20	)	$	(0.70	)	$	(0.65	)
Basic and diluted income (loss) from discontinued operations	$	—		$	(0.01	)	$	(0.02	)	$	(0.02	)
Basic and diluted income (loss) per share available to common shareholders	$	(0.48	)	$	(0.21	)	$	(0.72	)	$	(0.67	)
Denominator:
Basic and diluted	28,084,254			21,361,930			23,827,030			21,352,086

(1) The computation of diluted EPS does not include 41,259 shares of restricted stock, 774,394 options, 6,240,521 warrants up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes and 323,500 performance shares, as the effect of their inclusion would have been anti-dilutive.

(2) The computation of diluted EPS did not include 815,448 options, 6,240,521 warrants, 41,060 shares of restricted stock, up to 10,464,491 shares of underlying common stock issuable upon conversion of the Convertible Notes and 299,500 performance shares for the three months and nine months ended September 30, 2014, as the effect of their inclusion would have been anti-dilutive.

XML

Red Falcon Revolving Credit Facility (Details)		3 Months Ended		9 Months Ended
	Jul. 16, 2015 USD ($) Contract	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) Contract	Sep. 30, 2014 USD ($)	Jun. 30, 2015 USD ($)	Dec. 31, 2014 USD ($) Contract
Debt Instrument [Line Items]
Number of policies owned (contracts) | Contract		634		634			607
Life insurance policies with aggregate death benefit		$ 2,997,903,000		$ 2,997,903,000			$ 2,931,066,000
Life insurance estimated fair value		457,810,000		457,810,000			388,886,000
Interest expense		8,614,000	$ 4,303,000	21,491,000	$ 11,165,000
Interest payment and fees withheld from borrowings by lender				5,566,000	4,962,000
Cash paid for interest during the period				12,143,000	4,496,000
Revolving Credit Facility debt, at estimated fair value							$ 145,831,000
Revolving Credit Facility
Debt Instrument [Line Items]
Borrowings from revolving credit facility				36,880,000	36,004,000
Revolving Credit Facility debt, at estimated fair value		157,946,000		157,946,000		$ 157,946,000
Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility effective date	Jul. 16, 2015
Number of policies owned (contracts) | Contract	157
Revolving Credit facility, current borrowing capacity	$ 110,000,000	55,200,000		55,200,000
Line of credit facility, maximum borrowing capacity		54,900,000.0		54,900,000.0
Line of credit facility, remaining borrowing capacity		110,000		$ 110,000
Line of credit, amortization percentage	8.00%			8.00%
Borrowings from revolving credit facility	$ 54,000,000			$ 2,967,000	$ 0
Basis spread on variable rate				0.50%
Effective interest rate				5.50%
Interest expense		3,800,000
Interest payment and fees withheld from borrowings by lender		3,200,000
Cash paid for interest during the period		601,000
Revolving Credit Facility debt, at estimated fair value		55,700,000		$ 55,700,000
Revolving Credit Facility debt, outstanding		$ 55,100,000		$ 55,100,000
Yield maintenance provision.	5.00%			5.00%
Red Falcon Trust | Revolving Credit Facility | Applicable Margin
Debt Instrument [Line Items]
Basis spread on variable rate				4.50%
Red Falcon Trust | Revolving Credit Facility | Floor Rate
Debt Instrument [Line Items]
Basis spread on variable rate				1.00%
Red Falcon Trust | Revolving Credit Facility | Federal Funds Rate
Debt Instrument [Line Items]
Basis spread on variable rate				0.75%
Red Falcon Trust | Maintenance Costs | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit borrowing base percentage	100.00%
Red Falcon Trust | Policies pledged as collateral as determined by the lenders | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit borrowing base percentage	60.00%
Red Falcon Trust | Policies pledged as collateral excluding certain specified life insurance policies | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit borrowing base percentage	45.00%
Life insurance issuer concentrations that exceed 10% of total death benefit | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, percentage of remaining outstanding balance	65.00%			65.00%
Scenario 3 | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, percentage of remaining outstanding balance	35.00%			35.00%
Minimum | 10% of total fair value of our investments in life settlements | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, loan to value ratio	50.00%			50.00%
Minimum | Life insurance issuer concentrations that exceed 10% of total death benefit | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, loan to value ratio	25.00%			25.00%
Maximum | Life insurance issuer concentrations that exceed 10% of total death benefit | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, loan to value ratio	50.00%			50.00%
Maximum | Scenario 3 | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, loan to value ratio	25.00%			25.00%
Securities Pledged as Collateral | Red Falcon Trust
Debt Instrument [Line Items]
Number of policies owned (contracts) | Contract		157		157
Life insurance policies with aggregate death benefit		$ 604,800,000		$ 604,800,000
Life insurance estimated fair value		$ 117,400,000		$ 117,400,000
Securities Pledged as Collateral | Red Falcon Trust | Revolving Credit Facility
Debt Instrument [Line Items]
Number of policies owned (contracts) | Contract		157		157
Life insurance policies with aggregate death benefit		$ 604,800,000		$ 604,800,000
Life insurance estimated fair value		$ 117,400,000		$ 117,400,000

XML

Stock-based Compensation - Activity of Unvested Shares of Restricted Stock (Detail) - Restricted Stock	9 Months Ended
	Sep. 30, 2015 shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Common Unvested Shares outstanding, Beginning Balance (shares)	41,060
Granted (shares)	41,259
Vested (shares)	(41,060)
Forfeited (shares)	0
Common Unvested Shares outstanding, Ending Balance (shares)	41,259

XML

Consolidated Statements of Stockholders' Equity - 9 months ended Sep. 30, 2015 - USD ($) $ in Thousands	Total		Common Stock	Treasury Stock	Additional Paid-in Capital	(Accumulated Deficit)
Beginning Balance (in shares) at Dec. 31, 2014			21,402,990	0
Beginning Balance at Dec. 31, 2014	$ 215,103	[1]	$ 214	$ 0	$ 266,705	$ (51,816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(17,105)					(17,105)
Stock-based compensation (in shares)			41,259
Stock-based compensation	429				429
Purchase of treasury stock, net of costs (shares)				65,621,000
Purchase of treasury stock, net of costs	(348)			$ (348)
Common stock issued for rights offering, net of costs (in shares)			6,688,433
Common stock issued for rights offering, net of costs	38,334		$ 67		38,267
Retirement of common stock (shares)			(2,174)
Retirement of common stock	(12)				(12)
Ending Balance (in shares) at Sep. 30, 2015			28,130,508	65,621,000
Ending Balance at Sep. 30, 2015	$ 236,401		$ 281	$ (348)	$ 305,389	$ (68,921)

[1] Derived from audited consolidated financial statements.

XML

Consolidation of Variable Interest Entities

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation of Variable Interest Entities

Consolidation of Variable Interest Entities

The Company evaluates its interests in variable interest entities (“VIEs”) on an ongoing basis and consolidates those VIEs in which it has a controlling financial interest and is thus deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.

The following table presents the consolidated assets and consolidated liabilities of VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated in the Company’s financial statements as of September 30, 2015 as well as non-consolidated VIEs for which the Company has determined it is not the primary beneficiary (in thousands):

	Primary Beneficiary				Not Primary Beneficiary
	Consolidated VIEs				Non-consolidated VIEs
	Assets		Liabilities		Total Assets		Maximum Exposure To Loss
September 30, 2015	$	464,032	$	214,019	$	2,384	$	2,384
December 31, 2014	$	314,062	$	146,254	$	2,384	$	2,384

As of September 30, 2015, 439 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.2 billion and an estimated fair value of approximately $327.4 million were pledged as collateral under the White Eagle Revolving Credit Facility. In accordance with ASC 810, Consolidation, the Company consolidated White Eagle in its financial statements for the three months and nine months ended September 30, 2015 and 2014, and the year ended December 31, 2014.

As of September 30, 2015, 157 life insurance policies owned by Red Falcon with an aggregate death benefit of approximately $604.8 million and an estimated fair value of approximately $117.4 million were pledged as collateral under the Red Falcon Revolving Credit Facility. In accordance with ASC 810, Consolidation, the Company consolidated Red Falcon in its financial statements for the three months and nine months ended September 30, 2015.

XML

Fair Value Measurements - Changes in Life Expectancy Used to Estimate Fair Value of Revolving Credit Facility (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value				$ 145,831
Change in Value		$ 0
Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value		$ 157,946	$ 157,946
+6 Life Expectancy Months Adjustment | Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value			132,093
Change in Value	$ (25,853)
-6 Life Expectancy Months Adjustment | Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Value			$ 182,793
Change in Value	$ 24,847

XML

Stock-based Compensation (Tables)

9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Common Stock Option Activity

The following table presents the activity of the Company’s outstanding stock options of common stock for the nine months ended September 30, 2015:

Common Stock Options	Number of Shares		Weighted Average Price per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Options outstanding, January 1, 2015	807,949		$	8.50	4.48	—
Options granted	—					—
Options exercised	—					—
Options forfeited	(33,555	)	$	8.50	—	—
Options expired	—					—
Options outstanding, September 30, 2015	774,394		$	8.50	3.73	—
Exercisable at September 30, 2015	774,394		$	8.50	3.73	—
Unvested at September 30, 2015	—		—		—	—

Activity of Unvested Shares of Restricted Stock

The following table presents the activity of the Company’s unvested shares of restricted stock for the nine months ended September 30, 2015:

Common Unvested Shares	Number of Shares
Outstanding January 1, 2015	41,060
Granted	41,259
Vested	(41,060	)
Forfeited	—
Outstanding September 30, 2015	41,259

Activity of Performance Share Awards

The following table presents the activity of the Company’s performance share awards for the nine months ended September 30, 2015:

Performance Shares	Number of Shares
Outstanding January 1, 2015	323,500
Awarded	—
Vested	—
Forfeited	—
Outstanding September 30, 2015	323,500

XML

Earnings Per Share - Reconciliation Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2014
Restricted Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	41,259	41,060	41,060
Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	774,394	815,448	815,448
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	6,240,521	6,240,521	6,240,521
Convertible Debt Securities | Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	10,738,165	10,464,491	10,464,491
Performance Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	323,500	299,500	323,500

XML

Segment Information

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Segment Information

Segment Information

On October 25, 2013, the Company sold its structured settlement business, which was previously reported as an operating segment. The operating results related to the Company’s structured settlement business have been included in discontinued operations in the Company’s Consolidated Statements of Operations for all periods presented and the Company has discontinued segment reporting.